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Abstract 
For physiotherapists working in neuro-paediatric gait-rehabilitation, improving motor 
control of the lower extremity is a major focus. Nevertheless, our understanding of 
selective voluntary motor control (SVMC) is in its infancy. This PhD project aimed to 
contribute to close this gap by investigating the nature of SVMC of the lower extremity 
in children with cerebral palsy (CP) and providing a psychometric robust yet sensitive 
measurement instrument for quantifying SVMC. 
The first study investigated the influence of SVMC and other lower extremity and trunk 
motor impairments on gait capacity using multiple regression-analyses. Although 
SVMC was not kept within the final model, these study results revealed the 
importance of SVMC in relation to muscle strength, trunk control and gait capacity. 
The aim of the second study was to establish validity and reliability of the German 
version of the ‘Selective Control Assessment of the Lower Extremity’ (SCALE). 
Although the psychometric properties of the German SCALE were good, information 
about its responsiveness is lacking. Accordingly, a systematic review was carried out 
to identify a SVMC measurement instrument with the highest level of evidence for its 
psychometric properties and best clinical utility. As the findings showed the absence 
of appropriate, responsive SVMC measures, the aim of the last study was to modify 
the existing SCALE to make it more sensitive. Due to the positive findings in relation 
to the psychometric properties of the SCALE, its procedure was combined with a 
surface electromyography Similarity Index (SI). The first validity and reliability results 
of the SCALE-SI are promising and serve as benchmarks when applying the SCALE-
SI in future clinical and scientific practice. However, to use the SCALE-SI as an 
outcome measure for detecting therapy-induced changes of SVMC in children with 
CP, its responsiveness needs to be evaluated in future studies.  
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Chapter 1: Introduction 
1.1 Purpose of chapter 
The aim of this chapter is to describe the practical as well as scientific context in which 
this thesis has been arisen.  
1.2 “Will my child learn to walk normally?” – My ethical and 
professional dilemma 
“Will my child learn to walk normally due to your therapy?” or “Can you teach him to 
walk normally?” These kinds of questions are common questions parents asked me 
during the rehabilitation stay of their child at our rehabilitation centre in Affoltern am 
Albis in Switzerland. Although our centre is specialized in neuro-paediatric 
rehabilitation and I am a physiotherapist specialized in rehabilitating children’s gait, 
the answer to such questions cannot easily be given. Of course, as a therapist, I wish 
to answer these questions in an honest and clear way. Mainly to save parents and 
their child from having unrealistic therapy aims and thereby wasting their time. Exactly 
this ethical and professional dilemma became the starting point of my thesis. Firstly, 
this dilemma led me to search for practical as well as scientific facts which would 
guide me to an answer. During my practical work, I discovered that improvements of 
selective voluntary movement control (SVMC) of the lower extremity, as one 
fundamental prerequisite for a physiological gait pattern, could be achieved in some 
patients but not in others, or only to a minimal degree. Discussions with my colleagues 
supported this clinical observation. Nevertheless, the standard problem we 
experienced was how to measure changes in SVMC objectively and accurately. A 
robust, e.g. valid, reliable and responsive, as well as sensitive outcome measure for 
SVMC was necessary.  
Scientific literature revealed similar positive intervention trends regarding the 
trainability of SVMC, but also the lack of robust outcome measure. As there is no gold 
standard for measuring SVMC, a variety of measures, have been applied in these 
intervention studies, often with unknown psychometric qualities.  
On the assumption that improved SVMC would contribute to the 'normalisation' of the 
child’s gait pattern, the aim of my PhD was born: to find a validated instrument to 
measure therapy-induced changes of SVMC of the lower extremity in children with 
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CP. The following paragraphs contain a detailed introduction to the topic of SVMC 
and the structure of this PhD, thereby explaining the various difficulties associated 
with predicting the probability of improving gait function and quality though 
physiotherapy. 
1.3 Motor control problems in children with cerebral palsy 
“Cerebral Palsy (CP) describes a group of permanent disorders of the development 
of movement and posture, causing activity limitations that are attributed to a non-
progressive disturbance that occurred in the developing foetal or infant brain. The 
motor disorders of cerebral palsy are often accompanied by disturbance of sensation, 
perception, cognition, communication and behaviour, by epilepsy and by secondary 
musculoskeletal problems.” (Baxter et al. 2008). With an incidence of 2 to 2.5 per 
1000 children born alive (SCPE 2000), CP is the most common childhood motor 
disorder (Baxter et al. 2008). There are various neuropathological causes for CP (e.g. 
perinatal stroke, hypoxia-Ischaemia, encephalopathy, cerebral malformation), which 
can affect different areas of the brain (Dan et al. 2014). Depending on the 
neuropathology and injured neuroanatomical structure, motor control is disturbed to 
various extents, and different motor function impairments occur. From a motor control 
perspective, CP can be seen as a group of movement disorders which is primarily 
caused by impaired cortical control, andfurther restricts the central as well as 
peripheral sensori-motor system (Rosenbaum 2014). Therefore, the motor 
development of children with CP is disturbed and delayed. Primarily, the lesion in the 
white matter disrupts the cortico-cortical and cortico-spinal pathways and thereby 
impede the child’s motor control (Forssberg 2014). Due to injured cortical structure, 
the cortical motor output cannot reach the motor neurons in the spinal cords. This 
leads to a further alteration of the spinal interneuron networks, causing disturbed 
motor output as well as pathological changes within the muscle (Rose and McGill 
2005; Miller 2007). Consequently, the child has problems with learning and executing 
movements in a coordinated, physiological way. Developmentally, this lack of 
coordination leads to further alterations in the maturation of the corticospinal-tract 
(Forssberg 2014; Peacock 2009). While in neurologically intact children the bilateral 
corticospinal projections from the motor cortex to the extremity change into a 
contralateral projection within in the first year (of living), this maturation process is 
disturbed in children with CP (Eyre et al. 2001; Carr et al. 1993; Staudt 2007). 
Clinically, these alterations in cortical control make it difficult for the child to selectively 
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activate one muscle or muscle group. Co-movements (simultaneous movements of 
adjacent joints of the ipsilateral side) and/or mirror-movements (simultaneous 
movements of the contralateral joint), as well as mass-patterns (e.g. extension-
pattern: simultaneous hip, knee and foot extension) will occur and restrict the child’s 
goal-directed movement (Cahill-Rowley and Rose 2014; Fowler 2010). For instance, 
selectively extending the knee and simultaneously dorsiflexing the ankle – as required 
for initial contact during gait  – can be disturbed by a mass extension pattern, which 
leads to the simultaneous extension of the knee and the ankle, resulting in an 
“equinus” gait pattern (Gage et al. 2009). Furthermore, this impaired motor control is 
connected with the appearance of other upper motor neuron (UMN) lesion signs such 
as hypertonia, hyper-reflexia, muscle weakness, sensory disturbance, and sensory 
deficits (Cahill-Rowley and Rose 2014; Carr 2014; Miller 2007; Sanger et al. 2006). 
All these UMN lesion signs can reinforce each other, hampering motor control and 
development of the child even more and furthermore leading to the occurrence of 
secondary deformities (e.g. contractures) (Gage et al. 2009; Peacock 2009; Miller 
2007). This interconnection between SVMC and other UMN signs (spasticity, muscle 
weakness, sensory deficits, balance problems) in children with CP makes it 
challenging for a therapist to measure and treat SVMC separately from other UMN 
impairments (Cahill-Rowley and Rose 2014; Dobson 2010). As a clear distinction of 
SVMC from other UMN signs is fundamental for the valid measurement of SVMC, 
these issues are addressed in more detail in section 2.2 on the neurophysiological 
background of SVMC in CP. 
1.4 Importance of physiotherapy in training motor control 
In neuro-rehabilitation, one major physiotherapeutic goal is to restore the patient’s 
motor control as best as possible to maximize participation in society and quality of 
life (Mayston 2014; Miller 2007; Gage et al. 2009). Especially in children with CP, 
medical, therapeutic and financial health-care efforts are high in order to reach the 
best possible outcome. Due to the congenital nature of the brain lesion, patients can 
benefit from natural development and brain plasticity during rehabilitation which can 
enhance their motor recovery (Mayston 2001). On the other hand, as a diagnosis of 
CP is commonly associated with a normal or near normal lifespan, these patients are 
vulnerable to develop secondary deformities and chronic pain. Due to a combination 
of altered developmental growth factors (e.g. endocrine factors) and impaired motor 
control, biomechanical loading of muscles and bones is altered during movement and 
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posture right from the beginning of life. Over time, this non-physiological 
biomechanical stress causes muscle contractures and/or bony deformities to develop 
(Miller 2007; Gage et al. 2009). These contractures can worsen over time and thereby 
limit the child’s movement ability even more. This vicious cycle of impaired motor 
control and growth can cause pain and limit the patient’s quality of life. In many 
patients, (multiple) surgeries may be required during childhood/puberty (and 
adulthood) in order to realign muscles and bones physiologically and to relieve pain. 
Considering these two aspects, intensive rehabilitation and gait-therapy in children 
with CP are medically and economically essential. 
Since the work of Berta and Karel Bobath and other pioneers within neuro-
physiotherapy, several therapy concepts were developed and aimed to (re-)train 
physiological movements in patients with central nervous system lesions (Levin and 
Panturin 2011; Barber 2008; Mayston 2014). At its earliest inception, the Bobath 
concept focused on regaining normal movements through re-education. Its key 
techniques, namely therapeutic handling, facilitation, and activation of key points of 
control, aimed to improve patients’ motor control while using the different stages of 
normal motor development as guidance. Although this approach arose from their best 
intention (e.g. reducing the risks of secondary deformities) and the available 
knowledge at that time, new information about motor learning and neuroplasticity 
evolved and led to the new paradigm “Activity, activity, activity” (Damiano 2006). This 
paradigm promoted a shift from traditional and strict Bobath approaches to a proactive 
approach of promoting activity through more intense active training protocols, lifestyle 
modifications and mobility-enhancing devices (Mantovani and Scrutton 2014). 
Research showed that allowing children with CP to be more active and to move more 
while accepting compensatory/non-physiological movements resulted in improved 
physical and mental health (Mayston 2014). Although, nowadays the new “Activity” 
paradigm (has) arrived within neuro-paediatric physiotherapy, therapists are still 
challenged by the balancing act between allowing the patient to be more active, 
teaching physiological movement patterns, and preventing secondary impairments. 
As these secondary impairments (e.g. contractures) are known to develop as 
consequences from moving within non-physiological movement patterns, teaching a 
patient physiological movement patterns is still of importance (Vos et al. 2016; Levin 
2010; Voorman et al. 2007). If a patient, for instance, is not able to selectively activate 
the quadriceps to achieve full knee extension in gait, a knee-flexion contracture might 
develop, which hampers the ability to stand and walk even more. In the long term, 
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walking with a flexion contracture will lead to altered muscle-bone alignment and 
muscle insufficiency and may cause chronic pain. Consequently, this vicious cycle, 
which originated from impaired motor control and development, frequently results in 
reduced motor activity (Miller 2007; Gage et al. 2009).  
Despite these extensive clinical consequences of impaired SVMC and the traditional 
therapeutic interest in its training, scientific investigation of the efficacy of 
physiotherapy interventions to improve selective muscle activation has only started 
recently. The first of these studies have shown that SVMC of the lower extremity has 
improved as a result of Functional Electrical Stimulation (FES) and virtual reality 
enhanced (robotic) training as well as due to medical spasticity reduction (e.g. 
Botulinum-toxin, Selective Dorsal Rhizotomy) in combination with conventional 
physiotherapy (Rios et al. 2013; Sukal-Moulton, Clancy, L.-Q. Zhang, et al. 2014; Cioi 
et al. 2011; Approach 2011; Prosser et al. 2012; Bandholm et al. 2009; Damiano et 
al. 2012). Furthermore, research into the mechanisms of neuroplasticity supports the 
trainability of SVMC in neurologically impaired patients (Forssberg 2014; Nudo 2013; 
Caeyenberghs et al. 2010; Everaert et al. 2010). The lack of a psychometrically sound 
gold standard measure or agreed core-set of outcome measures for SVMC may be 
an important reason for this gap in the physiotherapy literature. It is our professional 
duty to close this gap of evidence, in order to ensure our clients and their family the 
best possible treatment. Only by the means of valid, reliable and responsive 
measurement tools, we will be able to investigate the efficacy of treatment approaches 
aiming to improve motor control. Accordingly, the next paragraph will explain the 
different types of measures and how their quality can be evaluated. 
1.4.1 Outcome measurement within neuro-paediatric physiotherapy 
Measuring and evaluating intervention outcome(s) is the cornerstone of good clinical 
and scientific practice. Although this statement sounds clear and logical, 
implementation into clinical and research practice is often not that straight forward. 
Often the professional is confronted with the challenge to find “the right tool for the 
job” (Rosenbaum 2014). If it is the interest to measure the effectiveness of an 
intervention, the purpose of the measure is to detect a change in the outcome of 
primary importance on the body functions and structures, activity or participation 
domains according to the International Classification of Functioning Disability and 
Health (ICF) continuum (Wright and Majnemer 2014). Furthermore, the level of 
measurement (e.g. ordinal, interval) needs to be equivalent to the expected change 
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of the intervention within the population of interest (Portney and Watkins 2000). 
Additionally, the measurement tool needs to have good psychometric properties (De 
Vet et al. 2011). Psychometric properties describe the measurement properties such 
as the internal consistency, reproducibility or reliability, validity and responsiveness of 
the outcome measure (De Vet et al. 2011).To help researchers and clinicians with the 
evaluation of psychometric properties, the COSMIN initiative (COnsensus-based 
Standards for the selection of health Measurement INstruments) provides a 
consensus about the terminology and definitions of these measurement properties 
and guidelines for their evaluation (Mokkink and Terwee 2010). Only by precisely 
knowing the benefits and limitations of the outcome measured used, appropriate 
evaluation of the intervention will be possible. A discussion of the evaluation of 
psychometric properties in accordance with the COSMIN guidelines will be presented 
in greater detail in chapter 2, as these are fundamental for this thesis.  
Although within the last years the number of measurement tools within the field of CP 
has increased in all domains of the ICF, there are still some outcome measures 
missing or their psychometric properties have not sufficiently been evaluated yet 
(Wright and Majnemer 2014; Mayston 2001). This seemed to be the case for a tool 
which measures therapeutically induced changes of SVMC of the lower extremity in 
children with CP. Therefore, the overarching aim of this thesis is to identify or to 
develop a psychometrically sound outcome measure for this purpose.  
1.5 Structure of thesis 
The thesis is structured as followed (Figure 1). The background chapter is divided into 
two main sections: Section one presents a detailed description of the population of 
interest with a focus on the pathophysiology of impaired SVMC and its functional and 
therapeutically consequences. Section two will summarise common problems when 
measuring SVMC, furthermore it will define relevant psychometric property quality 
criteria for outcome measures.  
Chapter 3 presents the methods and results of the first study. This study investigated 
the influence and the relevance of SVMC and other UMN motor impairments on gait 
capacity in children with CP. A description of the second study, which dealt with the 
translations and validation process of a recently developed clinical tool for the 
assessment of SVMC (“Selective Control Assessment of the Lower Extremity” 
(SCALE)) of the lower extremity in children with CP into German, is described in 
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chapter 4. The methods and results of a systematic review of the psychometric 
properties of measurement tools for SVMC of the lower extremity in children with CP 
are presented in chapter 5. In chapter 6, validation and reliability of a newly developed 
outcome measure for SVMC (SCALE-Similarity Index (SI)) is described. 
The final discussion chapter brings together the conclusions from each study and 
presents their implications in the context of neuropediatric gait-rehabilitation and 
research. Moreover, it relates to the start-up question of this PhD-project: “Will my 
child learn to walk normally due to your therapy?” 
 
Figure 1: Structure of thesis: 
Following a description of the theoretical background in relation to CP, SVMC and psychometric 
properties of outcome measures, the four studies, which have been carried out within the scope of this 
thesis, will be presented. The thesis ends with an overall discussion and conclusion.   
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Chapter 2: Chapter: Background 
2.1 Purpose of chapter 
The purpose of this chapter is to summarise the existing evidence as well as to identify 
gaps of knowledge in relation to the measurement of SVMC in children with CP. 
Findings in literature in relation to the focus of this thesis will be discussed to support 
the rationale behind this thesis. Consequently, the research questions will be 
presented.  
2.2 Cerebral Palsy and selective voluntary motor control (SVMC)  
In the “International Statistical Classification of Diseases and Related Health 
Problems” (ICD) diagnosis code, cerebral palsy is defined as  
“(G80) A group of disorders affecting the development of movement and posture, often 
accompanied by disturbances of sensation, perception, cognition, and behaviour. […] 
A heterogeneous group of non-progressive motor disorders caused by chronic brain 
injuries that originate in the prenatal period, perinatal period, or first few years of life. 
The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with 
spastic forms being the most common. The motor disorder may range from difficulties 
with fine motor control to severe spasticity (see muscle spasticity) in all limbs. […] 
Pathologically, this condition may be associated with leukomalacia periventricular. 
[…]”(CD-10-CM 2018).  
Although CP is a clinical diagnose, its diagnosis differs from other neurodevelop-
mental conditions, as accurate/sensitive diagnostic tests are missing (Rosenbaum 
2014). Therefore, CP is better understood as an umbrella term for a heterogeneous 
group of developmental movement and posture impairments affecting the child’s 
independence. The following paragraph’s aim is to explain the epidemiology and 
aetiology of this group of motor disorders with a specific focus on the underlying 
pathophysiology and functional consequences of their impaired motor control. 
2.2.1 Epidemiology of cerebral palsy 
As the confirmation of the clinical diagnose of CP relies more on the systematic clinical 
observation of the child’s motor development and less on pathognomic findings or 
laboratory test, collecting epidemiological data is challenging (Rosenbaum 2014; 
Eunson 2016). Furthermore, as CP is associated with an increased risk of infant 
mortality especially in low- and middle-income countries, information about its 
frequency and risk factors in those countries might be incomplete. Despite these 
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limitations, the fowling findings regarding the prevalence of CP can be summarised 
from the literature (Oskoui et al. 2013):  
 With an overall birth prevalence of around 2 per 1,000 live births, CP is the 
most common childhood disability of high-income countries (Eunson 2016). 
 CP has a higher prevalence in more deprived socio-economic populations 
(Rosenbaum 2014). 
 Although maternal and neonatal health care has improved worldwide during 
the last 40 years, the incidence of CP is stable and the number of children with 
more severe forms of CP has even increased. The latter results from the 
improvement in neonatal-care, which increased survival of the number of 
extremely premature infants (Baxter et al. 2008).  
 The strongest risks factors for developing CP are: 
- prematurity: born before week 28 of gestation, 
- low birth weight (e.g. small for gestational age infants), 
- twins or higher multiple births, 
- perinatal infection, 
- infants that are in poor condition at birth, 
- advanced maternal age and low maternal education attainment, 
- genetic preposition: autosomal recessive syndromes, usually in associa-
tion with microcephaly and learning difficulties (e.g. mutation in a 
Prothrombin gene which confers a mildly increased risk of hemiplegic 
cerebral palsy). 
2.2.2 Aetiology of cerebral palsy 
The aetiology of CP should be regarded as a sequence of causal factors occurring in 
series or in parallel, whichultimately lead to a damaging event(s) to the developing 
brain. The above-mentioned risks factors are not the causing factors for the brain 
lesion but may play a variable role in the causal pathway. For instance, prematurity is 
not the cause of CP, but a preterm infants has a higher risk to experience hypoxia-
ischemia, which is causative for the brain damage. The following (series of) pathways 
are known to be causative for development of CP (Dan et al. 2014; Badawi and Keogh 
2013):  
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 Cerebral malformations (1:100 birth; e.g. microcephaly; pachygyria, 
lissencephaly). Any malformation of its cortical sensorimotor system will lead 
to problems in volitional motor function.  
 Focal cerebrovascular disease (e.g. perinatal stroke), which can be caused by 
a blockage (ischemia) or a rupture (haemorrhage) and occur within a 
timeframe from perinatal until the neonatal period (up to 28 days after 
delivery). This is the most common cause for unilateral CP in term-born 
children (Hadzagic-Catibusic et al. 2017).  
 Hypoxia-ischemia and cerebral perfusion failure combined or followed by a 
neonatal encephalopathy, which lead to an increased vulnerability of the grey 
matter and acute hypoxia-ischemia. This type of injury is responsible for most 
cases with dyskinetic CP (not for spastic CP). 
 Endogenous (e.g. bilirubin) or exogenous neurotoxins, which lead to perinatal 
brain injury (e.g. kernicterus), often affect the extrapyramidal function as well 
and lead to dystonia or choreoathetosis type of CP. 
 Any prenatal, perinatal/intrapartum or postnatal maternal-foetal infections (e.g. 
placenta infection), different viruses (e.g. cytomegalovirus which causes 
multiple intracranial pathologies), bacterial or parasitic infections, which can 
directly or indirectly contribute to the pathogenesis of CP and are, moreover, 
common lesions to the white matter. 
 Endocrine causes, like the maternal thyroid hormone insufficiency (endemic 
cretinism), which is known to result in perinatal brain damage in the foetus and 
results in syndromes that resemble bilateral CP. Postnatal glucocorticoids 
treatment in preterm infants, which used to prevent chronic lung diseases, 
have shown to disturb normal brain growth and development as well.  
2.2.3 Classification of cerebral palsy 
One or a combination of factors listed above can lead to the development of CP. The 
severity of impairment of an individual child depends on the timing of the injury, the 
size and location of the brain damage (Baxter 2007), explaining the great 
heterogeneous clinical experiences within this patient group. To diagnose and help 
with the classification of these patients, the “Surveillance of Cerebral Palsy in Europe” 
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(SCPE 2013) offers a decision tree. According to this guideline, a child with CP is 
characterized by his/her topography of the involved body parts (uni- or bilateral 
involvement) as well as by his/her predominant tone abnormality (spastic, dyskinetic 
(with dystonic or chorea athetoid) and ataxic). The use of these classifications 
systems (Figure 2) allows to furthermore (theoretically) distinguish between the 
underlying pathology of these tone abnormalities and their motor impairments. 
 
Figure 2: Surveillance of Cerebral Palsy in Europe (2013): Classification tree for sub-types of CP 
The spastic group, which is the largest group (70-80%) within CP, is characterized by 
abnormal movement and/or posture, due to increased tone and pathological reflexes. 
These symptoms are caused by damage to the white matter (periventricular 
leukomalacia (PVL)) and are referred to as an UMN lesion. This cortical damage 
hampers the physiological neural-inhibition via the corticospinal tract (CST), causing 
an increased neuronal excitability throughout the nervous system (Ludeman et al. 
2008; Hoon et al. 2010; Lee et al. 2011; Glenn et al. 2007). Due to this impaired 
inhibitory function of the pyramidal tracts, the ability of some nerve receptors in the 
spine to properly receive gamma amino butyric acid is impaired. This leads to an 
increase of tone (hypertonia) in the muscles innervated by the affected pathways 
(Fowler 2010). Often, the muscles of the arms and legs are affected. The tongue, 
mouth and pharynx can be affected as well, which will affect speech, eating, 
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swallowingand breathing (Kesar et al. 2012; Wittenberg 2009). Spastic CP is 
described in combination with the topography that describes which limbs are affected, 
such as spastic unilateral or bilateral CP (Baxter 2007).  
The other two forms of CP dyskinetic and ataxic have an extrapyramidal origin, 
meaning that CNS structures outside the cortex are affected (Bax et al. 2006). This 
type of CP is present in only in 20-30% of the children with CP. Dyskinetic CP is 
characterized by abnormal movement and/or posture, which are of involuntary 
character (uncontrolled, recurring, occasionally stereotyped movements). Patho-
physiologically, the nuclei in the basal ganglia are known to be vulnerable to a bilirubin 
encephalopathy as well as to a hypoxic-ischemic brain injury, mainly causing this type 
of CP (Rosenbaum 2014). There are two sub-types of dyskinetic CP: dystonia and 
choreoathetosis. Dystonia is characterised by involuntary muscle activation patterns 
that result in slow twisting or repetitive movements, or abnormal sustained postures, 
that are triggered by attempts to move. The term athetosis describes involuntary, 
slow, continuous movements, which are present at rest and made worse by attempts 
to move. People with athetosis experience fluctuations in muscle tone – with muscle 
tone alternating between being floppy (hypotonia) and extremely variable movements 
(hyperkinesis) making it difficult to maintain a certain posture.  
Damage to the cerebellum is the main underlying factor for ataxic CP (Bax et al. 
2006). This subgroup is characterized by abnormal movement patterns and/or 
postures, where movements are carried out with abnormal force, rhythm and 
accuracy. People with ataxia often experience problems with the balance during 
walking and with theircontrol of eye movements, eye-hand coordination and speaking. 
2.2.4 Underlying pathophysiology of impaired SVMC in children with CP 
As explained above, control of movement and/or posture is impaired in all sub-types 
of CP. Nevertheless, the clinical appearance of impaired motor control, as well as 
their underlying pathologies differ between sub-types. While children with a lesion to 
extrapyramidal structures have more problems with the overall coordination and 
smoothness of movements during rest or while moving (i.e. dyskinesia subtype), 
children with a primarily pyramidal lesion (i.e. spastic subtype) experience more 
problems with the selective activation of a specific muscle or muscle group 
(Rosenbaum 2014; Baxter et al. 2008; Bax et al. 2006). An expert consensus group 
has defined SVMC as the "ability to isolate the activation of muscles in a selected 
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pattern in response to demands of a voluntary movement or posture" (Sanger et al. 
2006). The term ‘voluntary' within SVMC emphasizes the deliberate performance of 
selected muscle activation during functional tasks (Fowler 2010). As timing, force and 
speed of voluntary muscle activation are controlled through the CST and its structural 
and functional connections to other brain areas, damage of the CST is known to 
causes a loss of selective motor control (Rothwell 1987; Porter and Lemon 1993). 
How its altered function may negatively influence selective motor control in children 
with CP will be described and discussed in detail below. In the next section, the 
following four main points will be discussed with regard to the pathophysiology of 
SVMC: i) development and maturation of the CST; ii) motor cortex mapping; iii) CST 
networking and iv) sensory input and feedback. 
2.2.4.1 Maturation, functioning and impairment of the corticospinal tract  
The CST is a white matter motor pathway, which originates in the cerebral cortex and 
descends to alpha motor neurons and interneurons in the spinal cord. Neurons of the 
CST are UMNs that directly control muscle activation and thereby movement control. 
Structurally, the CTS consists of different parts: the crossed lateral CST, the 
uncrossed lateral CST, and the uncrossed anterior (ventral) CST. Some authors even 
report a fourth, the crossed anterior CST (Nathan, Smith and Deacon 1990). Although 
the functions of these different parts of the CST are known to differ, the exact 
functional role of each CST is still discussed and investigated. Overall, the CST is 
associated with the acquisition of (dexterous) motor skills. As the crossed lateral CST 
occupies 75–90% of the CST fibres, extending caudally to the dorsolateral fasciculus 
to the last sacral segment after crossing the medulla, it is the largest tract that 
iscontrolling mainly distal muscles (i.e. finger, ankle) involved in fine motor 
movements. Proximal muscles of the upper extremity as well as trunk and neck 
muscle are thought to be controlled by the uncrossed anterior CST (5-15% fibres of 
the CST) and other neural tracts, such as the cortico-reticulospinal tract (Jang 2014). 
Additionally, there is some evidence that together with the cortico-reticular tract, the 
anterior CST is involved in walking and postural control (Jang et al. 2013, Barthélemy 
et al. 2011). The function of the uncrossed anterior CST, which descends within the 
lateral funiculus and is located ventrally to the crossed lateral CST, has been 
suggested as a motor recovery pathway (Jang 2014). Following an injury of the lateral 
CST, it functions as an ipsilateral motor pathway from the unaffected motor cortex to 
the affected extremities together with the cortico-reticulospinal tract (Jang et al. 2013; 
 14 
Staudt 2007). Growth and devolvement of the CST tract within the spinal cord, as well 
as maturation of connectivity of these neurological structures, are explained in the 
next paragraph. 
a) Development and maturation of the CST 
Before the first CST axons invade the spinal cord, proprioceptive axons reach the 
intermediate grey matter of the spinal cord. This occurs at 7.5 weeks post-conception 
(Clowry 2007). Next, the motor neurons are innervated around 8.5-9.5-week post-
conception. This afferent ingrowth and increased density of axodendritic synapses 
can be observed intrauterine in the foetus, as movement shifts from spontaneous 
holokinetic movements into stimulus-evoked ideokinetic movements around the 8.5 
weeks post-conception (Welniarz, Dusart and Roze 2017). With full innervation of the 
ventral horn, the monosynaptic reflex arc is established around 14 weeks post-
conception. After muscle afferent input is completed, CST axon projection from the 
cortex to the spinal cords begins around the 17th-week post-conception. First CST 
fibres invade the grey matter around weeks 20 to 27, and fully innervate the ventral 
horn until the 35th-week post-conception (Welniarz, Dusart and Roze 2017). At the 
age of 2 years and under normal development, the synaptic network of the CST in the 
spinal cord with alpha motor neuron and the interneurons, as well as myelination of 
the tract is completed (Welniarz, Dusart and Roze 2017; Jang 2014; Clowry 2007). 
During this time, the CST and spinal cord undergo refinement of connectivity, 
eliminating polyneural innervations of muscles, into more selective ones. This 
refinement involves subsequent synaptic withdrawal as well as strengthening of 
repetitively activated connections (Welniarz, Dusart and Roze 2017; Clowry 2007). 
Selectivity of this neural refinement is an activity-dependent neuroplastic process, 
which involves structural as well as neurotransmitter modulation (Clowry 2007). 
During this critical developmental period of CST maturation, a high activation of N-
methyl-D-aspartate receptors has been observed, which regulates dendrites growth 
as well as it eliminates gap junctions between motor neurons. CST ingrowth further 
triggers upregulation of parvalbumin expression, which promotes inhibitory synapse 
formation. Due to these processes’ afferent, input into the ventral horn is subsequently 
reduced and inappropriate heteronymous connections are further reduced (Clowry 
2007).This improved neural refinement can clinically be observed, for instance in the 
occurrence of more mature (slower onset and greater threshold) stretch reflex 
response, upper-extremity fine-motor movements and independent walking in one-
 15 
year-old toddlers (Welniarz, Dusart and Roze 2017; Clowry 2007). If, however, CST 
damage occurs within in this critical period of developmental, the segmental and 
circuitry refinement is disturbed, which is known to alter motor development and 
control permanently (Welniarz, Dusart and Roze 2017; Clowry 2007; Staudt 2007). A 
developmental lesion of the cortex will alter innervation as well as gene expression of 
the spinal cord, resulting in a large number of muscle afferents in the ventral horn. In 
the activity-dependent competition for synaptic spaces within the spinal cord, 
physiological elimination of these muscle afferents is hindered by altered cortical 
activation in favour of more appropriate synaptic formation. This pathophysiological 
dominance of muscle afferents in synaptic space has been shown in several animal 
studies (Clowry 2007). These studies showed that unilateral inhibition of one cortex 
during this critical developmental period resulted in less active projection of the injured 
cortex, as well as it increased inappropriate activity from the ipsilateral spared cortex. 
When on the other hand muscle afferent activity was reduced, for instance by the 
means of BTX injection, studies in kittens showed that this resulted in fewer 
contralateral synaptic connections with CST axons (Martin et al. 2004). This suggests 
that synaptic refinement within the spinal cord can only happen when both segmental 
(peripheral) and descending (central) pathways serve to reinforce connectivity. 
Applying this finding to children with cerebral palsy explains why gaining adequate 
motor control is more difficult for them as compared to their normally developing 
peers. Firstly, due to their brain lesion, the output of their descending pathways is 
reduced, which in turn results in diminished movements (Staudt et al. 2003). 
Secondly, this diminished CST output results in non-physiological movement as well 
as in overall reduced motor activity and thereby in decreased segmental input 
(proprioception) required for refinement of synaptic connections. Furthermore, as the 
brain damage in children with CP often also affects the developing brain, their 
movement might be altered and reduced already intra uterine (Campbell et al. 2018). 
The overall effect is a distributed neuro-motor-control-circuit from cortical output and 
input. For instance, children with prenatal brain lesions show less frequent and more 
mass movements intrauterine (Horimoto et al. 1993). Postnatally, within the first 
month of development, this can further be observed by a paucity of leg movements, 
prolonged, monotonous kicking and less purposeful leg control (Campbell et al. 2018; 
Heathcock et al. 2005; Fetters et al. 2004). Another study comparing the acquisition 
of motor control between infant born preterm and term-born infants showed that 
preterm born infants require significantly more time to learn that their kicking can affect 
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movement of a mobile-play (Heathcock et al. 2004). Furthermore, the time window in 
which the decoupling of the movement of intra-limb joints is learned and which is a 
prerequisite for more complex purposeful movements, is prolonged in pre-term infants 
(Heathcock et al. 2004). 
b) Motor cortex mapping 
Early during brain development, corticospinal neurons can be found throughout the 
frontal, parietal, occipital and temporal lobes. However, through the development and 
refinement process of CST and spinal cord described above, the distribution of these 
neurons becomes restricted to the posterior frontal and anterior parietal lobes 
(Nathan, Smith and Deacon 1990). These cortical areas are associated with the 
primary motor cortex (M1), secondary motor area and somatosensory cortex.  
The understanding and definition of the different motor areas within the motor cortex 
started in 1870 by electrical stimulation experiments from Hitzig and Fritsch. They 
demonstrated that exciting the motor cortex in a dog could evoke muscle twitches. 
Within the same year, Ferrier did similar experiments with monkeys. In contrast to 
Hitzig and Fritsch, these experiments resulted not only in muscle twitches but also in 
more complex body movements. Ferrier concluded that the motor cortex controls 
complex features of movement rather than muscles per se, as Hitzig and Fritsch were 
suggesting (Rothwell 1987). Since then, these controversial findings have been 
discussed by many other researches within the field and are often phrased as the 
"muscles versus movement" debate (Philips 1975). One explanation for the diversity 
in findings is related to the difference in the electrical stimulations performed in these 
experiments: Stimulation of almost any area of the cortex (with sufficient intensity and 
under the appropriate conditions) can evoke complex movement. Although today, the 
true mosaic representation of CST, which favours a very selective muscle activation 
(i.e. comparing the motor cortex with the keys of a piano), is replaced by a notion of 
overlapping organization of CST cells, consensus with regard to the CST organization 
is still lacking. For instance, one group (Asanuma, Larsen and Yumiya 1980) suggests 
that the cortical neurons controlling a single muscle are focally arranged in a so-called 
interconnected cortical "efferent zone" in M1. In contrast, Phillips and Porter (1977) 
speak of CST neuron "colonies" for different muscles, which can overlap extensively 
within this cortex and form a ‘discrete’ or ‘mosaic’ fine-grained structure of cortico-
motor neuronal output (Omrani et al. 2017; Rathelot and Strick 2006). Others argue 
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that the primary motor cortex should be regarded as a dynamic machine, which does 
not directly code for movement parameters, but instead should be understood in terms 
of the rules that govern its pattern generation (Kaufmann et al. 2016; Graziano et al. 
2002). 
The primary motor area of this so-called M1 was found to be the largest of those three. 
Anatomically, it is laying along the precentral gyrus (Rothwell 1987). According to its 
map, movement control of the lower extremities is activated by the most medial parts, 
whereas movement of the upper extremity and face are located in the most lateral 
parts (Fig 3). In addition to this so-called medio-lateral projection, there is also a 
rostral-caudal gradient, as movements of the distal body parts are nearest to the 
central sulcus, whereas proximal body parts are represented more rostrally. Beside 
the different M1 locations, the relative size of areas devoted to movement of particular 
body parts differs. For instance, cortical areas of distal and fine-tuned movements (i.e. 
finger, hand, tongue) have a much larger representation than those of body parts of 
more proximal and gross motor movements. In order to selectively control these distal 
joint movements more, cortical output cells to the muscles and the local interneurons 
are needed, thereby engrossing a larger area. Graphically, this phenomenon is 
visualized by the so-called homunculus (Rothwell 1987).  
Next to M1, the most lateral part of the precentral gyrus, the secondary motor area 
(M2), is extending into the lib of the Sylvian fissure. Body representation of the M2 is 
the reserved version of M1. Compared to M1, M2 has been investigated less and its 
exact functioning is still being explored. Today, its role is mainly described in linking 
sensory cues to motor actions and thereby enabling adaptive choice behaviour 
(Barthas and Kwan 2017).  
The third motor area, which is termed the supplementary area (SMA), is rather than 
M3 found on the medial surface of the hemispheres. It differs from M1 in four main 
aspects: i) its threshold for stimulation is higher, ii) its somatotopic representation is 
poor; iii) its activation results in eliciting complex multi-muscle and –joint movements 
as well as iv) its activation is mainly bilateral. Functionally, it is therefore associated 
with movement's maintaining postural control and closely connected to other brain 
areas (Ruan et al 2018).  
 18 
In conclusion, due to the functional complexity of even normal motor control, a 
prediction of the nature of a certain impaired motor outcome by solely identifying the 
impaired underlying brain structure (somatotopic) is too simple.    
Nevertheless, the general structure and function of the motor cortex as described 
above, might help to explain certain clinical symptoms, for instance the occurrence of 
a phenomena called “proximal-distal-concordance”. This describes the increased 
distal impairment of lower extremity motor function in comparison to more proximal 
joints. As this phenomenon is mainly observed in children with spastic CP, it is thought 
to be related to impaired CST functioning following a PVL (Baxter 2007; Bax et al. 
2006). The PVL is characterized by multifocal cortical white matter necrosis and often 
occurs during the period with the greatest vulnerability of the brain somewhere 
between 26and 34 weeks of gestation (Beaulieu and Schneider 2013; Rha et al. 2012; 
Lee et al. 2011; Thomas et al. 2005; Staudt et al. 2003). As the CST fibres supplying 
the lower extremities and distal joints lie closest to the periventricular area (Fig 3), 
these fibres are more likely to be damaged than those providing more proximal joints 
(Staudt et al. 2003; Glenn et al. 2007). 
 
Figure 3: Periventricular Leukomalacia and somatotopic organisation of the motor cortex, showing 
the close proximity of the lesion, CST and motor cortex 
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c) CST Networking 
As discussed above, movement control cannot sufficiently be predicted by motor 
cortex representation (e.g., homunculus) alone. Although the CST itself might be 
considered a critical structure for motor control, research has shown that impaired 
motor control does not only occur due to a pure lesion of this structure alone (which 
is quite rare), but rather due to impaired CNS networking (Rothwell 1987). For 
instance, shortly after the experimental bilateral pyramidotomy in monkeys, these 
animals show normal gross motor movements (sitting, running, climbing, head 
control) (Lawrence and Kuypers 1986). They only experience problems in fine motor 
control of the fingers and hand (i.e. pinch grip for picking up food). Structurally, this 
explanation is reflected in the presence of direct monosynaptic (cortico motor neuron) 
projections from the CST, as well as polysynaptic ones and its collaterals to other 
structures of the central nervous system (i.e. brain stem, cerebellum, spinal cord). 
This network action or in-concert action of the CST with other brain structures is also 
evident in humans and will be described in the next two sections in relation to studies 
on gait control and the disappearance of mirror movements.  
Studies investigating motor control of walking in acephalic children have shown that 
the CST is not responsible for initiating and activating synergistic stepping patterns 
but might be more accountable for fine-controlling joint movements, especially around 
distal joints. This observation shows that intact midbrain structures, which are the 
origin of the rubrospinal tract (RST), seem to be responsible for the activation of a 
more stereotyped stepping movement (Hicks and Onodera 2012; Yeo et al. 2012; 
Yang et al. 2011). If both tracts are working functionally together under normal 
physiological conditions, the fine-tuning of the walking pattern is possible.  
Regarding the natural maturation process of learning to supress mirror movements 
(i.e. simulations movement of the contralateral joint), studies have shown that 
adequate cortico-cortical connections (networking) are required. Mirror movements 
can be observed in young children (under the age of 10 years), when ask to perform 
difficult movements. Neurophysiologically, the interhemispheric inhibition between the 
two M1s via the corpus callosum has not yet been sufficiently established in young 
children and thus allow bilateral cortical activation. As this refinement process is 
naturally reinforced by development in combination with repetitive activation (activity-
dependency) (Koerte et al. 2010), the degree to which ipsilateral projections 
disappear in children with CP depends on the time point the damage occurs and the 
 20 
severity of the damage. In general, early damage and largely disturbed motor output 
is associated with continuing ipsilateral projection. If the damage occurs later during 
development, some ipsilateral projection might be eliminated but other act together 
with contralateral ones, thus resulting in a mixed picture of ipsi- and contralateral 
organization (Kuo, Friel and Gordon 2018).  
In summary, motor control dysfunction in children with CP occurs not solely due to 
the white matter lesion of the CST itself, but even more profoundly due to its 
descending and ascending connections to several neural areas. Such as i) 
connections between different cortical motor and sensory areas, ii) the main motor 
output pathway to the spinal cord, iii) the loops connecting the cortex with the basal 
ganglia and cerebellum; and iv) ascending sensory information from the thalamus to 
the sensorimotor cortex (Forssberg 2014; Glenn et al. 2007; Lauer et al. 2005; Staudt 
et al. 2003). In relation to the disturbed descending pathways, cortical output cannot 
reach the motor neurons in the spinal cord and further disturb the typical development 
of all neural loops, resulting in secondary alternations of muscle activation, growth, 
and development (Cahill-Rowley and Rose 2014; Rose and McGill 2005). As the 
functional connection of cortical and subcortical pathways are working together, motor 
dysfunction in children with CP can affect many different systems (Staudt et al. 2003), 
which will be described in more detail in chapter 2.2.7 on impaired SVMC in children 
with CP along the ICF continuum. 
d) CST sensory input and feedback systems  
Another fundamental prerequisite of motor control is the integrity of the sensory 
feedback pathways. Any damage to the integrity of the sensory feedback system 
inevitably causes motor output as well as motor learning deficits (Marsden 1998; 
Sarlegna et al. 2006). There is an extensive network of direct (i.e. primary 
somatosensory cortex) and indirect pathways (i.e. ventral posterior nucleus of the 
thalamus) that deliver peripheral sensory information to the primary motor cortex. 
Integrating the sensory feedback system in our understanding of motor control 
increases its complexity exponentially. In the context of this thesis, sensory input in 
children with CP is often diminished. Wingert and colleges have shown that diplegic 
or hemiplegic CP can have proprioception deficits in all limbs (Wingert et al. 2009). 
This in turn alters their cortical input and thereby the output of the circular system. As 
the aim of this PhD lies in determining motor control output, there will be no further 
 21 
detailed explanation of the structural and functional networks of the sensory system 
with the CST.  
In summary, this section provided an overview of the role of the CST in initiating and 
controlling SVMC. By describing its activity-dependent development and synaptic 
ingrowth into adjacent central new structures, forming functional networks, it was 
demonstrated that impaired CST functioning results in decreased descending motor 
output and in the disturbed functioning of related structures. As the organization of 
the CST networks is highly complex, clinical symptoms of CST lesion are known to 
vary in appearance and intensity. The clinical symptoms occurring due to an injury to 
the CST and resulting impact on the connection to other structures of the central 
nervous system (as described in section 2.2.4.1) are called UMN signs (Sanger et al. 
2006).   
2.2.5  Clinical symptoms of corticospinal tract lesions 
The clinical symptoms occurring due to an injury to the CST and resulting impact on 
the connection to other structures of the central nervous system (as described in 
section 2.2.4.1) are called UMN signs (Sanger et al. 2006). They can be either so-
called “positive UMN signs”, such as spasticity, hyperactive reflexes, abnormal 
posture, dyskinesia, persisting developmental reactions and typically develop due to 
the missing inhibitory control of the CST (Sanger et al. 2003). Impaired SVMC, muscle 
weakness, as well as impaired coordination, belong to the negative UMN signs 
(Sanger et al. 2006). These negative signs are more difficult to observe and to 
measure clinically. Consequently, the focus of research and medical treatment rested 
on the assessment and treatment of the positive UMN signs, for instance spasticity 
for a long time (Cahill-Rowley and Rose 2014; Dobson 2010). However, the influence 
of negative UMN signs has revealed to be as limiting, or even more limiting for motor 
performance in children with CP. An increased scientific interest for these impairments 
has arisen within the last 15 years (Vos et al. 2016; Park and Kim 2013; Voorman et 
al. 2007; Desloovere et al. 2006; Østensjø et al. 2004). The difficulty of investigating 
positive and negative UMN signs separately lies in their common pathogenesis and 
their interconnected hidden neural pathways. Therefore, clinically, children with CP 
often present both positive and negative UMN signs (Figure 4) (Carr 2014). For 
example, a child with spastic (positive UMN sign) bilateral CP will also suffer from 
impaired SVMC and muscle weakness (negative UMN signs). 
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The following three neurophysiological processes which are caused by an injury to 
the CST are responsible for this mixed presentation of positive and negative UMN 
signs. First, due to impairment of the CST, the afferent segmental input is increased, 
which causes symptoms like hyperreflexia and spasticity (Hadzagic-Catibusic et al. 
2017; Hurvitz et al. 2014; Fowler 2010). As spasticity mainly involves antigravity 
muscles (e.g. extensor and adductor muscles in the lower extremity), an imbalance 
of muscle tone between the agonist and antagonist of the joint develops (Fowler 
2010). This can further lead to shortening of the hypertonic muscle around the joint 
and limits its range of motion or makes moving the joint painful.  
Second, a lack of refinement of the spinal cord networks disturbs reciprocal inhibition 
and causes primitive movement patterns to maintain (Hurvitz et al. 2014; Fowler 
2010). As the process of reciprocal inhibition is mainly associated with the appearance 
of impaired SVMC, this will be discussed in more detail in section 2.2.6 (“Altered 
processes, structures and networks in relation to impaired SVMC”), together with 
other involved neuroanatomical structures and networks.  
Third, the impaired cortical spinal control fails to lower thresholds for activation of 
alpha motor neurons, which results in a reduction in alpha motor neuron output and 
is thereby limiting the ability to activate the muscular resources fully. In the long term 
and especially during development, these three commonly altered neurophysiological 
processes due to UMN lesion alter normal muscle development and growth in children 
with cerebral palsy. Research on the muscle-morphology, -physiology and -
metabolism of children with spastic CP has shown the following changes due to the 
diminished central control: i) increased resting sarcomere length (3,7 μm), which 
alters the muscles position of optimal force production, and, therefore, might be one 
mechanical cause for the appearance of (dynamic) contracture (Smith et al. 2011; 
Shortland 2017); ii) decrease in muscle volume about 1/3 in comparison to 
neurological intact children (Vanmechelen et al. 2018; Noble et al. 2017; Noble et al. 
2014; Shortland 2011); iii) reduced elasticity (active component) and muscle-belly 
length and size (Barber et al. 2011); iv) atrophic muscle cells; v) increased amount of 
extracellular matrix (Noble et al. 2014); vi) reduced amount of satellite cells, which 
results in a limited ability to repair muscle (Smith et al. 2013); vii) reduced amount of 
type II muscle fibres (Hurvitz et al. 2014; Petersen et al. 2013; Downing et al. 2009; 
Poon and Hui-Chan 2009). Consequently, the muscle strength in children with CP is 
reduced compared to neurologically intact children (Shortland 2011). Altered 
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nutritional and endocrine factors, which are commonly found in these children as well, 
additionally worsen this muscular situation, especially regarding muscular synthesis 
and repair. All these altered muscular requisites lead to an altered muscle loading 
during function and activity and can furthermore lead to the development of 
musculoskeletal malformations, osteopenia, injury and chronic pain (Shortland 2011; 
Peacock 2009). 
2.2.6 Altered processes, structures and networks in relation to impaired 
SVMC  
Normally, when a muscle spindle is stretched, its stretch reflex is activated, and the 
opposing muscle group will be inhibited to prevent it from working against the resulting 
contraction of the homonymous muscle. This inhibition is controlled by the cortical 
motor output to inhibitory interneurons in the spinal cord. This inhibition prevents the 
opposing alpha motor neuron from firing, thereby reducing the contraction of the 
opposing muscle. Without this reciprocal inhibition, agonistic and antagonistic muscle 
groups might contract simultaneously (e.g. an undesired co-contraction), inducing a 
co-contraction and thereby increasing the net force on the joint. This finally results in 
higher energy expenditure. Mostly synergistic movement flexor/extensor patterns 
occur, which are normally suppressed under cortical control. The appearance of these 
primitive movement patterns associated with impaired SVMC is considered to result 
mainly due to the altered control of extrapyramidal motor tracts that originate in the 
brainstem (rubospinal, reticulospinal and vestibulospinal tracts) and central pattern 
generators (CPGs), which are located in the spinal cord. Especially the rubospinal 
tract (RST) seems to mediate gross movement patterns, those promoting extension 
and inhibiting flexion (Cahill-Rowley and Rose 2014; Fowler 2010). This function was 
shown when observing movement in anencephalic children. These children can 
perform synergetic stepping patterns, although they are born with no cortices (Peiper 
1963). Therefore, their intact midbrain structures, origin of the RST, seem to be 
responsible for the activation of these stereotyped movements (Hicks and Onodera 
2012; Yeo et al. 2012; Yang et al. 2011). Furthermore, the RST has found to be more 
anatomically and physiological prominent during early human development, which 
might explain why infant movements rely more on co-activation of synergists and 
antagonists than adult movements (Forssberg 1985). It is suggested that human 
movement becomes more and more selective by the developmental transition away 
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from RST reliance to primarily CST reliance (Cahill-Rowley and Rose 2014; Porter 
and Lemon 1993; Forssberg 1985). 
Other white matter structures which have also shown to play a role within diminished 
SVMC are the transcallosal motor fibres. As these fibres connect the corpus callosum 
and the primary motor cortices of the two hemispheres, they are important for the 
process of interhemispheric inhibition (Forssberg 2014; Kwon et al. 2014; Lee et al. 
2011; Lebel et al. 2012). Interhemispheric inhibition increases during normal 
development (Lebel et al. 2012). It enables a person to perform reciprocal alternating 
as well as selective movements, and it decreases the occurrence of involuntarily 
associated movements (Forssberg 2014; Kwon et al. 2014; Lee et al. 2011).  
Furthermore, the functioning of the sensory system is essential for SVMC. Besides 
the recruitment of the correct number of muscle fibres per motor unit, adequate 
proprioception is essential for SVMC (Rothwell 1987; Miller 2006). Especially sensory 
feedback is important when learning new voluntary movement strategies. Motor 
learning research has shown that general motor programs for basic/innate motor 
behaviours (e.g. eating, walking) are located within the spinal cord (Forssberg 2014). 
The neural networks, which are responsible for activating the “stored” movement 
programs involving multiple joints, are called CPGs (Barthélemy et al. 2011). The 
CPGs are controlled by descending systems and form the cortical and subcortical 
centres. As this cortical control is diminished in children with CP, their ability to initiate, 
adapt and stop their stored motor programs, for instance for learning to walk, is 
diminished (Begnoche et al. 2016). Recent studies on human walking have shown 
that especially the control via the CST plays an essential role in adapting the basic 
locomotor rhythmical movements such as during gait. For instance, a study by 
Barthélemy and colleagues (2011) reported correlations between a reduced 
corticospinal excitability of the tibialis anterior and the degree of foot drop during gait 
in patients with spinal cord injuries. Therefore, although basic motor programs are 
stored within the CPGs, their performance and their performance quality depend on 
cortical structures (Barthélemy et al. 2011). 
In summary, the aetiology of impaired SVMC is still in its infancy. Evidence suggests 
that the CST plays an essential role due to its mono- and polysynaptic connection 
with other areas central nervous structures (e.g. basal ganglia, spinal cord (CPGs)). 
Impaired SVMC could be caused by a loss of connections to the CST and thus would 
be classified as a negative UMN sign, a loss of inhibition of primitive flexor/extensor 
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patterns, which would be a positive UMN feature, or by a combination of both (Dobson 
2010). In relation to the complex pathophysiology of UMN signs, evaluating whether 
a lack of muscle force is primarily caused by a lack of strength, or if this weakness is 
more related to the inability of selective muscle activation, is not always clear. 
Similarly, establishing whether hypertonia is hampering movement, SVMC, or both, 
is challenging but of importance for the identification of an appropriate interventional 
approach.  
2.2.7 Impaired SVMC in children with CP along the ICF continuum  
The ICF continuum will be used as a common framework (Rosenbaum and Stewart 
2004) to describe the clinical presentation and functional consequences of impaired 
SVMC of the lower extremity in children with CP. The ICF was developed by the World 
Health Organization to describe the health status and the consequences of any illness 
for each individual person in a holistic manner. It presents the person’s health status 
on different levels: body structure and function level (health condition: e.g. PVL), 
activity level (functional consequences: e.g. gait problems), participation level (social 
consequences: e.g. attending a special school) and furthermore important personal 
and environmental factors (Figure 5). Impaired SVMC is listed in the ICF- Children 
and Youth (ICF-CY) under body functions “b7600: Control of voluntary movement 
functions - Functions associated with control over and coordination of voluntary 
movements” (Schiariti and Masse 2014). Although one could say that SVMC might 
not be of great importance for the child’s quality of life, as long as he/she can carry 
out all desired activities (e.g. walking), this statement might be only partly true. 
Impaired selective activation can initiate and worsen a vicious cycle of limited active 
movement, joint contractures, hampered motor function and diminished activity and 
participation (Levin et al. 2009; Wren et al. 2005; Bell et al. 2002; Johnson et al. 1997) 
(Figure 6). How this vicious cycle can be initiated by impaired SVMC and how 
impaired SVMC might thereby have consequences/influence on all ICF levels will be 
described in the next sections 3.2.7.1 – 3.2.7.3. 
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Figure 5: International Classification of Functioning, Disability and Health (ICF) continuum: 
Showing all levels which influence health, body function and structure, activity and participation level as 
well as personal and environmental factors and their interdependency.  
2.2.7.1 SVMC impairments on body functions and structures level  
As explained in the section above, the underlying injured body structure in children 
with impaired SVMC is the motor cortex and the CST, often due to a PVL (health 
condition). Impaired SVMC is known to result in the following two impairments on the 
body function level: the appearance of primitive mass synergy patterns and/or mirror 
movements (Cahill-Rowley and Rose 2014). Historically, Brunnstrom was the first 
who described the emergence of mass flexor and extensor synergies during motor 
recovery (stage 2) from hemiplegic stroke (Huang et al. 2016). This observation in 
stroke patients was supported by Perry (Perry 1993) who also observed these 
primitive patterns of mass extension and flexion in children with hemiplegic CP. In 
contrast to the adult stroke population, the appearance of mass synergy patterns in 
children with CP is also caused by the impaired maturation of the CNS’s structures 
and functions (Levin and Panturin 2011; Levin et al. 2009). For instance, during 
normal human motor development, tightly coupled stereotyped kicking movements of 
the lower extremity can be observed during the first month of living (Fetters et al. 
2004). With increased maturation, involving myelination of the CST, activation of the 
hip, knee and ankle joint becomes more and more uncoupled. This maturation 
process is impaired in children with CP. Therefore, an abnormal coupled kicking 
pattern persists in these children and will furthermore hamper and delay the child’s 
ability to reach other motor development milestones (e.g. crawling, walking) (Mayston 
2001). Another possible explanation for the appearance of mass synergies is an 
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increased cortical overlap of joint representation, which has been found for the upper 
extremity presentation in hemiparetic stroke patients.  
Maturation of the CST includes increased pruning of the axons. Its initial bilateral 
projection changes to contralateral within the first year of living (Van de Winckel et al. 
2013; Lebel et al. 2012; Eyre et al. 2001). Consequently, SVMC of the right lower 
extremity is controlled by the left motor cortex. Observations of children with unilateral 
spastic CP have shown that this change in cortical projection is use-dependent. Other 
investigations (Carr et al. 1993; Staudt et al. 2003) have shown that, depending on 
timing (prenatal, around birth and postnatal lesion) and extent of the lesion, children 
will have either contralateral (normal) projections (small lesions), both contralateral 
and ipsilateral projections (medium lesions) or ipsilateral projections (large lesions). 
Clinically, mirror movements often occur from the persistence of ipsilateral 
corticospinal projections between the non-lesion motor cortex and the paretic limb. 
Mirroring is defined as simultaneous, obligatory movement of the contralateral limb 
during ipsilateral movement of the same joint (Fowler 2010).  
2.2.7.2 Possible SVMC caused limitations on the activity level 
To show the connection between SVMC and possible limitations on the activity and 
participation level (section 3.3.7.3), back referencing to the body functions and 
structures level was necessary.  
At the ICF activity level, impaired SVMC interferes with motor performance, as it was 
recently shown by different studies. Some of these studies even suggest the superior 
importance of impaired SVMC in comparison to other UMN impairments. 
One possible consequence of impaired SVMC is that children with CP have difficulties 
in learning new motor skills and thereby reaching motoric milestones such as walking 
much later than their peers. The majority of children with milder forms of CP (e.g. 
Gross Motor Function Classification System (GMFCS) level I and II,), who learn basic 
gross motor skills within their first 2 years (e.g. to roll from a supine to a prone position 
and sit without support), walk independently between 3 and 5 years of age. Children 
with more severe forms of CP are functionally classified as GMFCS level III to V and 
do not learn to walk independently at all. These children either need a hand-held 
mobility device for walking (GMFCS level III), powered mobility devices (GMFCS level 
IV) or the help of another person for transport (GMFCS level V). The ability for 
reciprocal lower limb movements (Fedrizzi et al. 2000) is one of the most important 
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predictors of independent walking in children with CP. Reciprocal lower limb 
movements describe alternating limb movements to advance the body forward 
through crawling, walking and running. This coordinative process is neurologically 
interlinked with the maturation of white matter structures like the CST and the corpus 
callosum (transcallosal motor fibres), which are also involved in the process of 
interhemispheric inhibition (Begnoche et al. 2016; Peacock 2009; Gage et al. 2009).   
One of the most apparent characteristics of many ambulatory children with CP is that 
they do not walk ‘normally’, e.g. with different gait patterns in comparison with typically 
developing children (Gage et al. 2009; Miller 2007). This often means that their 
walking endurance and/or capacity to perform other tasks while walking (dual-tasking) 
is often reduced compared to their healthy peers (Postans and Granat 1999; 
Begnoche et al. 2016; Meyns et al. 2012). One of the reasons for the altered gait 
pattern is the decreased ability to achieve a physiological limb position in several 
phases of the gait cycle caused by extensor synergy patterns in the lower extremity. 
For instance, during the late swing phase, the physiological limb position is 
characterised by selective knee extension while hip and ankle remain flexed (Gage et 
al. 2009). In children with impaired SVMC, this uncoupled activation is replaced by an 
extensor-synergy pattern (obligatory co-activation of the quadriceps and 
gastrocnemius) (Zwaan et al. 2012; Damiano et al. 2000). As such overlap in muscle 
activation does neither occur in the neurologically intact children nor in children with 
idiopathic toe walking, this co-activation has been attributed to the neuropathological 
nature of impaired SVMC (Cahill-Rowley and Rose 2014). This synergistic extension 
pattern is one possible cause for forefoot contact during initial contact, which further 
hampers physiological weight bearing during stance and increases the risk of trips 
and falls (Rha et al. 2016). 
2.2.7.3 Possible SVMC caused disabilities on participation level 
The walking limitations described above, which are caused by impaired SVMC as well 
as by other common impairments (e.g. lack of muscle strength, balance, endurance), 
have shown to be potential barriers to participate in physical, recreational and social 
activities in the life of children with CP. A study by Palisano and colleagues (Palisano 
et al. 2004) found that children classified at GMFCS levels II and III were 4.6 times 
more likely to not participate i any activities with friends or others compared with those 
who walked without assistance (e.g. GMFCS level I). Therefore, the ability to walk 
without support, even for short distances, may affect independence in mobility and 
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participation in recreational, leisure and learning activities of the child and its family. 
Although the GMFCS level does not describe the quality of the gait pattern, lower 
GMFCS levels (I and II) are associated with more efficient walking patterns, which are 
known to be associated with more normal activation patterns. A study from Riad and 
colleges (Riad et al. 2013) showed that decreased selective motor control during 
walking has an influence on self-esteem (ICF personal factors) in children with mild 
unilateral spastic CP. Although these children are physically high functioning (GMFCS 
level I), their gait pattern deviations (Gait Profile Score) correlated with lower self-
esteem. This was even more pronounced when non-physiological arm movement was 
involved.  
To conclude, although impaired SVMC is an impairment on the body functions and 
structure level, it might cause, together with other common UMN signs, limitations and 
disabilities for children with CP and thereby reducing the child’s and family’s overall 
quality of life (Figure 6).  
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2.2.8 Trainability of SVMC 
The training to move as physiologically as possible is one of the central 
physiotherapeutic goals within neurological rehabilitation (Levin and Panturin 2011; 
Miller 2007; Mayston 2001). The rationale behind this therapy focus is to improve the 
patient’s movement efficiency as well as to reduce the development of secondary 
impairments like contractures and muscle insufficiency (Mayston 2014; Gage et al. 
2009). As most medical treatments and surgeries are focusing on reducing positive 
UMN signs like spasticity, physiotherapy and occupational therapy, they are the only 
disciplines that are trying to influence negative UMN signs like muscle weakness and 
impaired SVMC (Dobson 2010; Fowler 2010). A variety of therapy concepts exist (e.g. 
Neurodevelopmental treatment approach (NDT) / Bobath concept; Brunnstrom) 
aiming to improve voluntary, physiological activation of muscles in neurological 
patients (Levin and Panturin 2011; Pandian et al. 2012; Barber 2008; Mayston 2001). 
These approaches are based on the theories of motor learning and neural plasticity. 
These concepts suggest that the (re-)training of physiological movements is possible 
via the adaptive capacity/reorganization of the CNS (Shishov et al. 2017; Forssberg 
2014; Mayston 2014). Fundamental for this neural-plasticity is that sensorimotor 
learning takes place in a functional, motivating, repetitive and possibly adaptable 
environment (Johnston 2009; Trojan and Pokorný 1999). Furthermore, adequate 
sensory input is one key aspect of motor control and learning. As sensory input is 
known to be altered in children with CP, therapy approaches utilize appropriate 
sensory input, e.g. by facilitating task-specific physiological movement patterns, 
“placing” sensory-guided muscle activation to improve motor output (Levin et al. 2009; 
Mayston 2001; Trojan and Pokorný 1999). Although therapists apply these 
therapeutic methods regularly, scientific studies regarding the effectiveness of these 
methods to improve SVMC are scarce. The body of evidence is the largest for the 
adult stroke population and the effectiveness of upper extremity training in the 
paediatric population (Gordon 2016). The numbers of studies which investigated 
therapy-induced changes of SVMC in the lower extremity in children with CP is 
relatively limited (Chen et al. 2016; Pool et al. 2014; Karabay et al. 2015; Sukal-
Moulton et al. 2014; Jung et al. 2013; Carraro et al. 2014; Degelaen et al. 2013; 
Burdea et al. 2013; Prosser et al. 2012; Bandholm et al. 2012; Cioi et al. 2011; 
Byanton et al. 2006; Buckon et al. 2002). Table 1 gives an overview of these studies. 
In none of these studies, SVMC was the main/primary outcome. The interventions 
focused mainly on improving strength and range of motion around the ankle joint (to 
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improve gait function). As these improvements in ankle muscle activity are closely 
related to motor control output, the authors were interested in monitoring SVMC as 
well. Thereby, the selected interventions either assessed changes in SVMC via 
indirect treatment approaches (medical or surgical reduction of spasticity)(Carraro et 
al. 2014; Degelaen et al. 2013; Bandholm et al. 2012; Buckon et al. 2002),direct 
approaches by means of progressive strength/coordination training (Jung et al. 2013); 
robot-assisted devices combined with virtual reality feedback (Chen et al. 2016; 
Sukal-Moulton, Clancy, L. Q. Zhang, et al. 2014; Meyer-Heim and Van Hedel 2014; 
Burdea et al. 2013; Burdea et al. 2011; Byanton et al. 2006) or functional electrical 
stimulation (FES) (Karabay et al. 2015; Pool et al. 2014; Prosser et al. 2012). 
Interestingly, no study investigating the effect of a traditional neurodevelopmental 
treatment approach such as Bobath on SVMC was identified.  
However, in relation to the diversity of the interventions and measurement techniques 
of these studies as well as due to common methodological limitations (e.g. small and 
heterogeneous sample, lack of a control group, lack of previously evaluated outcome 
measure), the generalizability of these study results is limited. Nevertheless, these 
results show the trend of direct motor shaping approaches, which use sensory and 
visual feedback for lower limb. 
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Table 1: Interventions aiming to improve SVMC of the lower extremity in children with CP 
Author Intervention Measurement Effect 
 participants duration 
SVMC outcome 
measures 
reported 
values 
sig. 
change 
Interventions aiming to improve SVMC indirectly – via decreasing spasticity 
Selective Dorsal Rhizotomy (SDR) 
Buckon et 
al. 2002 
25 CP 
6 and 12 months 
post SDR 
sEMG plus isometric 
strength measures: 
co-contraction in the 
lower extremity 
co-contraction 
during knee 
extension 
normalized post 
SDR, but not 
during ankle 
movement  
positive 
trend 
Carraro 
et al. 
2014 
9 CP 
pre - post 12 
months 
Total SCALE score 
pre SDR:  
4(2-8) 
post SDR: 7(3-
10) 
yes 
Botulinum Toxin Injection (BTX) 
Degelaen 
et al. 
2013 
14 CP 
bilateral 
14 CP 
unilateral 
GMFCS I-II 
4 months post 
BTX 
interjoint coordination 
of hip and knee during 
swing phase, minimal 
relative phase analysis 
only plots 
stated as 
sign. but 
values not 
reported 
Bandhol
m et al. 
2012 
14 CP 
(7 interven-
tion vs 7 
control) 
GMFCS I 
12 weeks, 2 x 
training per week  
intervention 
group: custom-
made equipment 
that allowed 
isolated ankle DE 
control group: 
normal/regular 
training 
submaximal torque 
steadiness of isometric 
ankle dorsi- and 
plantarflexion 
torque 
steadiness of 
DE improved 
sign, similarly in 
the two groups, 
plus reduction 
in antagonist 
(soleus) co-
activity 
yes 
Abbreviations: SVMC: Selective Voluntary Motor Control; CP: Cerebral Palsy; SDR: Selective Dorsal 
Rhizotomy; BTX: Botulinum Toxin Injection; m. tib.ant: tibialis anterior muscle; m. gastroc: gastrocnemius 
muscle; sEMG: surface ElectroMyoGraphy  
 35 
(Table 1 continued) 
Author Intervention Measurement Effect 
 participants duration SVMC outcome 
measure 
reported values sig. change 
Interventions aiming to improve SVMC directly – via working on physiological muscle activation 
progressive strength training m. gastrocnemius 
Jung et al. 
2013 
6 CP   6 weeks, 3 
x training per 
week 
SMC and sEMG of 
m. tib.ant; m. 
gatsroc. 
not reported no 
Neuromuscular Electrical Stimulation (NMES) and conventional physiotherapy for ankle 
muscles 
Karabay et 
al. 2015 
28 CP 
GMFCS I-V 
  30 training 
sessions 
SMC of the ankle 
joint only 
per: 3 (1-4) 
post: 3 (1-4) 
no 
Functional Electrical Stimulation (FES) device: “Walk Aide” on active ankle dorsiflexion 
Pool et al. 
2015 
32CP (unilat) 
GMFCS I-II 
  16 weeks, 
3.3h (mean) 
  a day      
SMC of the ankle 
joint only 
SCALE more 
affected leg score 
SMC Pre: 0.11 (0.09) 
Post: 0.20 (0.12) 
SCALE: Pre: 4.94 
(1.12) Post: 6.06 
(1.53) 
sign. 
improvement in 
the intervention 
group, no in 
control group 
Pool et al. 
2014 
12 CP 
(unilat) 
GMFCS I-II 
  16 weeks, 
3.3h (mean) 
  a day      
SMC of the ankle 
joint only 
pre: 2 (0-4) 
Post: 3.5 (1-4) 
yes 
Prosser et al. 
2012 
19 CP 
GMFCS I-II 
  4 months, 
5.6h a day 
3D gait analysis: 
kinematic mean and 
peak DE during 
swing phase (control 
group no effect) 
pre: 1.9 (5.3) 
post: 3.1 (5.1) 
yes 
Virtual Reality augmented ankle robotic training device 
Chen et al. 
2016 
41 CP 
GMFCS I-III 
  6 weeks, 3 
x training 
  (laboratory 
and home- 
  based 
SCALE leg scores pre : 5.8 ± 2.7 
post : 7.3± 2.1 
follow-up : 7.3± 2.2 
yes 
Sukal-
Moulton et 
al. 2014 
28 CP 
GMFCS I-III 
  6 weeks, 2 
(75 min) x  
  training  
SCALE leg scores not reported stated as sign. 
but values not 
reported 
Cioi et al. 
2011 and  
Burdae et al. 
2013 
1 CP   12 weeks, 3 
x training 
DE / PF Torque and 
3D ankle kinematics 
during gait 
in-phase (s): pre: -
0.69; post: 0.10 
Anti-Phase (s): pre – 
post: 0.76 
0.42 
yes 
Wu et al. 
2010 
Wu et al. 
2011 
12 
GMFCS I-III 
  6 weeks, 3 
x training 
SCALE (all joints) 
sEMG (m. tib. ant; 
m. gastroc.) 
Electrogoniometer: 
ankle ROM 
not reported stated as sign. 
but values not 
reported 
Byanton et 
al. 2006 
10 CP 
GMFCS 1-II 
  one 90 min 
training  
  sessions  
Electrogoniometer: 
active ankle DE 
ROM 
greater mean ankle 
active ranges of 
motion into dorsi-
flexion during VR 
yes 
Abbreviations: SVMC: Selective Voluntary Motor Control; CP: Cerebral Palsy; SDR: Selective Dorsal 
Rhizotomy; BTX: Botulinum Toxin Injection; m. tib.ant: tibialis anterior muscle; m. gastroc.: 
gastrocnemius muscle; VR: Virtual Reality; NMES: NeuroMuscular Electrical Stimulation; FES: 
Functional Electrical Stimulation; sEMG: surface ElectroMyoGraphy; 2D: two dimensional; 3D: three 
dimensional; ROM: Range of Motion; DE: Dorsalflexion; PF: Plantarflexion; SMC: Selective Motor 
Control test; SCALE: Selective Control Assessment of the Lower Extremity; sign: significant   
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2.2.9 Neuronal structures and mechanisms involved in improving impaired 
SVMC 
This section will describe the underlying neurophysiological mechanism, concepts 
and neuroanatomical structures which may be involved when training SVMC. Section 
2.2.9.1 describes the concept and effectiveness of neuroplasticity. Section 2.2.9.2 
summarises the two therapy principals that are based on the concept of 
neuroplasticity: constrained movement therapy and mirror therapy. How these 
therapies have revealed to show potential to improve SVMC in the upper extremity, 
even post UMN lesions, will also be discussed in this section. 
2.2.9.1 Concept of neuroplasticity  
As mentioned above, neuroplasticity is the major concept supporting recovery or (re-
)training of selective voluntary movements in patients during neuro-rehabilitation 
(Nudo 2013). Neuroplasticity describes the “ability of the brain to form and reorganize 
synaptic connections, especially in response to learning or experience or following 
injury” (Nudo 2013). Hubel and Wiesel were the first scientists who discovered from 
their experiments on the visual cortex of kittens and monkeys that the development 
of the CNS is activity dependent and not predetermined, meaning that it will be shaped 
by the interaction with external factors (Forssberg 2014). The two commonly used 
slogans “Use it or lose it” and “neurons that fire together will wire together” nicely 
reflect this principle. This activity-induced plasticity is supported by developmental 
changes of the brain (e.g. disappearance of the ipsilateral CST projections) as well 
as by studies investigating cortical changes after training specific motor tasks. For 
instance, training the sensitivity of the fingers of monkeys will reorganise their cortical 
map in accordance with their trained fingers. Similarly, an increase of the cortical 
presentation of the joint needed for a repetitively performed activity has been 
observed in studies comparing professional athletes (e.g. badminton players) and 
musicians (e.g. pianists) with unprofessional controls. In neuro-(paediatric) 
rehabilitation, the concept of movement therapy has been mainly studied in unilateral 
stroke or CP involving upper extremity training like constraint-induced therapy or 
mirror therapy.  
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2.2.9.2 Neurophysiology of constraint-induced therapy and mirror therapy  
Constraint-induced therapy involves constraining movements of the less affected arm, 
usually with a sling or splint, while intensively inducing the use of the more affected 
arm. Several studies have shown that constraint-induced therapy is associated with 
an use-dependent cortical reorganization that increases the area of cortex involved in 
the innervation of movement of the more affected limb (Johnston 2009).  
Mirror therapy is another type of therapy that works on the principles of neuroplasticity 
and also makes use of another neural system (mirror neuron system) (Small et al. 
2012; Buccino et al. 2006; Bhattacharya and Lahiri 2002). In mirror therapy, the 
affected limb is placed behind a mirror, which is placed in such a way, that the 
reflection of the opposing (unaffected) limb appears in place of the hidden limb 
(Buccino et al. 2006). The patient is then asked to perform functional movements with 
the unaffected side while simultaneously looking into the mirror. As the brain 
prioritises visual feedback over somatosensory feedback concerning limb position, it 
receives the illusion that the affected limb is moving physiologically. Thereby, motor 
processes in the brain will become stimulated in the same manner as when the patient 
would have moved the limb. The mirror neuron system of the brain is the primary 
cause of this action. Although the understanding of this complex system is still in its 
infancy, the mirror neuron system is known to play an important role during 
observational learning and becomes activated in the brain immediately after birth 
(Buccino et al. 2006; Bhattacharya and Lahiri 2002). For instance, during the earliest 
stages of development, this system enables the baby to mimic gestures of its parents 
(Buccino et al. 2006). In later stages, it supports learning of more complex motor (e.g. 
talking, walking) and social behaviours, also by activating CPGs (Forssberg 2014). 
During mirror therapy, mirror neurons will become activated as this system is also 
involved with the process of laterality reconstruction (e.g. ability to differentiate 
between the left and the right side). Although mirror neurons are activated by visual 
input, research has shown that this system fails to be activated when the observer 
has no interest in the shown movement task or in those with autism. Mirror therapy 
has shown to be effective in conditions such as phantom limb pain, chronic pain 
syndromes and stroke and seems to normalize the neuropathic processes which 
cause issues with pain and disturbed movement control (Bhattacharya and Lahiri 
2002; Sütbeyaz et al. 2007).  
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As children with CP, in contrast to adult stroke patients, cannot rely on physiologically 
movement experience of their affected limb, the effectiveness of mirror therapy in this 
population needs to be investigated (Forssberg 2014). A recent fMRI study on children 
with unilateral spastic CP showed that solely by observing the movements of their 
paretic hand, similar brain areas of the mirror neuron system (bilateral inferior and 
superior parietal region) were activated in the same way as in neurologically intact 
humans (Dinomais et al. 2013). There are only a few studies on the use of mirror 
therapy for the lower extremity and all included adult stroke survivors (Sütbeyaz et al. 
2007; Small et al. 2012). Intervention studies on impaired upper extremity control in 
children with CP have shown that for instance home-based daily mirror therapy 
training resulted in significant improvements in strength and function of the paretic 
upper limb. Nevertheless, these improvements were not significantly better compared 
to the conventional home-training (Bruchez et al. 2016; Park et al. 2016).  
The RST has shown to play a role in the restoration and rehabilitation of impaired 
motor control (Cahill-Rowley and Rose 2014; Hicks and Onodera 2012). 
Ontogenetically, the RST is an older brain structure. Recent studies in animals and 
humans suggest that the RST is able to partially compensate for the loss of CST 
control. Studies with dogs and monkeys have demonstrated the recovery of motor 
function disabilities from CST lesions whereby the RST was spared. If the RST was 
injured in addition to a lesion of the CST, motor deficits would be permanent 
(Forssberg 2014). Furthermore, diffusion tensor imaging (DTI) studies in patients with 
stroke and a lesion of the CST showed higher fractional anisotropy of the red nucleus 
in the affected hemisphere during the acute and chronic phase of recovery. Further, 
the bilateral red nuclei were the only regions with greater fractional anisotropy during 
the chronic phase when compared to the uninjured control group (Hinkley et al. 2009; 
Yao et al. 2009). Functionally, an increased red nucleus fractional anisotropy 
correlated with better motor function in the patient group (Hinkley et al. 2009). These 
results suggest that increased RST activity compensates for CST damage in stroke 
patients. What role the RST could play in children with CP for compensating impaired 
motor function has not yet been investigated. From the perspective of brain 
development, it is suggested that with the increased maturation of the CST, infant 
movements become less synergistic, and thus rely less on the RST (Cahill-Rowley 
and Rose 2014).   
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Overall, the same concepts of neuroplasticity and motor learning fundamentally exist, 
whether or whether not a UMN lesion is present. The underlying neural structures and 
networks (motor cortices, mirror neurons, and RST) might be altered, but through 
adequate input these are also shape-able and thus allow for restoration and 
rehabilitation of impaired motor control. Therapeutically, this implies that selective 
movement training should take place in a functional and attractive and stimulating 
context for the patient (Meyer-Heim and Van Hedel 2014; Lotze 2003; Trojan and 
Pokorný 1998). This indicates that therapies such as mirror and constrained induced 
therapy, which involves functional training as well as additional visual and sensory 
stimuli (for guiding motor learning), could potentially promote neuroplasticity and 
motor learning. Furthermore, synaptic consolidation of learning is only possible after 
“enough” repetitions (“Neurons that fire together, wire together.”) have been 
performed. In summary, everybody can learn to play piano with the feet, as long as 
enough motivation, time (repetitions) and feedback is given.  
2.3 Outcome measures  
Measurements in medical science and clinic allow to quantify the physical or 
behavioural characteristics of patients (Wright and Majnemer 2014; De Vet et al. 
2011). The quantification of an impairment enables the researcher or clinician to 
collect specific, pre-defined information (data). The accumulation of this data supports 
the description and understanding of the measured characteristics outcome within the 
population of interest. Thereby it can help to understand a certain impairment (e.g. 
symptom) better or to evaluate the patient’s response (i.e. outcome) to a particular 
intervention. Outcome measures are defined as “tools that may be used to assess 
changes in particular attributes that are meaningful to a person’s life over time” 
(Ferguson 2017). The term ‘outcome’ reflects that this tool measures the result of a 
determinant (e.g. treatment, program, service) over a certain time phase. When 
applied before and after an intervention, it measures if and how much change 
occurred in the outcome variable. This knowledge is important for clients, service 
providers, clinical managers, policymakers as well as for researchers (Wright and 
Majnemer 2014). In order to select the “right tool” for any planned investigation, one 
should define the following testing criteria: i) purpose of the measurement (e.g. 
hypotheses: diagnostic, evaluative, prognostic), ii) population of interest (e.g. for 
which patient group was the tool originally developed?), iii) quality of the psychometric 
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properties, iv) intervention purpose (dependent variable), iv) feasibility of the 
measurement (e.g. costs, time) (Wright and Majnemer 2014; De Vet et al. 2011). 
Measurement has been defined as the “process of assigning numerals to variables to 
represents quantities of characteristic according to certain rules” (Portney and 
Watkins 2000). The variable of interest can either be continuous (the variable can 
take any value along a continuum of a defined range), discrete (the variable is 
measured in units / whole numbers) or dichotomous (qualitative variables, which can 
only take two values). When the variable can be observed during the measurement 
process (e.g. the range of motion), it is known to be of direct nature. As most 
characteristics are not directly observable during the measurement (e.g. the 
heartbeat, muscle strength, SVMC), they have to be measured indirectly. 
Furthermore, a measurement is defined by its scaling system, which applies certain 
rules/values to the variable of interest. The scale of measurement can either be 
nominal, ordinal, interval or ratio (Portney and Watkins 2000). The lowest level of 
measurement is the nominal scale (e.g. male = 0 or female = 1), which allows to 
classify people according to some criterion. Ordinal scales organise data into adjacent 
categories (e.g. SVMC is either normal = 2 or impaired = 1 or unable = 0) according 
to a severity-range. The main limitation of this scaling system is that its ordinal values 
do not represent quantity, meaning that they lack arithmetic properties (Portney and 
Watkins 2000; Bishop and Herron 2015). The next level of scaling is the interval scale 
wherein the intervals between the units of the measurement are known and of equal 
distance but are not related to a true zero (e.g., temperature in degrees Celsius). Only 
when using a ratio scale, a score in which zero represents total absence of the 
measured value, it will allow for a comprehensive interpretation. Therefore, classical 
guidelines recommend to apply mathematical and statistical operations only to 
interval or ratio scaled data and to stick to frequency counts for ordinal and nominal 
measures (Portney and Watkins 2000). However, there are a lot of examples in 
clinical and behavioural science in which ordinal data, for example data from validated 
questionnaires, has been used for statistical analysis. Ordinal measures are 
frequently used in medical and behavioural sciences for the reasons of clinical 
feasibility regarding time, costs, and expertise; some variables cannot be measured 
on another scale. Advocates for handling ordinal data arithmetically (as if they were 
interval data) suggest that a statistical procedure should be applied according to what 
is meaningful data and not strictly by the scale used (Norman 2010; Velleman et al. 
1993). They argue that statistical analyses are not an end in themselves, but rather a 
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means to an end, enabling investigators to think about the data. Despite this ongoing 
statistical debate, the decision on the best outcome measures the researchers’ 
hypotheses that the appropriate statistics depend on (De Vet et al. 2011).  On behalf 
of a robust interpretation of the study results, the researcher has to justify the chosen 
outcome measures and statistical procedure used.  
2.3.1 Psychometric properties 
Psychometric properties are defined as “quantifiable attributes (e.g. validity, reliability) 
that relate to the statistical strength or weakness of a test or measurement” (De Vet 
et al. 2011). Knowledge about the quality of the psychometric properties of outcome 
measure is essential for clinicians and scientists to estimate the robustness and 
correctness of the measurement (De Vet et al. 2011; Wright and Majnemer 2014). 
Only by knowing that the chosen measure is measuring what it is intended to measure 
(validity) and by knowing its error-range concerning its reproducibility (reliability), the 
tester can estimate whether a measured change is a real change. Reliability and 
validity are interlinked since reliability is a prerequisite for validity (Portney and 
Watkins 2000). Another important property, especially regarding outcome measures, 
is responsiveness. Responsiveness evaluates the measure’s sensitivity to change 
(Portney and Watkins 2000). 
The COSMIN checklist (Mokkink and Terwee 2010) was developed to provide 
standard guidelines for evaluating the methodological quality of any clinically or 
scientifically applied measure. The COSMIN group used a Delphi study to gain 
agreement on how psychometric properties are defined and how their quality should 
be evaluated (Mokkink and Terwee 2010). Although the checklist was originally 
developed for studies on the measurement properties of health-related patient-
reported outcomes, its application is also relevant for studies evaluating psychometric 
properties of other health measurement instruments (Mokkink and Terwee 2010). The 
main goal of the COSMIN group is to enhance the quality of studies being published 
and thereby improving the level of evidence for clinicians and researchers. The 
definitions of psychometric properties and instructions on how these should be 
assessed are of paramount importance to the main aim of this thesis: to identify a 
reliable, valid, and sensitive outcome measure of SVMC. Therefore, the following 
sections will discuss each psychometric property and its quality criteria. A summary 
of the definitions proposed by the COSMIN group is listed in table 2.  
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Table 2: Domains and definitions of measurement properties  
Domain Measurement property 
(COSMIN Box) 
Definition 
Reliability  The degree to which the measurement is free from 
measurement error: The extent to which scores from patients 
who have not changed are the same for repeated 
measurements under several conditions, e.g., using different 
sets of items from the same health related-patient reported 
outcomes (i.e. outcome measure) (internal consistency), over 
time (test re-test) by different persons on the same occasion 
(inter-rater) or by the same persons (i.e. raters or responders) 
on different occasions (intra-rater) 
Reliability (Box A) The proportion of the total variance in the measurements 
which is because of “true” differences among patients 
Internal Consistency 
(Box B) 
The degree of the interrelatedness among the items. 
Measurement error 
(Box C) 
The systematic and random error of a patient’s score that is 
not attributed to true changes in the construct to be measured. 
Validity  The degree to which an instrument measures the construct(s), 
it purports to measure. 
 Content (Face) 
(Box D) 
The degree to which the content of an instrument is an 
adequate reflection of the construct to be measured. (Degree 
to which (the items of) an instrument indeed look(s) as though 
they is/are an adequate reflection of the construct to be 
measured.) 
 Construct 
(Structural) 
(Box E-G) 
The degree to which the scores of an instrument are 
consistent with hypotheses (for instance with regard to internal 
relationships, relationships to scores of other instruments, or 
differences between relevant groups) based on the 
assumption that the instrument validly measures the construct 
to be measured. (Degree to which the scores of an instrument 
are an adequate reflection of the dimensionality of the 
construct to be measured.) 
 Criterion (Gold 
Standard) (Box H) 
The degree to which the scores of an instrument are an 
adequate reflection of a ‘‘gold standard’’ 
Respon-
siveness 
Responsiveness 
(Box I) 
The ability of an instrument to detect change over time in the 
construct to be measured 
 
2.3.2 Measuring the quality of studies presenting psychometric data 
The COSMIN checklist has shown to be a suitable tool to evaluate the methodological 
quality of studies evaluating the psychometric properties in health-related patient-
reported outcomes (e.g. questionnaires for assessing symptoms, functional status, 
health-related quality of life). Additonally,  it is suitable for objective outcome 
measures within the neuro-paediatric field (Gerber et al. 2016; Ammann-Reiffer et al. 
2014). The checklist consists of the three domains: reliability, validity, and 
responsiveness. Each domain contains one or more measurement properties 
(COSMIN box). The evaluation of each property is performed by scoring general (e.g. 
handling of missing values, sample size) and property-specific items given within each 
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COSMIN box (Appendix 1). A 4-point rating scale (‘excellent’, ‘good’, ‘fair’, ‘poor’ or 
‘not applicable’) is used for scoring each item. The lowest score of all items of chosen 
particular ‘COSMIN box’ (e.g. for reliability) determines the overall methodological 
quality of the psychometric property. In addition to the rating of the methodological 
quality of a study assessing one or more measurement properties, Terwee et al. 
(2007, 2010) proposed to rate the quality of the measurement properties themselves. 
This proposed rating scale is shown in Table 3. 
In the following sections of this thesis, both the COSMIN checklist and the Terwee 
quality criteria for each domain will be described in more detail. 
Table 3: Quality criteria for measurement properties 
Property Rating Quality criteria 
Content validity 
(Box D) 
+ 
A clear description is provided of the measurement aim, the target 
population, the concepts that are being measured, and the item 
selection AND target population and (investigators OR experts) were 
involved in item selection 
? 
A clear description of above-mentioned aspects is lacking OR only 
target population involved OR doubtful design or method 
- No target population involvement 
Criterion validity 
(Box H) 
+ 
Convincing arguments that gold standard is ‘‘gold’’ AND correlation 
with gold standard >0.70 
? 
No convincing arguments that gold standard is ‘‘gold’’ OR doubtful 
design or method 
- 
Correlation with gold standard <0.70, despite adequate design and 
method 
Construct validity 
(Box E,F,G) 
+ 
Specific hypotheses were formulated AND at least 75% of the 
results are in accordance with these hypotheses 
? Doubtful design or method (e.g. no hypotheses) 
- 
Less than 75% of hypotheses were confirmed, despite adequate 
design and methods 
Reliability 
(Box B) 
+ ICC or weighted Kappa>0.70; 
? Doubtful design or method (e.g. time interval not mentioned) 
- ICC or weighted Kappa <0.70, despite adequate design and method 
Responsiveness  
(Box I) 
+ 
Correlation with an instrument measuring the same construct >0.50; 
OR at least 75% of the results are in accordance with the 
hypotheses 
OR AUC>0.70 AND correlations with related construct is higher than 
with unrelated constructs  
 ? Solely correlation determined with unrelated constructs 
 
- 
Correlation an instrument measuring the same construct <0.50; 
OR <75% of the results are in accordance with the hypotheses; 
OR AUC<0.70 AND correlations with related construct is higher than 
with unrelated constructs 
Abbreviations: += positive rating; ?=indeterminate rating; -=negative rating; ICC= Intraclass correlation 
coefficient, AUC= area under the curve of the receiver operating characteristics curve; adapted from 
Terwee et al. (2007) 
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2.3.3 Reliability  
Reliability is defined as the degree to which the measurement is free from 
measurement error (Portney and Watkins 2000). There are three subtypes of 
reliability addressing slightly different aspects of this psychometric property: reliability, 
internal consistency and measurement error (De Vet et al. 2011). Internal consistency 
or homogeneity define as the degree of the interrelatedness among items. As this 
type of reliability is only relevant for the evaluation of questionnaires, it will be 
discussed in this thesis no further.  
Reliability concerns the reproducibility of the results, i.e. when a test is repeated over 
time on the same participants (test-retest reliability), when used by different assessors 
on the same occasion (inter-rater reliability), or by the same assessor(s) on different 
occasions (intra-rater reliability). When the agreement is high within the sample, the 
variance is low, meaning that the instrument is measuring precisely. Thereby reliability 
represents how much of the total sample variance is attributable to true differences 
between scores; it can be expressed by the following coefficient (Portney and Watkins 
2000):  
 
Reliability is excellent, when the coefficient is 1.00, meaning that the error is zero. As 
the errors increase, the ratio approaches zero and the reliability of the tool diminishes. 
Statistically, reliability can be expressed by measures of correlation and/or 
agreement. While correlations reflect the degree of how scores vary together (i.e. 
consistency), they are not a measure of the extent of agreement between the two sets 
of measurements. To establish that repeated tests result in the same values, 
estimates of agreement are needed. The COSMIN checklist for reliability 
recommends to apply an Intraclass Correlation Coefficient (ICC) (ICC model 2: inter-
rater; ICC model 3: intra-rater) for all continuous scores and to use a (weighted) 
Kappa for all other types of scores (Mokkink and Terwee 2010).  
According to the quality criteria from Terwee et al. (2007), the reliability of a certain 
measure is rated positive, when the ICC/or weighted Kappa is above 0.7. An 
indeterminate rate is given, whenthe study assessing reliability was methodologically 
flawed (COSMIN rating of ‘poor’), allowing bias to occur (e.g. time interval between 
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the measures was not stated or selected appropriately, participants condition was not 
stable between the two measurement occasions) (Appendix 1: Box B). If the design 
and method were adequately chosen, but the ICC or weighted Kappa was below 0.70, 
reliability would be rated negative (Terwee et al. 2007). 
When the agreement between the true value and the observed value is low, the 
source of “noise” that gets in the way of finding the true score must be detected. 
Measurement error(s) can occur either systematically (e.g. false calibration of the 
instrument) or randomly (e.g. fatigue). While systematic errors can be corrected, for 
instance by recalibrating the system or by adjusting the over- or underestimated 
measured value, the handling of random errors is more challenging, since these occur 
due to chance (e.g. mistakes, inattention) (Portney and Watkins 2000). The general 
assumption with random errors is that they will eventually cancel each other out, if 
enough measurements are taken. To minimize both types of error, the methodological 
testing procedure should be standardized, taking the common sources of errors into 
account. These errors include errors within the measurement (e.g. for technical 
measures: calibration error); rater/tester (e.g. different levels of work experience); 
subjective differences within the sample; environmental differences (Portney and 
Watkins 2000) such as temperature or time orthe time interval between the repeated 
measures. De Vet al. (2011) recommends the following analytic parameters to 
represent measurement error: 
 Standard Error of Measurement (SEM) = SEM=SD√(1-rxx): measures test 
scores that are spread around a “true” score 
 Smallest Detectable Change (SDC) = 1.96 × √2 × SEM: measures the 
variation in a scale due to measurement error 
 Limits of Agreement (LoA) = (95%CI of the mean difference ± 1.96*SD of the 
differences): represents the 95% confidence interval for both the upper and 
lower limits of agreement (Bland–Altman method). 
When evaluating the methodological quality of a study investigating the measurement 
error of an instrument in accordance to quality criteria of Terwee at al. (2007), similar 
items are applied, with an exception for the statistic items (Appendix 1: Box C).   
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2.3.4 Validity  
The validity of a measurement tool describes to which extent an instrument measures 
what it is intended to measure (Portney and Watkins 2000). The COSMIN checklist 
includes five different boxes within the validity domain: content validity, structural 
validity, hypothesis testing (construct validity), cross-cultural validity and criterion 
validity (Mokkink and Terwee 2010).  
The first form of validity is face validity, which reflects the “degree to which a 
measurement instrument looks as though it is an adequate reflection of the construct 
to be measured” (Mokkink and Terwee 2010). As this form of validity is dependent on 
subjective assessment, a quantified evaluation is not possible. Nevertheless, it is of 
great importance since an instrument or questionnaire, which seems to have low face 
validity, should not be further validated. Therefore, it is not separately listed within the 
COSMIN checklist but together with content validity. This is the next higher form of 
validity and uses expert-panel feedback as well as previously validated frameworks 
such as the ICF-CY to assess whether the measurement instrument (e.g. items, 
scaling system) adequately represents the construct it is aiming to represent. 
Evaluation of this type of validity focuses on how concrete the construct of interest 
and the chosen items are defined. Furthermore, the purpose of the instrument and 
the population of interest should be described in detail (De Vet et al. 2011) (Appendix 
1: Box D).  
After the face and content validity of an instrument have been confirmed, the 
validation process should continue by testing either its criterion validity or construct 
validity. If a gold standard measure is available, criterion validity should be evaluated. 
Criterion validity is defined by the COSMIN panel as “the degree to which the scores 
of a measurement instrument are an adequate reflection of a gold standard”. It is 
further subdivided into concurrent validity (the assumption that the test scores and 
gold standard scores are the same) and predictive validity (the assumption that the 
test scores predict the scores of the gold standard). The recommended statistical 
procedure depends on the measurement levels of the gold standard and the 
measurement instrument tested (Appendix 1: Box H) (De Vet et al. 2011). As a gold 
standard is often lacking in the field of paediatric neurorehabilitation, construct validity 
should be used to estimate the validity of the instrument. For the assessment of any 
type of construct validity (structural validity, hypotheses testing, cross-cultural 
validity), a priori formulated hypotheses about the (expected) relationships between 
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the instrument scores and another instruments or groups are tested (De Vet et al. 
2011; Mokkink and Terwee 2010; Portney and Watkins 2000).  
Structural validity investigates how and if the scoring system of a measurement tool 
is accurate through factor analysis (classical test theory or item response theory) (De 
Vet et al. 2011) (Appendix 1: Box E). 
When hypotheses testing is performed to evaluate the validity, a priori formulated 
hypotheses about the relationship of the measurement scores and the scores of 
comparator instrument or group are tested. The expected relationship could either be 
that both tools measure the similar construct (convergent validity) or that the 
instruments are measuring different constructs (discriminant validity). The robustness 
of this type of validity is strongly dependent on the previously defined construct of 
interest and the formulated hypotheses (Appendix 1: Box F). 
Cross-cultural validity has to be assessed when a measurement tool is translated 
into another language or has been adapted due to cultural differences. It tests the 
“degree to which the performance of the items in a translated or culturally adapted 
instrument is an adequate reflection of the performance of items in the original version 
of the instrument” (Mokkink and Terwee 2010). The COSMIN panel recommends the 
following translation process for measurement instruments (Beaton et al. 2007): i) 
translation of the instrument by two independent native translators who have the 
target language as their mother tongue; ii) creation of consensus version; iii) back-
translation into the original language by two other translators with the original 
language as their mother tongue and who are blinded to the original version, (iv) 
obtain approval by an expert committee meeting of all translators and scientists and 
clinicians involved; v) pilot testing of a pre-final version within a small sample; vi) 
obtain approval by the developers of the original version. Following this translation 
process, validation of the translated or culturally adapted instrument should be 
approved by testing expected correlations with related tools. For instance, it should 
be assessed whether a given measure is interpreted in a conceptually similar manner 
by respondents representing different genders or different cultural backgrounds. 
Statistically, this is known as the assessment of measurement invariance and 
commonly tested by factor analysis, logistic regression and item response theory 
techniques (Appendix 1: Box G). 
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In accordance to the quality property criteria from Terwee et al. (2007), all of the three 
construct validity forms are rated positive, if specific hypotheses have been 
formulated and if at least 75% of the results are in accordance with these hypotheses. 
If no hypotheses were formulated, the design will be doubtful, or the construct validity 
will be rated as ‘indeterminate’. A ‘negative’ rating is given if the design was adequate, 
but less than 75% of hypotheses were confirmed.  
2.3.5 Responsiveness 
While validity refers to the validity of a single score, responsiveness refers to the 
validity of a change score. Therefore, COSMIN considers responsiveness as an 
aspect of validity, which evaluates “the ability of an instrument to detect change over 
time in the construct to be measured” (Mokkink et al. 2010). Accordingly, whenever a 
scientist or a clinician aims to detect a change in a patient’s health condition due to 
recovery or intervention, responsive outcome measures should be used. Depending 
on the availability of a gold standard, responsiveness is tested either via criterion 
validation or construct validation. The main hypothesis within responsiveness testing 
is that the changes in the patients’ health status regarding the construct of interest 
are in the expected direction and magnitude in both instruments (new instrument 
versus gold standard/comparator instrument) (De Vet et al. 2011). Due to the focus 
on changes scores, a longitudinal study is required in which at least some of the 
patients are known to change on the construct of interest (e.g. due to natural recovery 
or intervention) and with at least two measurement occasions. Methodologically, the 
time interval between the two measurements as well as occurring events (e.g., 
interventions) within this time interval need to be stated and described. If a particular 
intervention is selected to assess responsiveness, the evidence regarding its 
effectiveness should have been established in advance. If an adequate gold standard 
is available, the a priori hypotheses should define the expected level of agreement 
between changes in the outcome measure of interest and changes on the criterion. 
Additionally, the strength of the relationship between the changes in scores of both 
tools should be defined. When construct validation is performed, the selected 
comparator measurement tool or group should be described in detail, including its 
psychometric properties of the comparator instrument (Mokkink and Terwee 2010). 
The statistical analysis of responsiveness depends on the predefined hypotheses and 
testing design (Appendix 1: Box I). Effect sizes, paired t-test and Guyatt’s 
responsiveness ratio are considered inappropriate to assess responsiveness, 
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because these parameters test either the magnitude or statistical significance of the 
change score or refer to the interpretability of the change score, but do not test its 
validity (De Vet et al. 2011). 
The quality of the responsiveness of a certain measure is rated positive if the 
correlation coefficient with an instrument measuring the same construct is above 0.50; 
if at least 75% of the results are in accordance with the hypotheses, or if the area 
under the curve of the receiver operating characteristics curve is above 0.70 and the 
correlations with related construct are higher than with unrelated constructs. 
Consequently, responsiveness quality is rated negative, if the values are below the 
previously given thresholds. If solely correlation coefficients are determined with 
unrelated constructs, responsiveness will be rated as ‘indeterminate’ (Terwee et al. 
2007). 
2.3.6 Outcome measures for measuring SVMC  
Section 2.2.8 discussed the lack of scientific evidence on nature as well as the 
trainability of SVMC (Cahill-Rowley and Rose 2014; Dobson 2010). A possible 
explanation for this gap in knowledge might be related to the problems in measuring 
SVMC (Gordon 2016; Fowler 2010; Dobson 2010; Zwaan et al. 2012). One problem 
is the interrelated pathological nature of UMN signs (Cahill-Rowley and Rose 2014). 
Section 2.2.7 discussed the interrelated nature of SVMC with other UMN signs as well 
as with other impairments of body function (e.g. lack of trunk control, balance 
problems). Due to the interrelated nature of UMN signs, an isolated investigation of 
SVMC is quite challenging in the practical measurement context. Questions like "How 
to differentiate between a lack of SVMC and muscle strength or spasticity?" must be 
taken into consideration to undertake a precise measurement (Fowler et al. 2009). 
One way to control for interfering effects of other impairments, for instance muscle 
weakness or spasticity, is to measure these two impairments independently. Another 
important aspect is that the tool itself is developed in a way that it controls for the most 
interfering factors (Portney and Watkins 2000).  
Another problem when measuring SVMC is that although the movement can be 
observed, the underlying controlling structure and processes are hidden. The ability 
to selectively activate a muscle or muscle group within a given movement or posture 
determines how the movement is performed. As most of our activities of daily life are 
complex, three-dimensional movements, which take place simultaneously over 
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multiple joints, measuring how the movement is performed is more challenging than 
measuring the quantity. For example, it is quite easy to assess, if and how fast a 
patient can stand up, but it is more complex to measure how he/she is standing up 
from sitting. For instance, a child could stand up physiologically by slightly leaning 
forward and lifting up by progressively straightening knees and hips; or in an 
unphysiological manner by e.g. leaning the trunk backward to extend the hips and leg 
and then pulling up with the help of the hands. The majority of available assessment 
tools are on the activity level and fail to measure how the patient is performing a motor 
task per se (Levin et al. 2011).  
Concerning the lack of SVMC outcome measures, the next two sections will 
summarise the currently available outcome measures of SVMC in children with CP, 
as well as in the adult population of patients with UMN lesion.  
2.3.6.1 Measures of SVMC in children with CP 
Literature revealed that in 1999 Boyd and Graham’s Selective Motor Control (SMC) 
test was the first test that aimed to measure SVMC. The authors were interested in 
measuring the changes in selective ankle control after Botulinum toxin injections 
(Boyd and Graham 1999). Later, Trost modified this assessment and also included 
the assessment of the selectivity around the knee and hip joints (Smits et al. 2010; 
Löwing and Carlberg 2009). In 2009, Fowler and colleagues developed the SCALE 
for assessing SVMC of the hip, knee, ankle, subtalar joint and toes (Fowler et al. 
2009). Although the SCALE and the SMC have similarities, as they both assess 
selectivity around the lower limb joints, the scoring and test procedure, as well as how 
they handled muscle weakness, differs. The SCALE does not only assess selective 
ankle movement but also subtalar and toe movement. Furthermore, its scoring system 
and testing position allow to differentiate between muscle weakness and selectivity 
(Fowler et al. 2009). The patient is asked to move the joint on verbal instruction, which 
allows to assess voluntary motor control. These assessment characteristics indicate 
high content validity of the SCALE concerning the definition of SVMC. This clinical 
assumption was confirmed by a mean content agreement of 91.9% from 14 
experienced clinicians (Fowler et al. 2009). Construct validity of the SCALE was 
supported by a significant inverse correlation (r = 0.83, p<0.01) with the participants’ 
GMFCS level in a study including children with CP (Fowler et al. 2009). Furthermore, 
the SCALE showed that impairment of SVMC increases from proximal to distal in 
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children with CP (Fowler et al. 2010) and that its score strongly correlates with swing 
knee extension acceleration during gait (r = 0.85, p<0.001) in the same patient 
population (Goldberg et al. 2011). Interrater reliability of 6 clinicians rating SVMC of 
20 participants with the SCALE was high, with ICC ranging from 0.88 to 0.91 
(p<0.001) (Fowler et al. 2009). According to these study results and in comparison to 
available alternatives, the SCALE is currently the most common assessment tool of 
choice for testing SVMC in children with CP (Dobson 2010). Nevertheless, as its 
scoring system is originally designed for diagnostic and prognostic and not for 
evaluative purposes (i.e. effects of treatment), its clinical application is limited (Fowler 
et al. 2009). To improve SVMC in children with UMN lesion, health professionals need 
to evaluate the effects of their interventions, and for this measurement instruments 
with an evaluative character are needed (Zwaan et al. 2012; Dobson 2010). 
2.3.6.2 Measures of SVMC in other populations with a UMN lesion 
Because of the lack of appropriate SVMC outcome measure in the neuropediatric 
population, the literature searched for alternative tools within the entire population of 
patients with UMN lesion. The aim of this systematic review was to create an up-to-
date overview of measures, which already have been reported and used to measure 
and/or evaluate SVMC of the lower extremity in patients with UMN lesions. 
A MEDLINE search revealed 1572 hits (Appendix 2). After screening titles and 
abstracts, 112 papers were included. These papers reported on outcome measures 
of SVMC ranging from simple observational tools to complex procedures like 
Transcranial Magnetic Stimulation (TMS) or functional Magnetic Resonance Imaging 
fMRI (Appendix 3). Several observation-based tools were identified for the 
assessment of  SVMC of the upper extremity (Wolf et al. 2001; Levin et al. 2004; Van 
de Winckel et al. 2006), the lower extremity and the overall body function (Collen et 
al. 1991; Gowland et al. 1993; Sødring et a. 1996; Chino et al. 1996; Ahemd et a. 
2003; Liu et al. 2002; Miller et al. 2008) in patients with stroke. Many assessments, 
like the Fugl-Meyer motor assessment (Gladstone et al. 2002), include subsections 
that specifically test SVMC of the lower extremity. Their scoring is similar to the ordinal 
scoring form with the paediatric assessments (SCALE; SMC) ranging from “0” = not 
able to move at all, over “1” = for impaired selective movement pattern, to “2” = for 
normal selective movement. As these tests were designed mainly to evaluate the 
initial motor control recovery of patients with stroke, their scoring system might be 
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suitable (i.e. sensitive) for detecting improvements of SVMC, but the ordinal scoring 
likely lacks sensitivity to evaluate therapy effects on SVMC in children with congenital 
brain injuries (Fowler et al. 2009). Additionally, their testing procedure is designed for 
the assessment of patients with hemiparesis only and is therefore not suitable for 
patients with diplegic or tetraplegic presentation of symptoms (Fowler et al. 2009). 
Hence, because of the limitations discussed above, none of these stroke assessment 
tools are indicated for either discriminative or evaluative assessment of SVMC in 
children with UMN lesion.  
Laboratory-based SVMC measures include tools which test any form of active range 
of motion (Pomeroy et al. 2003), force and torque (e.g. Dynamometer (Engsberg et 
al. 2001; Braendviket al. 2013), muscular activity (e.g. surface Electromyography 
(sEMG): on-off ratio (Doornik et al. 2008)); latency and activation time; 
Frequency/Wavelet Analysis (e.g. Prosser et al. 2010; Lauer et al. 2007); voluntary 
response index (Lee et al. 2004), as well as a combination of muscular activity and 
torque tracking (i.e. Knutson et al. 2011; van Hedel et al. 2010; Kiyama et al. 2011). 
Considering that SVMC and muscle weakness are different but also related 
impairments, measurements aiming to detect minor degrees of muscle weakness 
(submaximal strength) or using submaximal-torque tracking exercises are measuring 
selective motor neuron activation within the muscle, and thereby SVMC (van Hedel 
et al. 2010). Other laboratory SVMC measures use more complex measurement 
procedures focusing on the ICF body structure level, such as neuroimaging measures 
used for motor map localization (e.g. Wittenberg 2009; Möller et al. 2005) and TMS 
measuring corticospinal connections (e.g. Kesar et al. 2012; McKay et al. 2005). 
These papers provide an interesting insight into the underlying basic pathology (e.g. 
TMS norm values for children with CP (Kesar et al. 2012) and intervention-induced 
changes in SVMC (Everaert et al. 2010). The psychometric properties of sEMG 
(Zwaan et al. 2012), three dimensional gait analysis (Fowler et al. 2010; Fowler and 
Goldberg 2009; Goldberg et al. 2011) and isometric torque measurement (Bandholm 
et al. 2008) have been assessed (validity, reliability) in children with CP as well.  
Only the minority of measures had been tested on their psychometric properties: 
validity, reliability, and responsiveness. Especially for laboratory-based SVMC 
measures such as sEMG or torque measurements, evidence of their validity and 
responsiveness is lacking, despite the fact that they have been used in interventional 
studies. 
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Although the psychometric evidence for many instruments was limited, several 
measures seemed to be interesting, becausethey fulfil one or more criteria of a 
theoretically ideal SVMC measure: i) measuring SVMC in accordance to its definition 
(focusing on single-joint movement and muscle activation) (Sanger et al. 2006), ii) 
applicable also for bilateral involvement, iii) reference/norm values available, iv) child 
friendly application (e.g. short duration, non-invasive) and v) well reliable, valid and 
responsive. For example, sEMG measures allow to directly measure voluntary 
activation of a muscle. Even in patients with little muscle strength, sEMG can detect 
voluntary activations without actual or only small joint movements. sEMG analyses 
can also provide in-depth information on activation of the agonist, antagonist and 
synergists (e.g. on-off ratio (Downing et al. 2009; Olsen et al. 2013; Damiano et al. 
2000); latency and activation time (Tedroff et al. 2006); frequency or wavelet analyses 
(Lauer et al. 2005; Lauer et al. 2007)) and the voluntary response index (Zoghi et al. 
2013; McKay et al. 2005; Lee et al. 2004). Combining sEMG with kinematic 
measurements further allows assessing co- and mirror movements and the 
percentage of the movement cycle for which a muscle acts concentrically, 
eccentrically, isometrically or is inactive. This SVMC measuring approach was used 
by Perry et al. (2001), who investigated the effect of dorsal selective Rhizotomy on 
voluntary muscle activation in non-ambulatory children with CP during a cyclic 
movement with their leg while supine. When sEMG is combined with (submaximal) 
torque tracking (i.e. Damiano et al. 2000; van Hedel et al. 2010; Kiyama et al. 2011) 
or isometric force measures (e.g. dynamometry (Lebiedowska and Fisk 2003; 
Lebiedowska et al. 2004)) additional information about the patient’s voluntarily ability 
of submaximal force regulation can be gained. Again, this also allows the assessment 
of SVMC in relatively weak patients. Using this measurement strategy, van Hedel et 
al. (2010) observed that SVMC of ankle dorsiflexion was mainly affected in patients 
with stroke, but remained largely unaffected in patients with incomplete spinal cord 
injury, despite both groups of patients experienced comparable muscle weakness 
(Van Hedel et al. 2010). Another interesting combination of techniques was used in 
the “Brain Motor Control Assessment” (McKay et al. 2005; Lim et al. 2005). The “Brain 
Motor Control Assessment” measures the motor output from the central nervous 
system during a variety of reflex and voluntary motor tasks performed under controlled 
conditions using sEMG and TMS. One of its main outcomes, the “Voluntary Response 
Index”, is calculated from quantitative analysis of the comparison of sEMG data during 
defined voluntary movement in patients versus neurologically intact people (Lee et al. 
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2004). We consider this as one of the most promising SVMC measures because it 
has been validated and uses healthy reference values for normalization. 
Unfortunately, to our knowledge, the “Voluntary Response Index” has not been yet 
evaluated in children with UMN lesions.  
To conclude, although some measures for SVMC of the lower extremity are available 
in the population of patients with UMN lesions and have also been used to evaluate 
therapy-induced changes of SVMC, their level of psychometric evidence has not yet 
been evaluated systematically. Since the assessment of SVMC in children with CP 
differs from that in adult patients with UMN lesions, interchanging measurement tools 
will not be possible, or only after several necessary adaptations are made. In people 
with CP, the SCALE seems to be a very promising assessment tool. Nevertheless, its 
scoring system likely lacks sensitivity to detect therapy-induced changes. Using the 
SCALE’s testing procedures while recording neurophysiological measurements (e.g. 
sEMG, isometric torque measurement or TMS) seems to be a possible way to 
evaluate therapy-induced changes in SVMC. 
Nevertheless, to be able to choose the most valid, reliable, sensitive as well as 
practical tool for evaluating changes in SVMC in children with UMN lesions, a 
systematic review on psychometric properties of available tools is necessary. 
2.4 Rationale for the overall aim(s) of the thesis 
Summarizing the above stated main research findings and gaps in knowledge about 
SVMC of the lower extremity in children with CP, reveals the following key points:  
 The pathophysiological nature of SVMC in relation to other UMN signs and 
their interrelation to gross motor function is complex and yet not fully 
understood.  
 Recent research indicates that SVMC is an important predictor of gross motor 
function (including gait) in children with CP. 
 There are only a few studies investigating the effects of therapy on SVMC, 
and there is some evidence of the efficacy of these interventions. 
 Concepts of neuroplasticity and motor learning underpin the trainability of 
SVMC even in patients with UMN lesions.  
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 Both observational and laboratory-based measures for SVMC of the lower 
extremity are available for children and adults with UMN.  
 Validity and reliability of the SCALE have been assessed but its ordinal scaling 
may be too broad to measure therapy-induced changes of SVMC. 
 Currently, there is no gold standard for the measurement of SVMC in children 
with CP available.  
 The psychometric properties of only a few SVMC measures have been 
evaluated.  
 There is a lack of responsive assessment tools for the evaluation of therapy-
induced changes in SVMC in neurological patients. 
 Therefore, it is not known which measurement technique is best, regarding its 
psychometric qualities, for testing SVMC in children with CP.   
Therefore, in accordance with the bullet points above, this PhD included the following 
research questions. 
Study 1 
The aim of the first study was to investigate the influence and relevance of SVMC of 
the lower extremity in children with CP on the ICF activity level. We used regression 
modelling to determine the strongest predictor for gait capacity among the following 
UMN signs: impaired SVMC, spasticity, muscle weakness and impaired trunk control. 
Thereby, we formulated the following research questions:  
Research Question 1: Is SVMC, within a model of other common UMN motor 
impairments (spasticity, muscle weakness, impaired trunk control), an important 
predictor for gait capacity in children with CP? 
Research Question 2: What is the association of SVMC with other lower extremity 
impairments (spasticity, muscle weakness) and impaired trunk control? 
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Study 2 
Secondly, in relation to the recently noticed importance of SVMC in children with CP, 
it was of great clinical and scientific interest to translate the SCALE into German and 
to test the psychometric properties of this translated version.   
Research Question 3: Can the original version of the SCALE be translated into 
German, thus, by following international standardized translation procedure for such 
purposes? 
Research Question 4: How strong is the construct validity of the SCALE’s German 
version, in terms of 1) its correlation with the Fugl-Meyer test (criterion validity); 2) its 
correlation with the GMFCS (concurrent validity) and 3) its discriminative validity, by 
showing significant differences 3.1) across and between joint (pairs) (proximal-distal-
concordance); 3.2) for limb involvement (less/more affected limb) and 3.3) across and 
between GMFCS levels. 
Research Question 5: Is the inter-rater reliability of the German version of the SCALE 
as reliable as the original version?   
Research Question 6: What is the intra-rater reliability of the German version of the 
SCALE?  
Study 3 
Parallel to study 2 a systematic review of the psychometric properties of SVMC 
measurement tools for the lower extremity in children with CP was carried out:  
Research Question 7: Which SVMC measures exist for children with CP? 
Research Question 8: What is the level of evidence for the psychometric properties 
of these measures?  
Research Question 9: Which (if any) tool would be best suitable, regarding feasibility 
and psychometric quality, for measuring therapy-induced changes of SVMC in the 
lower extremity in children with CP? 
Study 4 
Based on the results of studies 2 and 3, the aim of the fourth study was to evaluate 
the psychometric properties of a new measurement tool for measuring SVMC of the 
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lower extremity in children with CP. This new outcome measure uses the SCALE 
testing procedures combined with sEMG recordings of 10 lower extremity muscles to 
calculate the so-called “Similarity Index”. It was developed to create a SVMC outcome 
measure which would be sufficiently valid, reliable and sensitive to measure therapy-
induced changes in SVMC. Although the author is aware of the importance of the 
assessment of responsiveness of a new tool, this could not be realized within the 
scope of this thesis.  
The following research questions determined the structure of this study: 
Research Question 10: Can the criterion validity of the SCALE-SI be established by 
a high correlation with the original SCALE?  
Research Question 11: Considering concurrent validity: Does the SCALE-SI show a 
similarly strong correlation with the GMFCS as the original SCALE?  
Research Question 12: Considering discriminative validity: Do SCALE-SI scores differ 
significantly between 1) neurological intact children and children with CP; 2) joint 
levels of both the less and more affected limb; and 3) limb involvement (less/more 
affected SCALE-SI score)?  
Research Question 13: Does the “SCALE-SI” show adequate relative and absolute 
test-retest reliability values? 
Taking all these different study aims into consideration, the overall aim of this PhD 
study was to investigate how to measure SVMC in the lower extremity in children with 
CP. Only by using robust outcome measures, it will be possible to evaluate 
therapeutic techniques aiming to improve children’s SVMC. Consequently, this will 
enable therapists to give parents an evidence-based answer to questions like “Will 
my child learn to walk normally due to your therapy?” or “Can you teach him to walk 
properly/normally?”  
 58 
Chapter 3: Study 1 
3.1 Purpose of chapter 
The purpose of this chapter is to describe the methodology and present and discuss 
the results in relation to the first two research questions (Section 2.4) concerning the 
relative contribution of SVMC and other UMN motor impairments as well as the 
variability in gait capacity observed in children with cerebral palsy. 
This chapter has been published in the Journal Disability and Rehabilitation in 2017: 
Balzer J, Marsico P, Mitteregger E, van der Linden ML, Mercer TH, van Hedel HJ. 
2017. Influence of trunk control and lower extremity impairments on gait capacity in 
children with cerebral palsy. Disabil Rehabil. 24:1-7 (Appendix 10). 
3.2 Background  
As described in chapter 2.2.7., although impaired SVMC is an impairment on the ICF 
body functions and structure level, it might cause limitations at ICF activity and 
participation level together with other common UMN signs. The importance of SVMC 
with regard to gross motor function has recently been shown in several studies 
(Chruscikowski et al. 2017; Vos et al. 2016; Park and Kim 2013; Kim and Park 2011; 
Ross and Engsberg 2002; Voorman et al. 2007; Desloovere et al. 2006) in ambulatory 
children with CP (GMFCS I-III). In these studies, SVMC and muscle strength were 
found to be stronger predictors for gross motor function compared to spasticity and 
range of motion (contractures). As the lower extremities and the trunk are involved 
during walking, knowledge about their individual and combined impact on gait is 
essential for developing optimal gait-rehabilitation intervention strategies 
(Chruscikowski et al. 2017, Saether et al. 2014). However, the influence of trunk 
control on gait received lesser attention – until now. Traditionally, disturbed motor 
control and lower extremity impairments were seen as the primary and secondary gait 
deviations,  (Gage et al. 2009). Abnormality of trunk kinematics during walking was 
mostly considered as a compensatory gait deviation. Recently, this focus has been 
amended by an increasing number of studies investigating the trunk and upper limbs 
during walking (Saether et al. 2014; Heyrman et al. 2014; Attias et al. 2014). This shift 
in focus coincided with the development of new trunk control measures for children 
with CP (Heyrman et al. 2014; Attias et al. 2014). The first studies in this field provide 
increasing evidence that altered trunk control during gait in children with CP should 
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not be considered solely as a compensation for gait deviation (due to altered lower 
extremity functioning), but should also be considered as a direct aspect of gait 
deviation (Saether et al. 2014; Heyrman et al. 2014). Until now, studies of ambulatory 
function have investigated the contribution of either lower extremity impairments 
(Noble et al. 2017; Vos et al. 2016; Park and Kim 2013; Kim and Park 2011; Ross and 
Engsberg 2007; Voorman et al. 2007; Desloovere et al. 2006) or  trunk control 
(Heyrman et al. 2014; Attias et al. 2014) with no study assessing both lower extremity 
impairments and trunk control, and evaluating their influence on gait. As both body 
functions are dependent on adequate motor control, the primary aim of this study was 
to investigate the impact of SVMC of the lower extremity and trunk on gait capacity 
(e.g. in this study, the time needed to perform the modified Timed Up and Go test or 
mTUG). 
Although the importance of SVMC and trunk control on ambulatory function in children 
with CP has been investigated, the association between these two impairments and 
that with other lower limb impairments (i.e. spasticity, muscle weakness) has not yet 
been established. For instance, as described in chapter 2.2.6, it remains uncertain 
whether the pathophysiological nature of impaired SVMC is a negative UMN on its 
own (due to a loss of CST connections), just one functional feature of a positive UMN 
pathology (due to a loss of inhibition and the release of primitive flexor/extensor 
patterns), or a combination of both. As these different aetiologies may have different 
implications for treatment of gait disorders, gaining more insight in the 
interdependency of these UMN signs is of clinical relevance. Several studies have 
reported the association between SVMC with other UMN lesions: A fair correlation (ρ  
= Spearman’s rho) between SVMC and spasticity of the plantarflexors (ρ = 0.300, p 
= 0.004; Østensjo et al. 2004) and with (ankle) range of motion (ρ = 0.303, p < 0.001; 
Park and Kim 2013); moderate correlation between SVMC and muscle strength (ρ = 
0.505, p < 0.001; Park and Kim 2013) and muscle volume (ρ = −0.580, p < 0.001; 
Hanssen et al. 2018). However, studies investigating the association between motor 
control of the lower extremity and that of the trunk are lacking. In order to provide 
evidence-based clinical decision making while treating ambulatory children with UMN 
signs, the secondary aim of this study was to gain more knowledge with regard to the 
association between impaired SVMC and muscle weakness, spasticity, and trunk 
control. 
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Based on previous studies (Noble et al. 2017; Ross and Engsberg 2007; Voorman et 
al. 2007; Desloovere et al. 2006), the following a priori hypotheses were formulated: 
i) there is a negative, moderate (correlation coefficient >.5) relationship between gait 
capacity and SVMC, trunk control and lower extremity muscle strength; ii) there are 
positive, weak (correlation coefficient <.5) relationships between spasticity and gait 
capacity; iii) SVMC, muscle strength and trunk control are the strongest predictors for 
gait capacity; iv) there are a positive, moderate correlations between SVMC and 
muscle strength with trunk control and v) there is a negative, weak relationship 
between spasticity and trunk control. 
3.3 Method 
3.3.1 Participants  
In- and out-patients of the “Rehabilitation Centre Affoltern am Albis, University 
Children’s Hospital Zurich” were recruited by convenient sampling. Inclusion criteria 
were: diagnosis of spastic CP, age between five and 20 years, ability to walk (Gross 
Motor Function Classification (GMFCS) level I-IV), and ability to follow simple 
instructions. Participants with additional movement disorders, with an unstable 
situation regarding their tonus-regulating medications and/or participants, who had a 
botulinum toxin injection within the last six months or any surgical correction within 
the last year, were excluded. The study was approved by the ethical committee of the 
Canton of Zurich (KEK-ZH-Nr.2011-0404). Informed consent and assent were 
obtained from parents and participants (respectively). 
3.3.2 Measurements  
All tesйts were carried out by the same two experienced neuro-pediatric 
physiotherapists within a maximum timeframe of one hour and in accordance to 
standardized procedures. 
3.3.3 Lower extremity assessments  
To assess SVMC at the hip, knee, ankle, subtalar and toe joints, the “Selective Control 
Assessment of the Lower Extremity” (SCALE), as described in section 2.3.6.1 of this 
thesis, was performed [27,28]. 
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Spasticity and muscle weakness of hip, knee and ankle flexion and extension 
movements were assessed with the “Modified Ashworth Scale (MAS),” and the 
“Manual Muscle Test” (MMT), respectively.  
The MAS (Bohannon and Smith 1987) scores spasticity on an ordinal scale ranging 
from “0” to “4” in accordance to the velocity dependent definition of spasticity from 
Katz et al. (1992). Although its criterion validity was established by using the 
pendulum test (Naghdi et al. 2007), its correlation with an increased alpha-motor-
neuron activation (Fleuren et al. 2010), as well as with increased muscle activation 
and resistance (Fosang et al. 2003) ranged from weak to moderate only. In children 
with CP, interrater-reliability of the MAS for the lower extremity joints ranged from 
weak to good (Fosang et al. 2003; Mutlu et al. 2008). 
Muscle strength was evaluated with the MMT in accordance to Kendall et al. (1993). 
Scores ranged from 0 – 5. Its scoring system was originally developed and tested on 
validity for determining muscle weakness in patients with poliomyelitis (Lovett and 
Martin 1916). Its interrater-reliability has not yet been tested in children with CP, but 
was moderately too good for children with muscular dystrophy (Cuthbert and 
Goodheart 2007). Although evaluation of the psychometric properties for the MAS 
and MMT in children with CP is limited, they were performed, as they are considered 
the clinical standard. Moreover, they have been used in previous studies, hence allow 
the comparison of our results (Vos et al. 2016; Ross and Engsberg 2007; Østensjø et 
al. 2004).  
3.3.4 Trunk control assessment  
Trunk control was assessed using the “Trunk Control Measurement Scale” (TCMS). 
This is a 15-item assessment that examines sitting balance during functional activities 
(Heyrman et al. 2011). The TCMS considers that the trunk should provide a stable 
base of support and that it is also an actively moving body segment. The first five 
items test static sitting balance, followed by ten items that test dynamic sitting balance. 
Dynamic sitting balance is further divided into two subscales, seven items testing 
‘selective movement control’ and three items testing ‘dynamic reaching’. Its validity 
was supported for children with spastic CP by i) moderate to strong correlations with 
the “Gross Motor Function Measure” (GMFM) (Heyrman et al. 2011; Mitteregger et al. 
2015), ii) significant differences between healthy children and children with CP 
(Heyrman et al. 2011) and iii) a strong correlation with centre of pressure measures 
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whilst sitting (Mitteregger et al. 2015). Its interrater-reliability was established as the 
ICC was 0.91 (Heyrman et al. 2011). 
3.3.5 Gait capacity assessment  
For assessing the participants' gait capacity, the paediatric version of the mTUG 
(Williams et al. 2005) was performed. It records the time a child needs to stand up 
from a chair with foot contact, to walk three meters to a target, turn around and return 
to the chair and finally sit down. Reliability and validity of the mTUG was supported 
by a study in a sample of 176 children without physical disabilities and 41 young 
people with physical disabilities due to CP or spina bifida (Williams et al. 2005). In this 
study, the mTUG was performed twice and the average time of the two trials was 
included into the analysis. 
3.3.6 Statistical Analysis 
Statistical analysis was performed with SPSS 17.0 (IBM, Armonk, USA). Alpha was 
set at 0.05 (two-tailed). The Shapiro-Wilk-test showed that the data of most scores 
was not normally distributed. Hence, Spearman’s correlation coefficients (ρ = 1 – 
(6∑d2) / n(n2 – 1)); Abbreviations: ρ = Spearman´s Rank Correlation Coefficient; d = 
differences between the ranks assigned to each squared observation; n = the 
numbers of observations in each (both) data sets)) were calculated between the 
mTUG, age, SCALE. MMT, MAS and TCMS total and sub-scores. We also calculated 
ρ between the TCMS total and sub-scores and the SCALE, MMTand MAS scores.  
In a second step, simple and multiple linear regression analysis (backward modelling) 
(Miles and Shevlin, 2001) were carried out to determine the most important 
predictor(s) for explaining mTUG variance. A model using SCALE, MMT, MAS and 
TCMS total scores as independent variables was analysed. For the regression 
analysis, the following assumptions were checked: i) homogeneity of variance via a 
nonsignificant Levin’s test; ii) lack of multicollinearity by calculating the tolerance and 
variance inflation factor for each independent variable; iii) lack of autocorrelation by 
calculating the Durbin-Watson test, and iii) a lack of outliers (case-wise diagnostic) 
based on the values of Cook’s and Mahalanobis’ distance (Bowerman and O’Connel 
2000; Field 2005). Based on the regression sample size guidelines by Miles and 
Shevlin (Miles and Shevlin 2001), we aimed for a sample size of 50 participants which 
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would be sufficient for a regression model with four predictors with a moderate to large 
effect size.  
3.4 Results 
Sixty-eight children with spastic CP gave informed consent for participation. Due to a 
lack of compliance (lack of motivation, concentration problems) or due to 
organizational issues (unavailable walking aids), 14 data sets were incomplete. As 
case-wise diagnostic for the regression analysis revealed that mTUG scores of two 
participants (GMFCS level IV) laid three standard deviations above the mean, these 
participants were classed as outliers and omitted from the analyses. Therefore, 
demographic and performance characteristics of 52 participants are presented in 
table 4. The 23 females and 29 males were on average 11 years and 9 months (SD 
4 years 6 months) old. Twenty-two children had a GMFCS level I, 12 had level II, 16 
level III and two level IV. Further clinical characteristics are presented in table 4.  
Table 4: Study 1 - Participants’ clinical and functional characteristics  
 spastic CP n=52 
Measures median (IQR) range 
MMT 
 total score (0-60) 
 
44.0 
 
(20) 
 
20 - 60 
SCALE 
total score (0-20) 
 
12.0 
 
(5.2) 
 
0 - 19 
MAS 
total score (0-48) 
 
2.5 
 
(4) 
 
0 - 20 
TCMS  
TCMS – static (0-20) 
TCMS – selective (0-28) 
TCMS - dynamic (0-10) 
TMS - total (0-58) 
 
19.0 
14.0 
8.0 
41 
 
(5.2) 
(8.2) 
(4.2) 
(14.2) 
 
4 - 20 
1 - 26 
1 - 10 
6 - 56 
mTUG (s.) 7.9 (5.5) 4.3 - 47.5 
Age (yy.mm) 11.7 (7.6) 5.9 - 19.11 
Abbreviations: MMT: Manual Muscle Test; SCALE: Selective Control Assessment of the Lower 
Extremity; MAS: modified Ashworth Scale; mTUG: modified Time Up and Go test; TCMS: Trunk 
Control Measurement Scale, SD: Standard Deviation; IQR: InterQuartile Range 
3.4.1 Correlation analysis  
Correlation results for the lower extremity impairments, TCMS and mTUG are 
summarized in Table 5. The MMT total scores showed the strongest relationship with 
both the mTUG and TCMS total score, closely followed by the correlations between 
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the total SCALE scores and the mTUG and TCMS total score. Lowest correlations 
were found between the MAS total scores and the mTUG or TCMS total score and its 
sub-scores. Only the correlation between age and gait capacity was weak and non-
significant. Corresponding scatter plots are shown in Figure 7. Furthermore, MMT and 
SCALE correlated strongly (Table 5). 
 
Figure 7: Study 1 - Scatterplots:  
a) Scatter plots and Spearman’s correlation coefficients (ρ) between lower extremity impairments, trunk 
control and gait capacity; b) Scatter plots and Spearman’s correlation coefficients (ρ) between lower 
extremity impairments and trunk control  
Abbreviations: MMT: Manual Muscle Test; SCALE: Selective Control Assessment of the Lower 
Extremity; MAS: modified Ashworth Scale; mTUG: modified Time Up and Go test; TCMS: Trunk Control 
Measurement Scale 
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Table 5: Study 1 - Spearman’s correlation coefficients (ρ) between lower extremity impairments, trunk 
control and gait capacity 
spearman`s rank (ρ) MMT SCALE MAS mTUG 
MMT (total) 1.00 
.849 
(p<001) 
-.255 
(p=.068) 
-.787 
(p<.001) 
SCALE (total) 
.849 
(p<.001) 
1.00 
-.435 
(p=.002) 
-.685 
(p<.001)) 
MAS (total) 
-.255 
(p=.068) 
-.435 
(p=.002) 
1.00 
.356 
(p=.010) 
TCMS - static 
.711 
(p<.001) 
.604 
(p<.001) 
-.189 
(p<.001) 
-.695 
(p<.001) 
TCMS - selective 
.665 
(p<.001) 
.717 
(p<.001) 
-.362 
(p<.001) 
-.493 
(p<.001) 
TCMS - dynamic 
.770 
(p<.001) 
.675 
(p<.001) 
-.218 
(p<.001) 
-.614 
(p<.001) 
TCMS (total) 
.764 
(p<.001) 
.757 
(p<.001) 
-.296 
(p=.033) 
-.597 
(p<.001) 
Age    
.093 
(p=.126) 
Abbreviations: MMT: Manual Muscle Test; SCALE: Selective Control Assessment of the Lower 
Extremity; MAS: modified Ashworth Scale; mTUG: modified Time Up and Go test; TCMS: Trunk Control 
Measurement Scale 
3.4.2 Simple and multiple linear regression analysis  
The above shown strong correlation coefficients (≥0.75) between the SCALE, MTT 
and TCMS indicated a probable risk of multicollinearity between these three 
predictors. This threat of multicollinearity was further shown in the Variance Inflation 
Factor (VIF) values for the SCALE and MMT (VIF: 4.968 and 4.439, respectively). 
Also, the average VIF (3.38) of the model was greater than 1 and should be 
considered when interpreting the results of this regression analysis (Hair et al. 2017). 
When applying a simple linear regression modelling to predict gait capacity, the TCMS 
total score alone explained most of the variance (54%) of the mTUG, followed by the 
SCALE (43%), the MMT (40%) and the MAS (31%). As age was not correlated with 
the mTUG, it was not included in the regression analysis (Table 6).  
A multiple backward regression model was applied to investigate which lower 
extremity and/or trunk impairments explain the greatest amount of variance in gait 
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capacity. In the first step the total SCALE score was removed from the model, followed 
by the MMT score. The TCMS was the strongest predictor with a standardized 
regression coefficient “β” of -0.624 (p<0.001), when explaining the variance in mTUG 
(R2 =.67, F(4,51) = 49.246, p<0.001). Together with the MAS, the TCMS remained in 
the final model and they both explained overall 67% of the mTUG variance. To 
improve the interpretation of these findings, this analysis showed that a decrease of 
trunk control in the amount of 12 TCMS points resulted in a 6.6 seconds increase of 
the mTUG (Table 6).  
Table 6: Study 1 - Simple and multiple linear regression analysis for predicting gait capacity 
Dependent 
variable 
Independent variable B Std. Error B β R² 
mTUG 
simple linear regression 
Constant 36.08 4.34   
MMT (total score)  -0.56 0.09 -.637 (p<.001) .40 
Constant 28.99 3.02   
SCALE (total score) -1.60 0.26 -.657 (p<.001) .43 
Constant 4.93 1.87   
MAS (total score) 1.67 0.35 .559 (p<.001) .31 
Constant 34.93 3.21   
TCMS total  -0.62 0.08 -.734 (p<.001) -.54 
Constant 11.83 4.32   
Age  0.04 0.36 -.016 (p=.909) .00 
multiple linear regression: MMT, SCALE, MAS,TCMS  (backward modelling) 
Step 1    
 
 
.68 
Constant 26.91 4.34  
SCALE 0.34 0.45 .139 (p=.459) 
MMT  -0.20 0.16 -.226 (p=.213) 
MAS 1.23 0.30 .410 (p<.001) 
TCMS  -0.46 0.11 -.542 (p<.001) 
Step 2    
 
.68 (p=.459) 
Constant 28.88 3.81  
MMT -0.12 0.12 -.136 (p=.306) 
MAS 1.11 0.26 .371 (p<.001) 
TCMS -0.44 0.11 -.520 (p<.001) 
Step 3    
 
.67 (p=.306) 
Constant 26.92 3.31  
MAS 1.12 0.26 .376 (p<.001) 
TCMS  -.528 0.07 -.624 (p<.001) 
Abbreviations: MMT: Manual Muscle Test; SCALE: Selective Control Assessment of the Lower 
Extremity; MAS: modified Ashworth Scale; mTUG: modified Time Up and Go test; TCMS: Trunk Control 
Measurement Scale; B: Beta (unstandardized regression coefficient); Std. Error B: standardized error of 
Beta; β: standardized regression coefficient; R²: coefficient of determination 
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3.5 Discussion 
The current study showed that among measures of lower extremity and trunk 
impairment, trunk control was the strongest predictor for gait capacity in children with 
CP. Furthermore, the strong correlations between SVMC and muscle strength with 
trunk control as well as with gait, underpin the important influence of these 
impairments on walking capacity. 
3.5.1 Prediction of gait capacity  
Until now, no study has investigated the impact of both lower extremity impairments 
and trunk control on gait capacity. In deviation to the initial hypothesis, that trunk 
control and leg muscle strength would be the strongest predictors for gait capacity, 
the MMT (surprisingly) and the SCALE scores were excluded from the regression 
model. The unanticipated exclusion of the MMT, as well as the exclusion of the 
SCALE, is likely to be caused by multicollinearity between TCMS, MMT and SCALE. 
As multicollinearity is a methodological limitation of this study, its cause and 
consequences will be explained in further detail in the section 3.6 under limitations.  
The results of the simple regression analysis are in agreement with those of previous 
studies, which reported the importance of SVMC (van der Linden et al. 2018; 
Chruscikowski et al. 2017; Park and Kim 2013; Kim and Park 2011; Ross and 
Engsberg 2007),strength (Park and Kim 2013; Kim and Park 2011; Ross and 
Engsberg 2007) and a minor influence of spasticity and gait capacity/performance 
(Park and Kim 2013; Kim and Park 2011; Ross and Engsberg 2007).  
Nevertheless, a direct comparison regarding the absolute strength of the relationship 
between our study and previously published research, is not appropriate due to the 
existence of several methodological differences: i) previous studies used different 
dependent variables such as three dimensional gait analysis (Desloovere et al. 2006), 
gross-motor function (Vos et al. 2016; Voorman et al. 2007; Østensjø et al. 2004), ii) 
differences in assessments/methods were used to quantify lower extremity 
impairments, iii) different levels of GMFCS of the study population, and iv) different 
statistical analyses (i.e Park and Kim 2013).  
Further comparing the simple and multiple regression results in terms of the 
importance of trunk control on gait, only one other study was found, which showed 
that trunk control (quantified by the “Segmental Assessment of Trunk Control”) 
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explained 38-40% variance of the GMFM in 92 children with CP (GMFCS I-V) (Curtis 
et al. 2014). In this study, the TCMS explained half of the variance of the mTUG within 
an ambulant sample (GMFCS I-IV). Although the results of this study confirmed the 
strong relationship between trunk control and gait capacity, a meaningful clinical 
interpretation of this finding in terms of causal relation between the two is difficult. This 
is due to the current lack of knowledge concerning the responsiveness of the TCMS 
and the lack of intervention studies which might have included the TCMS. Thereby, it 
is unknown how likely it is to increase a patient’s TCMS score and whether this results 
in an improvement of the mTUG.  
3.5.2 Relationship between lower extremity motor functioning and trunk 
control 
Regarding the secondary objective of this study, the a priori formulated hypotheses 
were confirmed by Spearman rank correlation coefficients exceeding 0.7 for the MMT 
and SCALE with TCMS. However, the correlation between MAS and the TCMS was 
lower than expected. These outcomes seem to support two clinical impressions, 
formed prior to conducting this study. Namely that patients with better active trunk 
control (e.g. due to training) or passive trunk control (e.g. supported sitting or brace) 
have a better capacity for improving selective movements and strengthening of their 
lower extremities. Furthermore, the strong relationships between the trunk and the 
lower extremity functioning might be explained by their close neuroanatomical 
positions on Penfield’s homunculus. To the author’s knowledge, this was the first 
study, which investigated the relationship between these two motor-control dependent 
body functions. Only one recent study was found, which addressed a similar topic. 
Heyrman et al (2014) investigated the impact of lower leg kinematics on trunk 
deviations in children with CP assessed during walking (as opposed to when sitting, 
as in our study). For measuring lower limb movements, they used the Gait Profile 
Score (GPS). They found no significant correlations between the trunk parameters 
during gait (e.g. Trunk Profile Score) and the GPS (r = 0.35, p = 0.13) and only fair 
correlations between the TCMS and GPS (r = -0.49). Furthermore, the correlations 
between trunk parameters assessed during sitting (TCMS) and gait were higher (r = 
-0.63 - -0.43). Therefore, they suggested that trunk deviations during walking are not 
exclusively associated with the presence of lower limb gait impairments and can thus 
be regarded as a discrete source of impairment and not merely a compensation 
(Heyrman et al. 2014) 
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3.5.3 Limitations and Methodological Considerations  
As mentioned above, the problem of multicollinearity should be considered when 
interpreting these results (Bowerman and O’Connel 2000). The correlation matrix 
revealed high correlations (ρ > 0.6) between the MMT vs. SCALE, MMT vs. TCMS, 
and SCALE vs. TCMS. Furthermore, the average variance inflation factor of the 
starting model was above “1”, which is considered as a threat to the validity of the 
model (Field 2005). The presence of multicollinearity of the aforementioned variables 
makes it impossible to obtain unique estimates of the explained variance, 
becausethese variables account for the similar variance and their beta values are 
therefore interchangeable (Type II error) (Miles and Shevlin 2001). 
The regression results showed that when predicting gait capacity by SCALE, MMT, 
MAS and TCMS scores, the SCALE and MMT scores were removed from the model  
since their scores explained a similar amount of variance in mTUG variance as the 
TCMS. Please note that these results do not indicate that SVMC and leg muscle 
strength do not influence gait capacity. The MAS, which on its own only correlates 
weakly with mTUG, seems to explain another part of the variance. Therefore, only the 
MAS and the variable with the highest beta value (TCMS) were kept in the final model.  
This interpretation is supported by the results of the simple regression analyses, which 
showed that SCALE and MMT explain the second and the third largest amount of 
variance in mTUG (43% and 40%, respectively).  
An alternative, although the more complex approach to handle multicollinearity, is to 
run a factor analysis (e.g. Structural Equational Modelling (Park and Kim 2013)) on 
the highly correlated predictors and to use the resulting factor scores (or latent 
variable) as a predictor (Hutchenson and Sofroniou 1999). As this statistical approach 
requires a larger sample size, it might be considered for future studies investigating 
similar research questions within a larger sample. 
Concerning further methodological limitations about the generalizability of these study 
results, the dominance of participants with a higher gross motor/walking abilities level 
(GMFCS I and II = 66.4% versus GMFCS III and IV = 33.6%)) should be considered. 
This underrepresentation of children with more severe mobility problems might also 
possibly explain the lower correlation with the MAS. The scatterplots of the MAS 
versus TCMS and mTUG reveal the dominance of participants with only a low level 
of spasticity.   
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Interpretation of the results is furthermore limited by the selected measures and 
joints/muscles. For instance, the focus of this study lied on flexors and extensors of 
the three major lower extremity joints. Furthermore, the participants’ lower limb range 
of motion, which can potentially also affect a patient’s gait capacity, was not reordered 
in this study. However, previous studies have shown no or weak correlations of this 
impairment with gait or walking performance (Desloovere et al. 2006; Østensjø et al. 
2004). Moreover, when interpreting the results in relation to muscle strength, it should 
be considered that an isometric strength test (MMT) was used in order to allow for 
comparison with previous papers (Vos et al. 2016; Ross and Engsberg 2002; 
Voorman et al. 2007; Desloovere et al. 2006; Østensjø et al. 2004). An isokinetic 
strength measure might have been more appropriated in relation to gait capacity. 
Although it would have been of clinical interest to know if particular joints or other 
assessments explain more variance than other joints or assessments, this would have 
required a much larger sample size. Therefore, based on the sample size guidelines 
(Miles and Shevlin 2001), only the total scores of the SCALE, MMT, MAS and TCMS 
were entered as predictors. 
Another limitation of this study and those of previous studies (Vos et al. 2016; Ross 
and Engsberg 2002; Voorman et al. 2007; Desloovere et al. 2006; Østensjø et al. 
2004) was that the chosen outcome measures (SCALE, MMT, MAS and TCMS) are 
rated by the observer rather than ‘objectively’ measured. To minimize a potential bias, 
the trained and experienced assessors (which were involved in previous studies on 
the translation, validation and reliability testing of these measures, see (Balzer et al. 
2016; E. Mitteregger et al. 2015; P. Marsico et al. 2017; Petra Marsico et al. 2017)) 
used standardized protocols and, except for the first author, were unaware of the 
hypotheses of this study.  
Finally, it should be considered that the mTUG (Williams et al. 2005) in comparison 
to other walking tests (i.e. 10-meter walking test) is a measure of both gait and 
balance activities and as such measures gait capacity in an ADL context. As the 
mTUG includes tasks like getting up, turning and sitting down, more leg strength and 
balance is required compared to walking only, children whose strength, balance and 
upper extremity functionality are more impaired (GMFCS levels III-IV) therefore 
experience considerably more difficulties with an mTUG than with straight walking 
only. This could have caused the non-linear relation between the SCALE and other 
measures of impaired body function and structures. A walking test, which only 
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assesses walking speed in a straight line (such as the 10-meter walking test) and not 
the ability to turn and to perform sit-to-stand transitions, may have resulted in more 
linear associations.  
However, when searching for previous studies investigating the association between 
walking speed and measures of impaired body function and structures to underpin 
this assumption, only one study was found, which displayed scatterplots indicating 
the linearity of this association rather than correlation coefficients only. In this study 
(van der Linden et al. 2018), associations between lower limb impairment and 
RaceRunning speed were indeed more linear than the relationship observed in the 
current study. 
3.5.4 Clinical implications and future work  
Firstly, these study results show how SVMC and other common UMN impairments of 
the lower extremity and the trunk influence gait capacity, independently and/or in 
combination. In particular, the relevance of trunk control on gait capacity in children 
with CP was shown for the first time. Based on this finding and findings of previous 
studies investigating trunk control (Heyrman et al. 2014; Attias et al. 2014; Heyrman 
et al. 2011; Curtis et al. 2014), it is suggested that therapists should address the 
potential importance of trunk control in addition to lower extremity functioning when 
attempting to improve gait in children with GMFCS I-III.  
Secondly, this study added new knowledge to the investigation on the 
interrelationships between of lower extremity and trunk motor control impairments. 
Results showed that while SVMC is strongly associated with muscle strength and 
trunk control, its association with spasticity is, although statistically significant, 
considerably weaker. This finding might advocate that impaired SVMC is a negative 
UMN sign by itself and not only a consequence of spasticity alone.  
Thirdly, in line with previous studies, spasticity was not the most important limiting 
factor for gait capacity in children with CP (Vos et al. 2016; Ross and Engsberg 2002; 
Voorman et al. 2007; Desloovere et al. 2006; Østensjø et al. 2004). These findings as 
well as a recently increasing number of studies investigating the influence of SVMC 
on gait development (Chruscikowski et al. 2017) and gross motor function (Vos et al. 
2016; Park and Kim 2013; Kim and Park 2011), challenge the traditionally claimed 
importance of spasticity management in ambulatory children with CP (GMFCS I-III). 
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3.6 Conclusion 
This study aimed to increase the understanding of the two main issues. Firstly, the 
influence of impaired SVMC and other motor control impairments on gait capacity in 
children with CP were investigated. Secondly, the interdependency of these different 
motor impairments. By using a regression model to predict gait capacity, with lower 
extremity and trunk function as independent variables, it was shown that trunk control, 
muscle strength and SVMC account for a similar amount of variance in gait capacity 
variance. Spasticity accounted for the remaining, but considerably lower amount of 
mTUG variance. Correlation analysis revealed that impaired SVMC is less associated 
with spasticity in the current sample, advocating that it is a negative UMN on its own. 
Its strong correlation with gait capacity demonstrates its relevance for functional 
movements within this group of children. Overall, the results of this study may inform 
clinicians in their assessment and treatment of ambulatory children with CP. 
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Chapter 4: Study 2 
4.1 Purpose of chapter  
This chapter describes the translation as well as the assessment of the validity and 
reliability of the German version of the SCALE. Thereby the purpose of this chapter 
is to answer research questions three to six of Section 2.4.  
This chapter was published in the Journal Developmental Medicine and Child 
Neurology in 2016: Balzer J, Marsico P, Mitteregger E, van der Linden ML, Mercer 
TH, van Hedel HJ. 2016. Construct validity and reliability of the Selective Control 
Assessment of the Lower Extremity in children with cerebral palsy. Dev Med Child 
Neurol. 58(2):167-72. (Appendix 11). 
4.2 Background 
The previous regression study (Balzer et al. 2017) on the influence of SVMC and other 
motor impairments on gait capacity in children with CP, underlined the importance of 
SVMC in daily motor control in this patient group. Furthermore, as explained in section 
2.2.7.2, impaired selective activation can initiate and worsen a vicious cycle of limited 
active movement, joint contractures, hampered motor function and diminished 
activity, thereby causing pain and appearance of secondary deformities in children 
with CP (Chruscikowski et al. 2017; Vos et al. 2016; Park and Kim 2013; Kim and 
Park 2011; Ross and Engsberg 2002; Voorman et al. 2007; Desloovere et al. 2006). 
Therefore, robust assessment of SVMC in children with CP is of great clinical and 
scientific interest. Although the clinical importance of physiological muscle activation 
is obvious, routinely assessment of SVMC is rare in the clinical environment (Dobson 
2010). As described in section 2.3.6.1, this lack of clinical SVMC assessments might 
be explained by the following main complications in measuring SVMC. Firstly, testing 
SVMC is challenged by the coexistence of other motor signs (e.g. muscle weakness, 
spasticity). Secondly, SVMC needs to be measured indirectly (Cahill-Rowley and 
Rose 2014). Thirdly, in the German speaking areas, clinical application of 
assessments in another language is rare due to the language barrier. To enable 
regular assessment of SVMC also in German speaking areas and to thereby improve 
our knowledge in this central impairment, the aim of this study was to translate the 
English SCALE version, which was originally developed by Fowler and colleagues in 
2009. The SCALE was selected for translation for the following reasons: i) it allows to 
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measure SVMC in accordance to the above stated definition form Sanger et al. 
(2003), ii) it asses five main joints of the lower extremity; iii) testing position and 
procedure are well selected for children with bilateral involvement; iv) SCALE’s 
validity and reliability testing haven shown promising results (Fowler et al. 2009; 
Fowler et al. 2010) .   
To establish discriminative validity of the German SCALE’s version, the fowling 
hypotheses were set: i) the German SCALE version would show a similar proximal-
distal concordance than the original version (Fowler et al. 2009), ii) SCALE scores 
would differ significantly between the less and more affected limbs, and iii) across and 
between different GMFCS levels. For concurrent validity, a high positive correlation 
(p>0.70) between the SCALE and the Fugl-Meyer Assessment (FMA) was expected. 
Furthermore, it was hypothesized that children with spastic CP and a high degree of 
muscle weakness and/or spasticity would have lower the SCALE scores. For 
reliability, ICC values exceeding 0.8 (see also Fowler et al. 2010) and acceptable 
levels of absolute measurement error were expected.  
4.3 Method 
4.3.1 Participants  
In- and out-patients of the “Rehabilitation Centre Affoltern am Albis, University 
Children’s Hospital Zurich” were recruited by convenience sampling. A minimum 
sample size of 25-30 participants was required, to provide an accurate estimate of the 
random error. Inclusion criteria were: diagnosis of CP, age between five and 20 years, 
ability to walk (GMFCS level I-IV), and the ability to follow simple instructions. 
Participants with an unstable situation regarding their tonus-regulating medications 
and/or who had a botulinum toxin injection within the last six months or any surgical 
correction within the last year were excluded. The study was approved by the ethical 
committee of the Canton of Zurich (KEK-ZH-Nr.2011-0404). Informed consent and 
assent were obtained from parents and participants. 
4.3.2 Measurements  
In order to translate the original SCALE version into German, the following 
international guidelines from Beaton et al. (2007) were followed: i) translation into 
German by two independent native German speaking physiotherapists, ii) creation of 
consensus version, iii) back-translation into English by a translation company, and iv) 
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endorsement by the authors of the original version (Beaton et al. 2007). The final 
German SCALE version is provided in Appendix 4. For comparison the original 
English Version of the SCALE can be found in Appendix 5. 
Testing procedures were standardized according to the assessment guidelines. All 
tests were carried out by the same two experienced neuro-paediatric 
physiotherapists, one assessing and one assisting. Tests were performed for both 
legs within a maximum timeframe of one hour. 
SCALE administration required patients to perform specific isolated movement 
patterns at the hip, knee, ankle, subtalar and toe joint. SVMC of each joint movement 
was scored on a three-point ordinal scale. SVMC was scored as “normal” (2 points) if 
the patient could move the tested joint isolated (e.g. without moving other joints), 
within at least 50% of the possible range of motion and at a physiological cadence 
cued verbally by the therapist (e.g. “flex, extend, flex”). If any deviation in performance 
occurred (movement performed slower, below 50% of the range of movement, with 
co-/mirror-/synergistic-movements), selectivity was regarded as “impaired” (1 point). 
The score “unable” was given, if no joint movement could be made or mass-synergy-
patterns occurred. SVMC was scored separately for each joint, for each limb and for 
both limbs together. 
To analyse discriminative validity, patients were classified according to their limb 
involvement and GMFCS level (I-IV). The MMT (Kendall et al. 1993) leg-score was 
used to determine the more and less affected leg. If MMT scores were similar, further 
differentiation was based MAS (Bohannon and Smith 1987) scores. 
To assess the SCALE’s concurrent validity, the FMA (Woodbury et al. 2007) was 
measured. The FMA is a valid assessment tool for testing SVMC in stroke and 
contains specific items for testing selectivity of the knee (items III a; IVa) and ankle 
joint (items III b; IV b). Like the SCALE, the FMA uses a 3-point ordinal scale to score 
(0 = cannot perform; 1 = performs partly; 2 = performs fully) selectivity of the joint 
movement. 
Furthermore, when correctly applied, the MMT should also reflect the selective 
activation of a muscle (group). Therefore strength of the hip and knee flexors and 
extensors and of ankle dorsi- and plantar-flexors were assessed by the MMT (0 to 5; 
(Kendall et al. 1993). 
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Despite spasticity and SVMC being different constructs, spasticity can negatively 
influence SVMC, whereforewe were interested in correlating the SCALE with MAS 
scores (0-4; (Bohannon and Smith 1987). We assessed the MAS also for hip, knee 
and ankle joints.  
The SCALE assessment was video-taped for (intra- and inter-rater) reliability testing, 
in order to minimize participants’ strain. The camera was positioned in front of the 
participant. This position allowed the observation of the tested joint movement and 
possible compensatory and mirror movements of the contralateral limb as well as 
other body parts. Although an additional video from the sagittal plane may have 
allowed for a more accurate evaluation of the range of motion of the ankle and knee 
joint, none of the raters experienced difficulties in evaluating whether the movement 
exceeded 50% of the passive range of motion (one criterion that differentiates 
between normal or impaired SVMC) or not. For reliability testing, the videotaped 
assessment was scored twice within a timeframe of six to eight weeks after the first 
scoring. Rater(s) was (were) blinded to the results of the first scoring (intra-rater) or 
results from the other rater (inter-rater). 
4.3.3 Statistical Analysis 
The Shapiro-Wilk-test showed that most scores were not distributed normally, hence, 
non-parametric statistical tests were used. 
Therefore, a Friedman-test was performed to determine whether SCALE scores 
differed between all joint-pairs of each leg. Alpha was set at 0.05 (two-tailed). Post-
hoc differences between adjacent joints (e.g. hip versus knee), as well as between 
sum scores of the more and less involved leg, were determined with the Wilcoxon 
signed rank test (to adjust for multiple comparisons, alpha was set at 0.01). 
Differences in total SCALE scores for children categorized via GMFCS level were 
evaluated with the Kruskal-Wallis test. A priori post-hoc significance levels were set 
for successive pair-wise testing between adjacent GMFCS levels (e.g. level I versus 
II, II versus III) with Mann-Whitney-U tests (post-hoc tests: alpha=0.025). Effect size 
(r) was calculated in accordance to Rosenthal (1994) (r = │Z / √N│ Abbreviations: Z 
= z-score; N = number of participants (sample)). 
To further evaluate the validity of the SCALE Spearman’s rank correlation coefficients 
(ρ = 1 – (6∑d2) / n(n2 – 1)) between SCALE scores on joint, limb and total levels and 
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FMA, MMT and MAS scores were calculated. Relative intra- and inter-rater-reliability 
was evaluated ICCs 2.1 (two-way mixed model; type absolute agreement: ICC (2,1) 
= MSR – MSE / MSR + (k-1) MSE + (k/n)(MSC – MSE); Abbreviations:  MSR = mean 
square for rows; MSE = mean square for error; MSC = mean square for columns; n = 
number of participants (sample); k = number of raters/measurements; (Koo and Li 
2016)). Absolute reliability was determined by the SEM (SEM=SD x √(1-rxx); 
Abbreviations: SEM: Standard Error of Measurement, SD: Standard Deviation; rxx: 
reliability value (ICC (2,1)) and the minimal detectable change (MDC) (MDC = SEM × 
√2 × 1.96; Abbreviations: SEM: Standard Error of Measurement) (Haley and Fragala-
Pinkham 2006). Statistical analysis was performed with SPSS 17.0 (IBM, Armonk, 
USA).  
4.4 Results 
Forty-two children with spastic CP gave informed consent to participate in this study. 
One child did not complete the assessments due to a lack of compliance. As an 
allocation of the more and less affected leg was not possible in two data sets, these 
datasets were omitted from all analyses. Therefore, demographic and clinical 
characteristics of 39 children with spastic CP (unilateral n=20; bilateral n=19) were 
available. Eighteen children were female. Twenty-three children had a GMFCS level 
I, five had level II, eight level III and three level IV. Further characteristics are 
presented in Table 7. 
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Table 7: Study 2 - Participants’ characteristics 
 
 
Spastic CP (n=39) 
mean age: 12y 6mo [SD 3y 7mo] 
Measures mean (SD) median (IQR) range 
 
SCALE 
less affected leg (x/10) 
more affected leg (x/10) 
total score (x/20) 
 
 
6.6   
4.5  
11.2  
 
 
(2.8) 
(2.0) 
(4.5) 
 
 
7.0  
5.0  
13.0  
 
 
(4.0) 
(3.0) 
(4.5) 
 
 
0 - 10 
0 - 9 
0 - 19 
FMA 
less affected leg (x/8) 
more affected leg (x/8) 
total score(x/16) 
 
5.7  
3.8  
9.6  
 
(2.9) 
(2.5) 
(5.1) 
 
8.0  
5.0  
11.0 
 
(4.0) 
(3.5) 
(8.0) 
 
0 - 8 
0 - 8 
0 - 16 
MMT 
less affected leg (x/30) 
more affected leg(x/30) 
total score(x/60) 
 
24.8  
20.9  
45.6  
 
(6.1) 
(5.5) 
(11.0) 
 
28.0  
23.0  
49.0  
 
(11.0) 
(9.0) 
(17.5) 
 
10 - 30 
9 - 30 
20 – 59 
MAS 
less affected leg (x/24) 
more affected leg (x/24) 
total score (x/48) 
 
1.9  
3.4  
5.4  
 
(3.1) 
(3.2) 
(6.0) 
 
1.0 
2.0  
3.0  
 
(2.5) 
(3.0) 
(5.0) 
 
0 - 14 
1 - 16 
1 - 30 
Abbreviations: MMT: Manual Muscle Test; SCALE: Selective Control Assessment of the Lower 
Extremity; MAS: modified Ashworth Scale; mTUG: modified Time Up and Go test; TCMS: Trunk Control 
Measurement Scale, SD: Standard Deviation; IQR: InterQuartile Range  
The German version of the SCALE can be found in Appendix 4. 
4.4.1 Discriminative validity 
SCALE scores of contra-lateral joint-pairs (e.g. knee vs knee) of the less affected leg 
were significantly higher compared to those of the more affected leg, with the 
exception of the hip joint (Wilcoxon Signed Ranks Test: Z = -1.414 ,  p = 0.157, r (r = 
│Z / √N│) = .226) (Figure 8a). SCALE scores were generally lower for distal compared 
to proximal joints for both legs (Friedman´s-test, Chi-square value of 89,988 (p<0.001) 
for the less affected side, Chi-square value of 129,036 (p<0.001) for the more affected 
side), except of the ankle versus toes for the less affected leg and bilaterally for the 
subtalar joint on toes (Figure 8a). SCALE limb scores were higher for the less (median 
(Mdn)=7; interquartile range (IQR)=0-10) compared to the more affected limb (Mdn=5; 
IQR=0-9; Wilcoxon Signed Ranks Test: Z = -4.649, p<0.001, r = .744.). When 
classifying participants in accordance to their diagnosis, statistically significant 
differences between the less and more affected limb were present for children with 
unilateral limb involvement (less affected: Mdn=9; IQR=7-10 versus more affected: 
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Mdn=4.5; IQR=3-6; Wilcoxon Signed Ranks Test: Z = -3.733, p<0.001, r = .835) and 
bilateral involvement (less affected: Mdn=6; IQR=2.5-6 versus more affected: Mdn=5; 
IQR=3.5-7; Wilcoxon Signed Ranks Test: Z = -2.877, p = 0.003, r = .660) (Figure 8b).  
Furthermore, SCALE scores differed significantly between GMFCS levels (Kruskal-
Wallis-test: Chi-square value = 12.058, p<0.001), and more specifically between 
GMFCS level I and II (Mann-Whitney-U-test: U = 13.500, p=0.007, r = .506)  (Figure 
8c). 
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4.4.2 Correlations  
For the total SCALE score high correlations between and FMA and MMT were found 
(Figure 9a). The magnitude of the correlations between SCALE limb and joint scores 
and the clinical measures were comparable to those presented for the total scores. 
There was a negative moderate correlation between the SCALE and the MAS total 
scores (Figure 9b). 
 
Figure 9: Study 2 – Spearman’s rank correlation coefficient (ρ) of total SCALE scores and common 
clinical assessments for children with spastic CP:  
a) concurrent validity: SCALE versus Fugl-Meyer Assessment (FMA) and SCALE versus Manual Muscle 
Test (MMT); b) correlation SCALE and Modified Ashworth Scale (MAS)  
Abbreviations: SCALE: Selective Control Assessment of the Lower Extremity; FMA: Fugl-Meyer 
Assessment MMT: Manual Muscle Test; MAS: modified Ashworth Scale  
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4.4.3 Reliability 
With ICC values exceeding 0.9 for limb and 0.8 for joint SCALE scores in children with 
spastic, intra- and inter-rater-reliability of the SCALE can be considered excellent. The 
MDC varied between 1.79 and 1.96 points (Table 8). 
Table 8: Study 2 - Intra- and Inter-rater reliability of the SCALE 
  Spastic CP (n=38) 
  Intra-rater reliability Inter-rater reliability 
  less 
affected leg 
more affected 
leg 
less affected 
leg 
more affected 
leg 
Descriptive Mean (SD)1 6.55 (2.86) 4.63 (2.16) 6.55 (2.86) 4.63 (2.16) 
Mean (SD)2 6.00 (2.81) 4.74 (2.50) 6.29 (2.94) 4.53 (2.16) 
Relative 
Reliability 
ICC 0.92 0.96 0.94 0.91 
p value <0.001 <0.001 <0.001 <0.001 
95% CI 0.90 - 0.97 0.93 - 0.98 0.89 - 0.97 0.84 - 0.96 
Absolute 
Reliability 
(SCALE points) 
SEM 0.71 0.64 0.69 0.68 
MDC95 1.96 1.79 1.92 1.88 
Abbreviations: ICC, Intra-class correlation coefficient; CI, Confidence Interval; SD, Standard Deviation; 
SEM, Standard Error of Measurement; MDC95, Minimal Detectable Change at 95% confidence. Please 
note, due to a failure in a video-recording of the SCALE, we could include data from only 38 participants 
in the reliability analyses. 
4.5 Discussion 
Construct validity as well as intra- and inter-rater reliability of the German SCALE 
version in children with spastic CP are supported by this study.  
4.5.1 Validity 
Regarding SCALE’s discriminative validity between adjacent or contra-lateral joint-
pairs, between more versus less affected limb and between GMFCS-levels, the 
hypotheses of this study were partly confirmed and in line with previous results 
(Fowler et al. 2009).  
Concerning the SCALE’s ability to discriminate between the more and less affected 
limb in children with hemi- and diplegia, differences were significant for both groups, 
but for the later subgroup the difference was below the MDC.  
On joint-level, SCALE scores of the hip joint did not differ between the more and less 
impaired limb. This could be due to the limited number of participants with greater 
motor impairment at the hip (e.g. GMFCS level IV) and the large number of children 
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with near maximal scores (ceiling effect: ceiling effect, e.g. 10 participants had a 
maximum total SCALE score for their less affected leg). SCALE scores at most distal 
joint-pairs tended to be lower with an exception for comparison between the subtalar 
joint and the toes. This trend was observed previously by Fowler et al. (2010) and 
Brunnstromm (1966) who reported that selective inversion and eversion were 
described as the most challenging movements for children with CP as well as adult 
stroke patients. As these movements rarely occur in isolation during daily activities 
(but frequently in combination with the movement of other foot-joints in supination or 
pronation), their movement performance might be experienced as unusual. Another 
neurophysiological explanation might be that the cortical representation of the lower 
extremity is largest for the great toe (Rothwell 1987). 
The SCALE’s discriminative validity was reflected in an overall difference between the 
GMFCS levels. Nevertheless, due to the small sample size, there were only significant 
differences between GMFCS level I and II and interpretation should be handled with 
caution. Performing a power analysis (80% power, two-tailed alpha .05) revealed that 
a sample size of 19 participants in GMFCS level II and III and 29 participants in 
GMFCS level III and IV, would be required to determine statistically significant 
differences between these GMFCS levels. 
The strong correlation between the SCALE and FMA, illustrated in figure 9a, confirms 
that both assessments measure broadly similar constructs. Correlation coefficients 
between SCALE and MMT were also of similar magnitude. This could indicate that a 
correctly applied MMT will partially reflect the ability to selectively activate a muscle 
(group).  
Regarding the additional hypothesis in relation to the association between SVMC and 
spasticity, only a moderate negative correlation was found. This result is in line with 
the findings of the previous regression study. Specific in this sample was the large 
variation of SCALE scores in participants with low MAS scores (Figure 9b). This range 
of SCALE scores in children with low spasticity might indicate that a mild level of 
spasticity does not necessarily affect SVMC negatively, while a clearer inverse 
relationship between SCALE and MAS is seen in participants with higher MAS values. 
However, the latter would have to be confirmed in studies including participants with 
a larger ranger of MAS values than reported in our study in which the majority was 
only mildly affected (e.g. mostly GMFCS levels I and II).  
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Furthermore, like Fowler et al. (2009), we found a high inverse relationship (ρ ≤ -0.80) 
between the severity of CP (GMFCS levels) and the total SCALE score. Tying this 
together with the results of the previous regression study, which showed that the 
SCALE strongly correlated with gait capacity (mTUG), the importance of SVMC for 
the child’s mobility level was furthermore shown.  
4.5.2 Reliability 
The hypothesis regarding reliability of the SCALE was confirmed. Excellent intra-and 
inter-rater reliability for the SCALE could be established as well as clinically 
acceptable values of absolute reliability for SCALE limb scores. As these results are 
based on a second rating of video-recordings, the ICC’s might be slightly higher than 
when rated via a second assessment, where interfering factors like the participant’s 
compliance or state of health might have altered testing conditions. For future studies, 
the accuracy of the video recordings could be improved by performing an additional 
video recording from the sagittal plane. However, the current values of this study are 
similar to previously reported observations by Fowler and colleagues (2009).  
4.5.3 Limitations and Methodological Considerations  
With regard to the methodological limitations of this study, it should be mentioned that 
grouping the results for the less and more involved limb might have decreased 
variability between participants, which could have resulted in lower correlation 
coefficients and ICC values. Nevertheless, our observations are broadly comparable 
with previous reports (Fowler et al. 2009). 
4.5.4 Clinical implications and future work 
By establishing validity and reliability properties of the German SCALE version, this 
study contributed to the translated version of the SCALE to the German speaking 
medical field. This enables regular clinical assessment of SVMC of the lower extremity 
in children with CP and might, in the long term, improve medical understanding and 
treatment of this central impairment.  
In order to improve our pathophysiological understanding of the “real” nature of 
SVMC, especially in relation to its connection with spasticity, future cohort-studies 
including participants with also higher levels of spasticity and lower mobility levels 
(GMFCS III-V) would be informative. Furthermore, in order to gain clinical meaningful 
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SCALE threshold values for discriminating between GMFCS levels, future studies 
with a large sample might want to include a ‘ROC curve analysis’. 
In relation to the absolute reliability of the SCALE, it was shown that an increase of 
more than 2 SCALE points for the more affected leg in children with CP could be 
considered a true change (MDC). A future study on the responsiveness of the SCALE 
is needed to provide insight into whether such changes can be achieved with current 
rehabilitative (e.g. training or botulinum toxin) or surgical interventions (e.g. SDR). In 
order to expand SCALE’s application from a diagnostic tool to an evaluative one, and 
to counteract the limitation of its ordinal scale, it might be appropriate to consider 
combining its test procedure with a neurophysiological measure (Dobson 2010; 
Zwaan et al. 2012). 
4.6 Conclusion  
In conclusion, previous results about the SCALE’s validity, inter-rater reliability and 
increased distal impairment of SVMC were supported by this study. New evidence for 
construct validity of the German SCALE version in relation to common clinical tests in 
children with spastic CP, as well as important reliability aspects such as intra-rater 
reliability and MDC values, were added. Future studies need to investigate SCALE’s 
responsiveness and thereby evaluate its sensitivity in measuring therapy-induced 
changes of SVMC of the lower extremity in children with CP. 
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Chapter 5: Study 3 
5.1 Purpose of chapter 
The purpose of this chapter is to describe the methodology and to present and discuss 
the results of the systematic review evaluating psychometric properties of SVMC 
measures. Thereby it aims to answer research questions 7-9, looking for a valid, 
reliable and responsive tool for measuring therapy-induced changes of SVMC in 
children with CP. 
This chapter was published in the Journal Developmental Medicine and Child 
Neurology in 2017: Balzer J, van der Linden ML, Mercer TH, van Hedel HJ. 2017. 
Selective voluntary motor control measures of the lower extremity in children with 
upper motor neuron lesions: A systematic Review. Dev Med Child Neurol. 59(7):699-
705. (Appendix 13). 
5.2 Background 
In accordance to the previous study (study 2) (Balzer et al. 2016), the following two 
main results can be summarized in relation to the German SCALE version. Firstly, 
validity and reliability of the SCALE as an assessment tool for children with CP was 
confirmed. Secondly, the SCALE’s limitation in relation within its ordinal-scaling in 
measuring therapy-induced changes of SVMC were discussed. As the SCALE was 
originally developed for diagnosis and prognostic purpose only, its ordinal scoring 
system might be too broad to measure clinical changes of SVMC. That improvements 
of SVMC are desirable was indicated by the results of the first study (Chapter 1, Balzer 
et al. 2017), showing that the importance of SVMC on gait in children with CP. 
Therefore, a systematic review of the psychometric properties of SVMC measures for 
the lower extremity for children with UMN lesions was carried out. Although the 
population of interest for this PhD project is children with CP, for the purpose of the 
review it was expanded to children with all UMN lesions in order to find all available 
SVMC outcome measures within the neuro-paediatric population.  
As this was, at least to the author’s knowledge, the first review of SVMC outcome 
measures, they were two aims of this review. Firstly, it was aimed to provide an 
overview of all available SVMC assessment tools for the lower extremity. Secondly, 
the level of evidence of the psychometric properties of the identified assessment tools 
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were evaluated. Thereby, the review was aimed to find (if any such tool is available) 
the SVMC outcome measures, which scored best on psychometric properties and 
clinical utility in children with a UMN lesion. The ultimate aim was to identify a measure 
of SVMC with the highest level of evidence for its psychometric properties and the 
best clinical utility. 
5.3 Method 
5.3.1 Search Strategy  
In order to identify studies assessing the psychometric properties of outcome 
measures of SVMC in children with an UMN lesion, the following databases were 
searched without any time limit until July 2016: MEDLINE, EMBASE, CINAHL, 
PsycINFO, SCOPUS, Cochrane and PEDro. The search strategy included keywords 
and synonyms for SVMC, as well as names of tools previously used to measure 
SVMC, the population of interest, and a validated search filter for finding studies on 
measurement properties (Terwee et al. 2009). Please see Appendix 6 for the applied 
search strategies for all searched databases. In addition, the reference lists were 
hand-searched for articles to identify additional studies. 
5.3.2 Study Selection  
A previously developed proprietary database was used (Microsoft Access 2010) to 
systematically enter the data and score the methodological quality of the studies 
(Ammann-Reiffer et al. 2014). Inclusion and exclusion criteria were defined in 
advance. In accordance to the definition of SVMC stated in the introduction, only 
papers dealing with selective movement of one joint of the lower extremity or with a 
primary selective (not synergistic) voluntary multi-joint movement were included. For 
example, papers dealing with the ankle dorsiflexion during initial contact or 
investigating pathological synergy patterns during walking (e.g. activation of the m. 
rectus femoris and m. semitendinosus during swing phase) were included, whereas 
papers measuring SVMC over the whole gait cycle or during gross motor coordination 
tasks were excluded. Considering that SVMC comprehends how accurately and 
smoothly someone can isolate the selection of a particular muscle group, papers 
describing the measurement of submaximal torque steadiness were included (e.g. 
ICF body function level b7300 power of isolated muscle activation). However, studies 
on maximal voluntary contraction were excluded, as patients with impaired SVMC 
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tend to produce maximal force by using mass synergy patterns. Furthermore, 
neuroimaging measures, testing structural and metabolic intactness of the involved 
underlying neurophysiological structures, or networks involved in SVMC (e.g. ICF 
body structure levels 1100 CST, primary cortex) were excluded. Only papers dealing 
with children and youths (3 to 21 years of age) with UMN lesions were included. This 
age range was chosen for neurophysiological reasons (e.g. maturation of the 
corticospinal tract) and practical reasons (e.g. compliance/understanding). Studies 
with the explicit aim to assess one or more psychometric properties were included, as 
well as cohort-studies indirectly investigating the psychometric characteristics of an 
outcome measure by for instance looking at the difference between neurological intact 
children and those with UMN lesion. All other forms of indirect evidence (e.g. 
intervention studies) were excluded. Only manuscripts published in English and 
German were included for review.  
Two reviewers (J.B. and M. vdL.) independently screened all titles and abstracts of 
the papers. In cases of doubt, the full text article was consulted to decide whether or 
not the study met the inclusion criteria. If no consensus could be achieved, there was 
a third reviewer available. 
5.3.3 Quality Evaluation  
Evaluation of the methodological quality of the included papers was carried out 
independently by J.B. and M. vdL. by using the 4-point rating scale (‘excellent’, ‘good’, 
‘fair’, ‘poor’ or ‘not applicable’) of the COSMIN checklist (Mokkink and Terwee 2010). 
As explained in Section 2.3.2, the COSMIN-checklist consists of three domains, 
namely validity, reliability and responsiveness (Mokkink and Terwee 2010). Each 
domain contains one or more measurement properties. The reviewer selects the 
measurement properties (COSMIN boxes) evaluated in the study and scores the 
specific item-lists via the aforementioned ordinal scoring system. The lowest score of 
all items of the chosen COSMIN box determines the overall methodological quality of 
the paper. In line with previous COSMIN reviews in the field of neuro-paediatrics, we 
adopted the overall COSMIN score by omitting the item regarding sample size 
(Ammann-Reiffer et al. 2014; Gerber et al. 2016). 
To ensure that both raters scored the papers in accordance to the guidelines and to 
allow other raters to arrive at the same conclusion, the following procedures were 
established prior to the independent COSMIN rating: raters familiarized with the 
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COSMIN manual and terminology and discussed the scoring of two papers and 
established additional rating rules (Appendix 7). Although the COSMIN manual 
provides general rules for all boxes and items, for some items, the COSMIN rating is 
still open to subjective interpretation, e.g. ‘time interval appropriate’. It is for this 
reason that COSMIN itself recommends specification of additional rules for individual 
reviews (De Vet et al. 2011). If the two reviewers could not agree on a scoring, a third 
reviewer was available.  
For the assessment of the quality of the measurement properties, the updated criteria 
suggested by Terwee et al. (2007) were applied (Appendix 8). The overall level of 
evidence for each SVMC measure and each measurement property was evaluated 
according to the Cochrane Back Review Group Criteria ‘strong’, ‘moderate’, ‘limited’, 
‘conflicting’, ‘unknown’ (Appendix 9) (Van Tulder et al. 2003). This overall score was 
given in relation to the methodological quality of the study and the results of the 
measurement properties. Again, criteria for sample size were adapted as follows: 
sample size > 100 subjects of the combined studies was rated as ‘strong’ [+++ or ---
]; sample size between 50-99 was rated as ‘moderate’ [++ or --]; sample size between 
25-59 as ‘limited’ [+ or -]; and sample size fewer than 25 as ‘unknown’ [?](Ammann-
Reiffer et al. 2014). 
5.4 Results 
5.4.1 Description of the included studies 
The systematic search resulted in 3590 references being identified. Based on the 
titles and abstracts, 33 papers were included for full-text reading. After applying the 
inclusion and exclusion criteria, 17 papers were retained for review (Figure 10).  
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Figure 10: Study 3 - Flow chart systematic review 
These 17 papers described the measurement properties of four clinical, ordinal-
scaled, assessment tools (SMC; mTrost; Gillette’s SMC test; SCALE)and three 
laboratory-based interval-scaled measurement tools (kinematic measures, sEMG, 
and torque steadiness). The majority of studies tested SVMC of the ankle or the knee 
joint. 
The following psychometric properties were evaluated: hypotheses testing/construct 
validity was assessed in 17 studies, reliability in six (inter-rater n=5; test-retest n=3; 
intra-rater n=1) and both content and criterion validity in one study. Responsiveness 
was not evaluated in any study. Most studies tested the SCALE (n=9), followed by 
studies evaluating torque steadiness measures (n=2), kinematic measures (n=4), and 
sEMG of selected lower limb muscles (n=1). The age of the participants in the studies 
included for the final review ranged from two to 21 years, with the exception of one 
study in which the oldest participant was 28 years old. Although this age range was 
slightly wider than the one set by the inclusion criteria (3-21 years), discussing this 
issue ended in the common decision for inclusion. As the main age ranged from 9 
years and 3 months to 16 years, the youngest and the oldest participant were seen 
as outliers. Sample size varied from eight to 51 participants. All studies included 
children with a diagnosis of cerebral palsy. In two cohort studies, data of children with 
CP who had undergone a SDR were compared to those of a control group children 
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with CP who had not (Engsberg et al. 2004). The comparison of SVMC between 
children with and without SDR was therefore considered an assessment of the validity 
of the SVMC tool. Four other cohort studies (Manikowska et al. 2016; Anon n.d.; 
Bandholm et al. 2009; Arpin et al. 2013) investigated the construct validity of the 
SVMC instrument, by comparing patients with CP versus participants who were 
neurologically intact. General characteristics and clinical utility for each SVMC 
measure is summarized in Table 9. The methodological quality per measurement 
property as well as the overall evidence criteria can be seen in Table 10. 
5.4.2 Hypotheses testing  
Of the 17 papers, which evaluated construct validity (‘hypotheses testing’), ten papers 
included clinical assessment tools and seven papers laboratory-based measurement 
tools (Table 9 and 10)  
Nine of the ten papers regarding clinical assessment tools evaluated construct validity 
of the SCALE. The modified COSMIN scores of three of these eight SCALE papers 
were ‘good’ (Fowler and Goldberg 2009; Fowler et al. 2010; Goldberg et al. 2011), 
four were rated as ‘fair’ (Fowler and Goldberg 2009; Rha et al. 2016; Rha et al. 2015; 
Lim 2015),one as ‘excellent’ (Balzer et al. 2016) and one as ‘poor’ (Yasuaki Kusumoto 
et al. 2016). Quality of construct validity was evaluated in accordance to Terwee et al. 
(2007) as ‘positive [+]’ in eight papers (Fowler et al. 2009; Fowler et al. 2010; Goldberg 
et al. 2011; Fowler and Goldberg 2009; Rha et al. 2015; Rha et al. 2016; Lim 2015; 
Balzer et al. 2016) and as mixed ‘positive/negative [+]/[-]’ in one study (Yasuaki 
Kusumoto et al. 2016). Overall, there was ‘moderate positive [++]’ evidence (Van 
Tulder et al. 2003) for construct validity of the SCALE in terms of: i) its correlation with 
the GMFCS (Fowler et al. 2009; Balzer et al. 2016) and ii) its proximal-distal 
concordance (SVMC is more often and/or more severely impaired in distal body parts) 
(Fowler et al. 2010; Balzer et al. 2016). A ‘limited positive [+]’ evidence level was given 
for its validity testing with the Berg Balance Scale (Lim 2015) and for predicting knee 
flexion during initial contact during stance phase of gait (Rha et al. 2016). Three 
studies investigated relationships between total limb SCALE scores and knee flexion 
during swing phase. Two studies (Goldberg et al. 2011; (Fowler and Goldberg 2009) 
found significant correlations,one did not (Rha et al. 2015). Therefore, their level of 
evidence was rated as ‘conflicting [±]’. In relation to the poor quality of the Kusumoto 
et al. (2016) study, who investigated the relationship between the SCALE and knee 
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extensor strength, its level of evidence was rated as ‘unknown [?]’. Therefore, this 
study did not contribute to the overall evidence level of the SCALE.”  
In the other three SVMC clinical assessment tools, construct validity was only 
evaluated for Gillette’s SMC test. The study of Manikowska and collaegues (2016) 
compared Gillette’s knee flexion SMC scores in patients with CP versus participants, 
who were neurologically intact using electromyography. This study received a ‘poor’ 
modified COSMIN score, but results were rated as ‘positive [+]’ in accordance to 
Terwee et al. (2007). The level of evidence (Van Tulder et al. 2003) was evaluated as 
‘unknown [?]’. 
Seven papers investigated construct validity of SVMC using laboratory-based 
measurement tools including lower limb kinematics (Engsberg et al. 2004; Engsberg 
et al. 2008; Goldberg et al. 2011; Fowler and Goldberg 2009), sEMG (Zwaan et al. 
2012) and torque steadiness (Bandholm et al. 2009; Arpin et al. 2013). Two kinematic 
papers (Goldberg et al. 2011; Fowler and Goldberg 2009) were already evaluated in 
relation to the SCALE’s construct validity in the previous paragraph. As there is no 
gold standard measure for quantifying SVMC, and the papers are cohort studies 
investigating the correlation between the SCALE and kinematic measures for SVMC, 
they could be regarded as studies investigating the construct validity of the SCALE, 
but also of the kinematic measures, depending on which measure is regarded as more 
‘established’.  As the quality and evidence rating of the two studies (Goldberg et al. 
2011; Fowler and Goldberg 2009) is the same as presented above, the results will not 
be repeated here. Their COSMIN methodological quality was rated as ‘fair’ and quality 
of construct validity was rated as ‘positive [+]’ in three studies (Engsberg et al. 2008; 
Bandholm et al. 2009; Arpin et al. 2013) and as mixed ‘positive/negative [+]/[-]’ in two 
(Engsberg et al. 2004; Zwaan et al. 2012). As the sample size was too small (n<25) 
in three studies, the evidence level was only scored for one kinematic (Engsberg et 
al. 2008) and one sEMG (Zwaan et al. 2012) study. As the results of these studies 
were ambiguous in supporting the construct validity of the SVMC measurement 
method, a ‘conflicting [±]’ evidence rating was assigned. 
Overall, the methodological quality of the majority of the above mentioned studies was 
reduced due the absence of a priori formulated hypotheses, thereby limiting their 
COSMIN (Mokkink and Terwee 2010) as well as validity quality (Van Tulder et al. 
2003) scoring. 
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5.4.3 Content and Criterion Validity 
Content and criterion validity were only assessed for the SCALE (Table 10) (Fowler 
et al. 2009; Balzer et al. 2016) COSMIN rating (Mokkink and Terwee 2010) of content 
validity was considered ‘poor’. Although 14 experts were involved on item-agreement 
for statements about content, administration and grading of the SCALE, the paper 
lacked a description whether all items were relevant for the construct or for the 
population of interest (Fowler et al. 2009). The quality rating of the results  (Mokkink 
and Terwee 2010) was scored as ‘indeterminate [?]’, and the evidence as ‘unknown 
[?]’. 
The method applied to establish criterion validity of the SCALE was rated as 
‘excellent’ (Balzer et al. 2016). As the Fugl-Meyer Assessment (item III and IV) 
measures a similar construct as the SCALE and their correlation exceeded 0.70, the 
SCALE criterion validity results were rated as ‘positive [+]’. Therefore, a ‘limited 
positive [+]’ evidence level was given for criterion validity of the SCALE. 
5.4.4 Reliability  
Reliability was investigated in three of the four clinical assessment tools (SMC 
(Löwing and Carlberg 2009; Smits et al. 2010), mTrost (Smits et al. 2010), SCALE 
(Fowler et al. 2009; Balzer et al. 2016)) and in two of five laboratory-based SVMC 
tools (kinematic (Engsberg et al. 2004), torque (Bandholm et al. 2009)). The SMC 
test-retest reliability was tested in two studies (Löwing and Carlberg 2009; Smits et 
al. 2010). The modified COSMIN rating for SMC inter-rater reliability ranged from ‘fair’ 
(Smits et al. 2010) to ’good’ (Löwing and Carlberg 2009). The methodological quality 
of inter-rater reliability of the mTrost test was also rated ‘fair’ (Smits et al. 2010). Inter-
rater reliability of the SCALE was tested by two studies and scored as ‘excellent’ 
(Balzer et al. 2016) and ‘good’ (Fowler et al. 2009). The SCALE’s intra-rater reliability 
was further investigated and received a ‘good’ modified COSMIN score (Balzer et al. 
2016). The methodological quality of test-retest reliability for the kinematic (Engsberg 
et al. 2004) and torque steadiness (Bandholm et al. 2009) measure was evaluated as 
‘good’. Overall, studies assessing inter-rater reliability were rated lowest for COSMIN 
items describing the statistical procedures (e.g. description of weighted scheme ICC, 
Kappa). The items regarding the stability of participants between the two or more 
assessments and the description of test conditions were the most limiting items for 
the four studies on test-retest and intra-rater-reliability.  
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Applying the quality criteria (Terwee et al. 2007) for measurement properties revealed 
‘positive [+]’ results for four reliability studies (Engsberg et al. 2004; Fowler et al. 2009; 
Balzer et al. 2016; Löwing and Carlberg 2009); mixed‘ positive/negative [+]/[-]’ results 
in three studies (Bandholm et al. 2009; Löwing and Carlberg 2009; Smits et al. 2010), 
and negative [-]’ results for inter-rater reliability of the SMC test (Smits et al. 2010).  
When evaluating the overall evidence level using Cochrane guidelines (Van Tulder et 
al. 2003), we found ‘moderate positive results [++]’ for the inter- and intra-rater 
reliability of the SCALE (Fowler et al. 2009; Balzer et al. 2016). ‘Moderate negative 
results [- -]’ were evident for the inter-rater reliability of the SMC (Löwing and Carlberg 
2009; Smits et al. 2010) and ‘limited negative results [-]’ for the m-Trost (Smits et al. 
2010). Due to the low sample size (n<25), the evidence level of the test-retest 
reliability of the kinematic (Engsberg et al. 2004) and torque steadiness measurement 
(Bandholm et al. 2009) studies was scored as ‘unknown [?]’ 
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5.5 Discussion  
This review revealed a limited number of psychometric studies investigating SVMC 
measures in children with UMN lesions. The overall evidence was further limited, 
because10 out of 17 studies were cohort studies with a limited methodological quality 
(e.g. ‘poor’ or ‘fair’) - except one study (Fowler and Goldberg 2009), which scored 
‘good’ according to modified COSMIN rating guidelines. No study investigated 
responsiveness, which would be crucial regarding the measurement of therapy-
induced changes of SVMC.  
The chosen age range (2-21 years) for this review, might have been wide when 
considering developmental issues which are known to influence SVMC (e.g. 
maturation of CNS function), as well as the importance of the participants’ cognitive 
understanding and motivation for the SVMC measurement procedure/testing. 
Nevertheless, this age range was chosen due to the overall limited number of studies 
available for review. Future studies regarding SVMC measures may choose to 
investigate psychometric properties in separate age groups (e.g. pre CNS maturation 
2y-7y and post < 8 years). 
5.5.1 SVMC Assessment Tools 
The SCALE was the most often investigated assessment tool, in terms of the number 
of studies conducted and in the number of its measurement properties investigated. 
The SMC and m-Trost were only rated on reliability, thus lacking evidence on their 
validity. The Gillette’s SMC test was only investigated on its validity, lacking evidence 
about its reliability. In terms of psychometric quality, the SCALE had the highest level 
of evidence with a moderate positive level of evidence concerning its inter-rater 
reliability and its construct validity, and an unknown and limited level of evidence of 
content and criterion validity, respectively. Another advantage of the SCALE in 
comparison to the other assessment tools (SMC, m-Trost,) lies in its evaluation of five 
lower extremity joints rather than one or three joints. In addition, clinical utility (Table 
9) of the SCALE, as well as of the other SMC assessment tools, was scored high as 
time, costs and resources are low. However, in terms of limitations, the SCALE’s 
ordinal scoring system relies on the impression of the rater (e.g. therapist, consultant), 
which make it to a subjective measurement. Finally, as discussed already in the last 
chapter, the SCALE’s ordinal scoring system (normal, impaired, and unable) may lack 
sensitivity to detect certain therapy-induced changes of SVMC.  
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5.5.2 SVMC laboratory-based Measures  
The construct validity of the kinematic, sEMG and torque steadiness was assessed, 
but none of the papers evaluating these measurement techniques explicitly 
mentioned that the assessment of validity was an a priori objective. Because of this, 
the formulation of hypotheses was often absent thus diminishing their modified 
COSMIN score to ‘fair’. Only two laboratory-based SVMC measures (kinematic 
(Engsberg et al. 2004) and torque steadiness (Bandholm et al. 2009)) were assessed 
regarding their test-retest reliability. In terms of psychometric quality as well as clinical 
utility (see Table 9), none of the identified laboratory-based measures seem to offer 
a great advantage over the other. The equipment that was required to record the 
outcome measures was often customized, making it difficult for other groups 
(researchers or clinicians) to apply and confirm or extend findings of studies exploring 
the laboratory-based measures using sEMG, kinematics or torque measurements. 
Furthermore, the measurement procedures appear time consuming and complex in 
comparison to more routinely applied clinical assessments. Personnel also required 
extensive training in the application and analysis of these measures (see Table 9).  
In summary, the results from this systematic review show the limited level of evidence 
regarding the psychometric properties (reliability and validity) and absence of 
evidence regarding the responsiveness of currently available SVMC measures of the 
lower extremity in children with UMN lesions.  
5.5.3 Limitations and methodological considerations  
Low inter-rater agreement when rating the quality of the evidence in systematic 
reviews (e.g. rating Risk of Bias in Cochrane type reviews) can be an important 
methodological issue, which should be considered when conducting a systematic 
review (Jørgensen et al. 2016). In this review, agreement between the raters for all 
COSMIN items was high. Only five out of 246 items needed further discussion, and 
none required the rating of a third reviewer. This high agreement was likely the result 
of the specific rating rules, which we established as recommended by the COSMIN 
group. For example, when scoring the reliability items 4-7 for the SCALE, we decided 
in advance to score the use of video for the evaluating of the inter- and intra-rater 
reliability as appropriate, because this allows a discrete evaluation of the scoring 
system by maintaining the stability of test conditions and patient status, as well as 
saving on time and resources. In contrast, a video approach was not considered to 
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be appropriate for determining test-retest reliability when the stability of the patient is 
evaluated.  
In line with other neuro-paediatric COSMIN reviews (Ammann-Reiffer et al. 2014; 
Gerber et al. 2016; Lennon et al. 2015), the rating of the sample size item (modified 
COSMIN score) was modified. This is, because the sample size is often limited in 
clinical neuro-paediatric studies and not comparable with large scale epidemiological 
healthcare studies using patient-reported outcome measures for which the COSMIN 
guidelines were initially evaluated. This modified scoring improved the overall rating 
of all studies with the exception of the construct and content validity score of the 
studies from Fowler et al. (2009) and Zwaan et al. (2012). Although this modified score 
was, it would be recommended for future psychometric studies to include studies with 
a sufficiently large sample size (>30).  
Other reasons for scoring poor were the lack of ‘a priori’ formulated hypotheses (box 
‘hypothesis testing’) and for one study (Fowler et al. 2009) the lack of evaluating each 
item separately for its content validity (box ‘content validity’). While it was considered 
to be important that each single question should be evaluated separately for its 
content validity in a Health Care Questionnaire (where the COSMIN was originally 
developed for), it could be questioned whether the same rating rules are necessary 
for an assessment tool like the SCALE that consists of a similar procedure repeated 
for different joints.  
5.5.4 Clinical implications and future work 
The results of this review show that the SCALE is the most frequently investigated 
assessment method in the population of CP children and also, that is has the highest 
quality rating of the evidence of its psychometric properties. Its responsiveness to 
change has not been assessed, but it may be expected that due to its ordinal scoring 
system its sensitivity to measure changes of SVMC is limited. To improve its 
sensitivity and simultaneously to benefit from its child-friendly procedure, combining 
the SCALE with another, more sensitive measure appears to be promising. This idea 
has also been proposed in the previous study of this PhD project (Chapter 4, Balzer 
et al. 2016) as well as in other studies (Zwaan et al. 2012; Dobson 2010). While Zwaan 
et al. (2012) found no convincing evidence for detecting extensor and flexor synergies 
during gait using sEMG in children with CP, they reported a significant cross-
correlation between extensor synergy activities measured using sEMG and the m-
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Trost test. They concluded that “sEMG measures still may be useful for selective 
motor control measurement because it measures selectivity at the level of the specific 
muscles involved, provided the appropriate task is used” (Zwaan et al. 2012). As 
walking requires selective as well as synergistic movements, this may not be an 
appropriate task for the assessment of SVMC. The tasks embedded in the SCALE 
(isolated single-joint movements) were developed in accordance with the definition of 
SVMC (Sanger et al. 2006; Fowler et al. 2009). Combining SCALE’s ratings for single-
joint movements with sEMG, recordings would further allow for directly measuring 
voluntary activation of a muscle even in patients with low muscle strength (manual 
muscle test grade of 1), whereby no real joint movement occurs. 
5.6 Conclusion  
This systematic review revealed a limited number of psychometric studies evaluating 
the validity and reliability of SVMC measures in children with UMN lesions, whereas 
no studies evaluated responsiveness. The SCALE appeared to have the highest level 
of evidence regarding its reliability and construct validity compared to other clinical 
and laboratory-based measures of SVMC. Nevertheless, SCALE’s application as a 
measure to assess therapy-induced changes in SVMC is questionable due to its 
broad scoring system. Concrete ideas on how to expand SCALE’s application to 
sensitively measure therapy-induced changes of SVMC in children with UMN lesions 
were present.    
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Chapter 6: Study 4 
6.1 Purpose of chapter 
This chapter provides an overview of how the last study developed within the context 
of this PhD project. Furthermore, research questions 10 to 13 of Section 2.4 will be 
answered by describing the chosen method and presenting as well as discussing the 
study results. 
This chapter is in preparation for being published in the Journal Neurorehabilitation 
and Neural Repair. 
6.2 Background 
The results of the previously described three studies (Balzer et al. 2016; Balzer, 
Marsico, et al. 2017; Balzer, van der Linden, et al. 2017) led to the design of this fourth 
study. First, the regression study showed the relevance of SVMC for mobility in 
children with CP and thereby underlined the importance of determining this negative 
UMN sign (Balzer, Marsico, et al. 2017). Second, the appropriate feasibility, validity 
and reliability of the SCALE as a diagnostic and prognostic assessment tool was 
confirmed. Third, the systemic review (Balzer, van der Linden, et al. 2017) revealed a 
lack of responsive SVMC outcome measures that are required detecting therapy-
induced changes of SVMC. In addition, the results of the systematic review also 
showed that the SCALE was the tool with the highest level of evidence regarding its 
reliability, validity and clinical utility. Consequently, the idea arose to use the SCALE 
testing procedure, and to measure the level of SVMC via an appropriate interval-
scaled measurement tool. In accordance with the systematic review results, EMG is 
suggested as a suitable measure to collect during the SCALE testing due to the 
following reasons: i) it measures SVMC in accordance to the definition of SVMC: 
focusing on muscle activation during single-joint movement (Sanger et al. 2006), ii) it 
can detect voluntary activations without actual or during small joint movements 
(allows for measuring patients with muscle weakness as well); iii) it is also applicable 
for bilateral involvement (detecting mirror movements) and iv) its child friendly 
application (e.g. short duration, non-invasive). However, besides these benefits of 
sEMG, its limitations when used as a repeated measure are also well known. 
Differences in electrode placement, muscle size, subcutaneous fat thickness and 
muscle-fibre geometry can lead to absolute amplitude differences both within and 
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between participants. Normalization techniques to minimize this variability have been 
shown to be less appropriate in children with CP, due to their inability to reliably 
perform maximal voluntary contractions (Shuman et al. 2017; Zwaan et al. 2012; 
Bojanic et al. 2011). The Similarity Index (SI) is an outcome measure derived from 
sEMG, which uses bilateral prototype activation-patterns (collected from a 
neurologically healthy control group) in order to decrease the impact of this inter and 
intra subject variability. In the original paper (Lee et al. 2004), the SI is calculated as 
part of the Voluntary Response Index (VRI), that was developed for measuring 
selectivity in patients with spinal cord injury. The SI was one of the outcome measures 
resulting from the initial systematic search (study 3) aiming to identify SVMC tools 
used in the entire population of UMN lesions (Balzer, van der Linden, et al. 2017). 
The SI is a measure of the similarity between the sEMG pattern of lower leg muscles 
(5 for each leg) during a maximal standardized movement derived from a participant 
with a UMN and average pattern derived from a health control group. Mathematically, 
the participants’ SVMC is thereby expressed as a ten-dimensional vector, which is 
compared in length and direction with the norm-vector. The SI can take any value 
between 1 to 0. While values close to “1” indicate that the SVMC is (near) normal, 
lower values indicate that the sEMG pattern of the movement deviates from the norm. 
Because the SI is derived from both legs, co- and mirror movements lower the value 
of SI, hence indicating a more abnormal sEMG pattern. However, the SI takes every 
muscle activation into account and cannot differentiate between physiological prime 
mover activities and pathological co- and/or mirror activities. As such, the SI is an 
unweighted measure, which compares the overall activation pattern of all involved 
muscle with the mean activation pattern recorded for the healthy population (norm).   
In summary, the sEMG based SI algorithm has the following properties. I) It employs 
a normalization technique by including norm data from a neurologically intact control 
group. Thereby, it is not dependent on other normalization techniques (i.e. maximal 
voluntary contractions), which have shown to be inaccurate when performed with 
children with CP. II) The SI can detect, although not differentiate bilateral co- and 
mirror-activations, which are important in relation to the definition of SVMC. III) It uses 
a standardized testing procedure (single and multi-joint movements), which is similar 
to the testing movements of the SCALE procedure. Therefore, calculating the SI 
algorithm when using the SCALE procedure for testing seems feasible. IV) It has 
acceptable validity and reliability in patients with spinal cord injuries (McKay et al. 
2005; Lim and Sherwood 2005; Lee et al. 2004). V) It measures SVMC on an interval 
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scale. Accordingly, the SI seemed to be an appropriate interval measure, capable of 
measuring SVMC while asking the child to perform the SCALE testing procedure. 
Therefore, the aim of this study was to investigate the validity and reliability of the 
‘SCALE-SI’, in which the SI algorithm objectively quantified SVMC while the child is 
performing the SCALE testing procedure. In line with study 2 (Balzer et al. 2016) as 
well as with the assessment of the validity of the SCALE’s performed by Fowler et al. 
(2009), the following hypotheses were formulated to investigate the validity of the 
SCALE-SI. Firstly, to establish concurrent validity of the SCALE-SI, a high positive 
correlation (p>0.70) between the SCALE-SI and the SCALE was expected. Secondly, 
concerning its discriminative validity, the following statistically significant differences 
were expected: i) between children with CP and neurological intact children; ii) across 
all and between SCALE-SI joint scores (hip vs. knee) for each limb (Children with CP 
only), and iii) between the less and more affected limb (children with CP only). Finally, 
test-retest reliability should be at least moderate, with ICC values exceeding 0.65 
(similar levels as in the study of Lim and Sherwood 2005) and acceptable absolute 
measurement errors. 
6.3 Method 
6.3.1 Participants  
Thirty-one neurologically intact adults were recruited by convenience sampling in 
order to collect norm values needed for the calculation of the SI. Adults between 18 
and 50 years, who were symptom-free in terms of any central or peripheral 
neurological injury and who had no surgery of the lower limbs within the last year, 
were included. 
Furthermore, in- and out-patients of the “Rehabilitation Centre Affoltern am Albis, 
University Children’s Hospital Zurich” were recruited by convenience sampling from 
June 2017 until March 2018. According to recommendations for adequate sample 
size for assessment of validity, we aimed to include 30 children with CP (Mokkink and 
Terwee 2010). Inclusion criteria were: clinical diagnosis of spastic or mixed CP, age 
between 5 and 20 years, and ability to follow simple instructions. Children with a 
primarily dystonic or ataxic impairment, an unstable situation regarding their tonus-
regulating medications and/or children who had a botulinum toxin injection within the 
last 6 months or any surgical correction within the last year of the lower extremity were 
excluded. For establishing discriminative validity, 32 neurologically intact children 
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were recruited. Only children and young people aged 6-18 years, and without any 
medical history of neurological and/or orthopaedic diagnosis within the lower 
extremity were included.  
The study was approved by the ethical committee of the Canton of Zurich (KEK-ZH-
Nr.2011-0404). Informed consent and assent were obtained from parents and 
participants, respectively. 
6.3.2 Measurements 
All tests were carried out by a team of three testers (one experienced neuro-paediatric 
physiotherapist and two human movement scientists) within a maximum timeframe of 
1h and in accordance to standardized procedures.  
In order to gain information about the degree of spasticity, the MAS (0-4) was applied 
for flexors and extensors muscle of the hip, knee and ankle joint (Bohannon and Smith 
1987). 
For the SCALE-SI, which consisted of the SCALE testing procedure while 
simultaneously recording bilateral multichannel sEMG activities, the following sEMG 
setting was applied. Self-adhesive Ag/AgCl dual snap gel electrodes (Noraxon Inc, 
Scottsdale/USA) with a diameter of 10 mm and an inter-electrode distance of 20 mm 
were applied bilaterally in accordance to SENIAM guidelines to the following muscles: 
m. gastrocnemius medialis (GM), m. peroneus longus (PL), m. tibialis anterior (TA), 
m. rectus femoris (RF), and m. semitendinosus (ST). The recorded sEMG data was 
then offline processed with the SI algorithm to quantify SVMC. The participant was 
then positioned on a custom-made wooden seat-rest, which had been furnished with 
special openings for the sEMG sensors of the ST (Figure 11a).  
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Figure 11: Study 4 - SCALE-SI testing setup: 
a) Customized testing seat for avoiding pressure on the sEMG sensors of the m. semitendinosus; b) 
Leg-holder for ankle and STJ movements; c) Recorded norm SCALE-SI sEMG-patterns of the right 
Subtalar Joint (STJ) data set STJ movements, Note: Trigger-Markers for each movement direction 
(event-window).   
Abbreviations: R / L TibAnt: right / left m. tibialis anterior; R / L PeronLong: right / left m. peroneus longus; 
R / L RectusFem: right / left m. rectus femoris, R / L Gastroc: right / left m. gastrocnemius; R / L Semitend: 
right / left m. semitendinosus 
First, baseline activity of one minute was recorded in sitting position, while the legs 
were hanging relaxed. Then, the original SCALE testing procedure was carried out to 
assess SVMC at the hip, knee, ankle and subtalar joints. SVMC of the toes was not 
measured due to impracticability of applying EMG on small foot-muscles of children. 
In order to minimize positional changes, which are known to interfere with sEMG 
measures, the SCALE procedure was slightly adjusted by, firstly, testing SVMC of the 
hip in sitting (instead of lying) position and, secondly, by changing the order of testing 
of the joints: knee, ankle, STJ, hip (instead of hip, knee, ankle, STJ). Furthermore, to 
maximize relaxation of the muscles, which would not become activated under 
physiological movement, the following adaptations were made, and the following 
standardized instructions were given. The lower leg was positioned on a pedestal just 
 109 
proximal to the ankle joint to allow for maximal relaxation of the RF while assessing 
ankle and STJ movements (Figure 11.B). Before each joint movement, the child was 
instructed to relax all other muscles as much as possible and to focus just on the 
muscles, which were used to move the body segment. 
In line with determining leg dominance (Chapman et al. 1987), we determined the less 
affected leg by asking participants with which leg they kick a ball. In children with CP, 
we also relied on the diagnosis (e.g. in cases of unilateral spastic CP).   
For the assessment of test-retest reliability of the SCALE-SI in children with CP, the 
measurement was repeated by the same tesing team under similar conditions (time 
of day, room). In order to have stable yet independent measurements, assessments 
were repeated seven to15 days later and data were written on a new blank collection 
form. 
6.3.3 Data recording and processing  
Data acquisition was performed with a 16-channel Myosystem 1400A (Noraxon Inc, 
Scottsdale/USA) with a sample frequency of 1000 Hz and a bandwidth of 30–500 Hz. 
sEMG patterns of the ten muscles were recorded during the four joint movements 
within one session. In line with the SCALE manual, each joint movement was 
performed bidirectionally (e.g. knee: extension, flexion) and fluently repeated three 
times (e.g. no rest, in one smooth action). Event markers, identifying the start and end 
of each of these voluntary movement (e.g. knee: extension, flexion, extension, flexion, 
extension, flexion) (Figure 11c), were triggered manually by the tester who observed 
the movements. A total of 56 event markers was set per SCALE-SI procedure (e.g. 
per joint, seven markers to identify the three repetitions of each movement direction 
(flexion / extension)); this was repeated for each of the eight joints that were tested).  
All sEMG signals were filtered using a 20 HZ high pass filter (Finite Impulse Response 
(FIR) filter). An Infinite Impulse Response (IIR), 50Hz Rejecter filter, was only used 
for signals which showed 50Hz noise due other electronic devices. Correct event 
marker placement as well as artefact detection took place via visual off-line inspection. 
Position and reason for the all movement-artefacts were documented for the further 
data processing. Movement artefacts occurred either due to involuntary sEMG-cable 
contact with seat or due to manual sEMG-sensor contact by the participants. 
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Further sEMG data analysis was performed using Matlab (version 2017b). Firstly, 
movement artefacts were corrected manually by removing (minimal cutting) them 
from the data. Second, baseline correction was performed by using the lowest activity 
values for each of the 10 muscles recorded during the test trial itself. This deviation 
from the original protocol was necessary, because the muscle activity during the initial 
baseline-trial was in many participants higher than during the SCALE-SI trial, causing 
negative values. Next, the sEMG data within each movement event-window was 
rectified using a root mean square (RMS) algorithm. The rectified individual 
manoeuvre sEMG data were then averaged across the three repetitions of each motor 
task (e.g. extension-flexion, extension-flexion, and extension-flexion). The SI 
quantifies the similarity between the sEMG activation-pattern of the participant and 
the norm (derived from the adult control group) and was calculated using the algorithm 
described by Aslan et al. (2013). The SI is one of the numeric outcomes of the VRI, 
which furthermore comprises of the “Magnitude” (Mag). The Mag is derived from the 
total mean activity of all ten muscles recorded during the voluntary motor task. It 
represents the length of the ten-dimensional vector. The following four equations were 
used: 
Equation 1: Response Vector (RV): The RV consists of the mean activity of each of the ten muscles, 
averaged over the three movement repetitions (e.g. extension-flexion), and was derived for each of the 
eight joint movements per leg. Quantitatively, the RV describes the absolute activity in each muscle 
during each phase of each movement. 
 
(Aslan et al. 2013) 
Equation 2: Magnitude (Mag): The magnitude of the RV is calculated by using the square root of the 
sum of the squares of the activity of each of the 10 muscles; it represents the length of this vector. 
 
(Aslan et al. 2013) 
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Equation 3: The Prototype Response Vector (PRV) was computed by averaging the RVs of the 31 
neurologically intact adults. 
 
(Aslan et al. 2013) 
Equation 4: Similarity Index (SI): The SI is the scalar product of the norm response vector and a 
participant’s response vector divided by the product of their magnitudes. It ranges from 0 to 1. Values 
close to “1” indicate that the participants’ SVMC is very similar to that of the norm.  
 
(Aslan et al. 2013) 
6.3.4 Statistical Analysis 
As the Shapiro-Wilk-tests showed that the majority of SCALE-SI scores (joint, leg, 
total) were not normally distributed, non-parametric tests were applied to test our a 
priori formulated research hypotheses. Data were presented for the less and more 
affected leg.  
Concurrent validity was evaluated by calculating Spearman’s rank correlation 
coefficients (ρ = 1 – (6∑d2) / n(n2 – 1)) between SCALE-SI and conventional SCALE 
scores for each separate joint (joint score: 2-0), limb (summed joint score per leg: 0-
10), and the total scores (summed leg score: 0-20), respectively, as well as between 
the SCALE-SI total score and the GMFCS level. 
The discriminative validity of the SCALS-SI was determined using the following 
statistical tests: i) a Mann-Whitney U Test to compare differences of the SCALE-SI 
scores (separate joints, limb, total) between children with CP and their neurologically 
intact peers; ii) a Friedman Test to determine whether SCALE-SI scores differed 
between the four adjacent joint pairs within a limb and consecutive post-hoc Page 
tests in order to evaluate differences between joint pairs (e.g.,hip versus knee),and 
iii) a Wilcoxon Signed Rank Test to investigate whether differences exist between the 
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less and more affected leg within a group of children with either bilateral or unilateral 
leg involvement. Effect size (r) was calculated in accordance to Rosenthal (1994) (r = 
│Z / √N│). Alpha was set at 0.05 (two-tailed) (Portney and Watkins 2000). 
Relative test-retest reliability was evaluated by a two-way random ANOVA model (ICC 
(2,1) = MSR – MSE / MSR + (k-1) MSE + (k/n)(MSC – MSE) (Koo and Li 2016)), as 
each participant was rated by a single rater and the results were to be generalized to 
other raters. Correspondingly, 95% confidence intervals were calculated for joint and 
leg scores as well.  
Absolute reliability was determined by the SEM (SEM=SD (of test and retest) x √ (1-
rxx (ICC2.1))) and the MDC (MDC= SEM × √2 × 1.96) (Haley and Fragala-Pinkham 
2006). Statistical analysis was performed with R. Studio (version 3.4.0). 
6.4 Results 
Twenty-four children with spastic and mixed type of CP (bilateral n=20; unilateral n=4) 
gave informed consent to participate in this study. Age ranged from 6y9m to 17y4m. 
Fourteen participants were male. Nine children had GMFCS level I, four had level II, 
five level III and six level IV. Further characteristics are presented in table 11. Due to 
organizational issues, three children could not participate in reliability testing. 
Therefore, 24 data sets were available for validity testing and 21 for reliability testing.  
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Table 11: Study 4 – Participants’ characteristics 
Abbreviations: SCALE-SI: Selective Control Assessment of the Lower Extremity – Similarity Index; MAS: 
Modified Ashworth Scale; sd: standard deviation; IQR: Interquartile Range. MAS* (n=21): Due to 
organizational issues, three children could not participate in reliability testing. 
A descriptive summary of the norm (neurological intact adults n=31 (female n=14); 
mean age of 33y 7mo [SD 7y 4mo]) and control group (neurological intact children 
n=32 (female n=16); age range from 6y to 17y6m [SD 3y 5mo]) is shown below (Table 
12). 
  
Participants’ characteristics: children with CP (n=24) 
 less affected leg more affected leg  
hip knee ankle STJ leg hip knee ankle STJ leg Total 
SCALE-SI (n=24) 
mean 0.75  0.76 0.84 0.83 0.79 0.71 0.72 0.72 0.67 0.70 0.75 
Sd 0.17 0.18 0.19 0.15 0.14 0.19 0.20 0.26 0.24 0.17 0.14 
median 0.76 0.78 0.93 0.89 0.83 0.77 0.74 0.80 0.63 0.71 0.75 
IQR 0.30 0.29 0.20 0.26 0.17 0.19 0.36 0.39 0.35 0.19 0.26 
range 
0.39- 
0.98 
0.40-
0.97 
0.37- 
0.99 
0.52- 
0.97 
0.50- 
0.94 
0.31- 
0.99 
0.39- 
0.99 
0.19-
0.99 
0.16- 
0.99 
0.41- 
0.95 
0.19- 
0.52 
SCALE (n=24) 
mean 1.38 1.33 1.38 1.12 5.21 1.25 1.21 0.92 0.62 4 9.21 
Sd 0.58 0.64 0.71 0.9 2.26 0.53 0.59 0.83 0.65 2.11 4.04 
median 1 1 1.5 1 5.5 1 1 1 1 4 9.5 
IQR 1 1 1 2 3.25 1 1 2 1 4 0 
range 0-2 0-2 0-2 0-2 1-8 0-7 0-2 0-2 0-2 0-2 1-15 
MAS*(n=21) 
mean 0.55 0.95 0.85 NT 2.63 0.60 1.10 1.13 NT 3.19 5.81 
Sd 1.14 1.06 0.75 NT 2.53 1.06 1.32 0.77 NT 2.76 5.06 
median 0 1 1 NT 2.00 0 1 1 NT 2.00 4.00 
IQR 1 2 1 NT 2.25 1 2 1 NT 4.25 4.75 
Range 0-1 0-3 0-2 NT 0-8 0-2 0-3 0-2 NT 0-9 0-17 
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Table 12: Study 4 – Norm and control group characteristics 
Abbreviations: SCALE-SI: Selective Control Assessment of the Lower Extremity – Similarity Index; sd: 
standard deviation; IQRR: Interquartile Range. 
6.4.1 Validity 
Spearman-rank correlations between the SCALE-SI and the SCALE joint pairs were 
moderate to strong, with the exception of two weak and non-significant correlation 
pairs (for the less affected ankle and the more affected knee joint). The correlations 
for the summed leg scores were strong (less affected leg: ρ = 0.75; more affected leg: 
ρ = 0.78; for both: p<0.001) (Table 13). A high correlation was found for the total 
scores (ρ = 0.90, p<0.001) (Table 13). There was a high (negative) correlation 
between the total SCALE-SI and the GMFCS (ρ = -0.74, p<0.001) (Figure 13). 
  
Norm group: neurologically intact adults (n=31) 
 less affected leg more affected leg  
hip knee ankle STJ leg hip knee ankle STJ leg Total 
SCALE-SI  
mean 0.93 0.93 0.96 0.94 0.94 0.94 0.95 0.95 0.91 0.94 0.94 
sd 0.10 0.10 0.07 0.07 0.04 0.09 0.04 0.10 0.09 0.05 0.04 
median 0.98 0.97 0.99 0.95 0.95 0.97 0.96 0.98 0.94 0.95 0.95 
IQR 0.06 0.05 0.04 0.06 0.00 0.05 0.03 0.03 0.09 0.00 0.00 
range 
0.54-
0.99 
0.57-
0.99 
0.61-
1 
0.66-
1 
0.85-
0.99 
0.66-
0.99 
0.84-
0.99 
0.45-
1 
0.64-
1 
0.76-
0.99 
0.83-
0.98 
Control group: neurologically intact children (n=32) 
 less affected leg more affected leg  
hip knee ankle STJ leg hip knee ankle STJ leg Total 
SCALE-SI  
mean 0.91 0.89 0.95 0.92 0.92 0.93 0.88 0.92 0.93 0.91 0.92 
sd 0.13 0.13 0.06 0.08 0.06 0.10 0.14 0.09 0.08 0.06 0.05 
median 0.98 0.95 0.97 0.94 0.94 0.97 0.94 0.97 0.95 0.93 0.93 
IQR 0.10 0.12 0.06 0.05 0.00 0.11 0.10 0.11 0.05 0.00 0.00 
range 
0.47-
0.99 
0.35-
0.99 
0.78 -
1 
0.66-
1 
0.73-
0.98 
0.56-
0.99 
0.33-
0.99 
0.58- 
1 
0.60-
1 
0.73-
0.89 
0.75-
0.98 
SCALE 
mean 1.81 1.61 1.71 1.71 8.35 1.90 1.77 1.81 1.94 7.42 15.77 
sd 0.40 0.50 0.46 0.46 3.26 0.30 0.43 0.40 0.25 1.06 3.85 
median 2 2 2 2 8 2 2 2 2 8 16 
IQR 0 1 1 1 2 0 0 0 0 1 2 
range 1-2 1-2 1-2 1-2 4-15 1-2 1-2 1-2 1-2 4-8 8-23 
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Table 13: Study 4 - Correlations SCALE scores vs SCALE SI 
Correlations 
SCALE-scores 
vs SCALE-SI 
less affected side more affected side 
Spearman-rank 
correlation  
p-value 
Spearman-rank 
correlation  
p-value 
Hip  ρ=0.53* 0.00825 ρ=0.45* 0.02786 
Knee  ρ=0.61* 0.00161 ρ=0.35 0.09291 
Ankle  ρ=0.33 0.1093 ρ=0.56* 0.00394 
STJ  ρ=0.67* 0.00033 ρ=0.55* 0.00513 
Leg  ρ=0.75* <0.001 ρ=0.78* <0.001 
Total score ρ=0.9*  (p<0.001) 
 
 
Figure 12: Study 4 - Correlation total SCALE score and GMFCS levels 
Abbreviations: SCALE-SI: Selective Control Assessment of the Lower Extremity – Similarity Index; 
GMFCS: Gross Motor Function Classification System 
Concerning discriminative validity, all SCALE-SI scores (separate joints, legs and 
total) were significant lower (Mann Whitney U test total score: U = 87.000, p<0.001, r 
= .65) in children with CP when compared to their neurological intact peers (Table 
14). There were no significant differences in the SCALE-SI between the four joint-
pairs, neither for the less nor for the more affected leg (Friedman test, Chi-square 
value of 4.950, p = 0.18 for the less affected side; Chi-square value of 3.00 p = 0.39) 
(Fig 13). There was no statistically significant difference between the more and less 
affected leg in children with bilateral diagnosis (Wilcoxon Signed Rank Test: Z = -
0.971, p=0.64, r = .217), but one for children with unilateral involvement (Wilcoxon 
Signed Rank Test: Z = -2.214, p=0.027, r = -.904) (Fig 14). 
 116 
Table 14: Study 4 - Differences neurologically intact children vs. children with 
CP 
Mann Withney U Test 
SCALE-SI  
less affected side more affected side 
NI CP NI CP 
Hip  
median (IQR)  0.98 (0.10) 0.76 (0.30) 0.97 (0.11) 0.77 (0.19) 
p-value p<0.001* p<0.001* 
Knee  
median (IQR)  0.95 (0.12)  0.78 (0.29) 0.94 (0.10) 0.74 (0.36) 
p-value p=0.001* p=0.005* 
Ankle  
median (IQR)  0.97 (0.06) 0.93 (0.20) 0.97 (0.11) 0.80 (0.39) 
p-value p=0.04* p<0.001* 
STJ  
median (IQR)  0.94 (0.05) 0.89 (0.26) 0.95 (0.05) 0.63 (0.53) 
p-value p=0.02* p<0.001* 
Leg  
median (IQR)  0.94 (0.00) 0.83 (0.17) 0.93 (0.00) 0.71 (0.19) 
p-value p<0.001* p<0.001* 
Total score 
median (IQR)  NI = 0.93 (0.00) CP = 0.75 (0.26) 
p-value p<0.001* 
Abbreviations: SCALE-SI: Selective Control Assessment of the Lower Extremity – Similarity Index, STJ: 
SubTalar Joint; NI: Neurologically Intact children; CP: Cerebral Palsy; sd: standard deviation  
 
Figure 13: Study 4 – Hypotheses proximal-distal-concordance:  
the tested joints (hip, knee, ankle, STJ) are displayed on the x-achses while the participant’s level of 
SVMC (mean SCALE joint score in blue and mean SCLAE-SI in green) is displayed on the x-achses. 
Abbreviations: SCALE-SI: Selective Control Assessment of the Lower Extremity – Similarity Index, STJ: 
SubTalar Joint: LA-SI: SCALE-SI for the less affected limb; MA-SI: SCALE-SI for the more affected limb; 
LA-SCALE: SCALE of the less affected limb; MA-SCALE: SCALE of the more affected limb 
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Figure 14: Study 4 – SCALE-SI grouped by leg involvement and diagnosis:  
bilateral involvemnet n=20; unilateral involvement n=4; grey shadow box plot = less affected leg, white 
box plot = more affected leg. 
Abbreviations: SCALE-SI: Selective Control Assessment of the Lower Extremity – Similarity Index  
6.4.2 Reliability 
With ICC values exceeding 0.9 for the total, 0.8 for the limb and 0.7 for the joint 
SCALE-SI scores and the lower limits of the 95% CI all above 0.4, the test-retest 
reliability was moderate to good. The MDC varied between 0.14 (total score) and 0.42 
(more affected ankle) (Table 15). Bland Altman plots for SCALE-SI joint and leg levels 
are shown in Figure 15 for the less affected side and in Figure 16 for the more affected 
side. 
Table 15: Study 4 - Relative and ablsolulte reliability SCALE-SI  
  
  Children with spastic CP (n=24) 
  less affected leg more affected leg  
  hip knee ankle STJ leg hip knee ankle STJ leg Total 
Descrip-
tive 
Mean 
(SD)1 
0.75 
(0.18) 
0.75 
(0.19) 
0.82 
(0.20) 
0.81 
(0.16) 
0.78 
(0.14) 
0.69 
(0.19) 
0.70 
(0.19) 
0.69 
(0.26) 
0.63 
(0.23) 
0.68 
(0.16) 
0.75 
(0.14) 
Mean 
(SD)2 
0.70 
(0.22) 
0.77 
(0.16) 
0.83 
(0.19) 
0.80 
(0.17) 
0.78 
(0.15) 
0.68 
(0.18) 
0.72 
(0.20) 
0.67 
(0.27) 
0.63 
(0.24) 
0.68 
(0.18) 
0.72 
(0.28) 
Relative 
Reliabil-
ity 
ICC 
(2.1) 
0.77 0.77 0.72 0.70 0.86 0.80 0.76 0.74 0.84 0.88 0.90 
p 
value 
<0.00
1 
<0.00
1 
<0.00
1 
<0.00
1 
<0.001 
<0.00
1 
<0.00
1 
<0.00
1 
<0.00
1 
<0.001 <0.001 
95% CI 
0.51 -
0.90 
0.51 -
0.90 
0.42 - 
0.87 
0.40 - 
0.87 
0.66 - 
0.94 
0.57 - 
0.91 
0.50 - 
0.90 
0.47 - 
0.89 
0.64 - 
0.93 
0.72 - 
0.95 
0.87 – 
0.98 
Absolute 
Reliabil-
ity  
SEM 0.12 0.12 0.15 0.14 0.09 0.12 0.15 0.14 0.10 0.08 0.05 
MDC 0.35 0.33 0.40 0.38 0.26 0.32 0.42 0.40 0.26 0.23 0.14 
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Figure 15: Study 4 - Bland-Altman Plots: Test retest reliability SCALE-SI – less affected side 
less affected joint children with CP (n=24), Rows: A) Hip joint; B) Knee joint; C) Ankle joint; D) STJ 
joint; E) leg 
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Figure 16: Study 4 - Bland-Altman Plots: Test retest reliability SCALE-SI - more affected side: 
 more affected joint children with CP (n=24), Rows: A) Hip joint; B) Knee joint; C) Ankle joint; D) STJ 
joint; E) leg  
Abbreviations: ICC, Intra-class correlation coefficient; CI, Confidence Interval; SD, Standard Deviation; 
SEM, Standard Error of Measurement; MDC, minimum detectable change. Please note, we could include 
data from only 21 participants in the reliability analysis.  
6.5 Discussion 
The results demonstrate that SVMC in children with CP can be quantified as the 
degree of similarity between the sEMG pattern of ten muscles in a person with CP 
and that of a group of neurologically intact adults. Thereby showing that combining 
the SCALE testing procedures with sEMG is an objective and probably more sensitive 
approach than the clinical assessment without sEMG recordings.  
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6.5.1 Validity 
The SCALE-SI concurrent validity as assessed by its correlation with the SCALE was 
good for the sum scores (less affected leg: ρ = 0.75; more affected leg: ρ = 0.78; for 
both: p<0.001)), but less for the individual joint scores. The weaker correlation at the 
joint level might be explained by the fact that there were some children with CP whose 
SVMC joint performance was scored as “unable/0” by the SCALE, but their sEMG 
muscle-activation patterns were adequate although within a very low amplitude. As 
there were also children with low SCALE scores and less physiological sEMG muscle-
activation patterns, these findings indicate the ability of the SCALE-SI to detect SVMC 
sensitively and independently from muscle strength. Exactly this increased sensitivity 
in measuring SVMC, especially within the lower SCALE levels (0 and 1), was the aim 
when introducing the SCALE-SI as a new measure.  
However, the strong association of the SCALE-SI sum scores with the SCALE sum-
scores (e.g. sum scores per leg or the total score) and with the GMFCS confirms the 
validity of this new measure. The high negative correlation with the GMFCS is also in 
line with previous results of the original SCALE and confirms our concurrent validity 
hypothesis that children with higher SVMC have better mobility (Kusumoto et al. 2016; 
Balzer et al. 2016; Fowler et al. 2009). 
Our first discriminative validity hypothesis was that the SCALE-SI scores of children 
with CP would be statistically significant from those of neurological intact children. 
This hypothesis was confirmed. To the author’s knowledge, this study was the first, 
which applied the SI to a neurological impaired population other than those studies 
that applied the SI after a stroke or spinal cord injury. By acquiring comparable 
reference-type muscle activation patterns from neurologically intact adults as well as 
from peers, SCALE-SI discriminative validity was established. As SVMC is known to 
be maturation-dependent, data from neurological intact adults were collected to gain 
norm values from individuals, in whom SVMC is known to be fully and optimally 
developed. In contrast, the comparison with neurological intact peers aimed to reflect 
on the developmental component when measuring SVMC. Our results confirm the 
developmental aspect of SVMC (Cahill-Rowley and Rose 2014; Staudt et al. 2003; 
Rothwell 1987). While in the adult reference population, all SCALE-SI scores fall 
between 1 and 0.75, this range widens to 0.5 in neurological intact peers until the age 
of 10 years (Figure 17).  
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Figure 17: Study 4 - SCALE-SI:  
Magnitude vs. Similarity plots for the A) hip, B) knee, C) ankle and D) STJ joint. The magnitude (the 
length of the multichannel EMG based-vector) is presented on the x-axis, while the SI index (the direction 
of the multichannel EMG based-vector) is displayed on the y-axis. Please note that the magnitude is a 
non-normalized value and displays the level of activation of the muscles, while the SI values display the 
similarity of the activation pattern in comparison to the norm. This figure shows that children with CP 
(circular shape) differ in both values in comparison to their peers (triangular shape). 
 less affected joint in children with CP (n=24);  more affected joint in children with CP (n=24);  
▲ less affected = dominant joint in neurologically intact children (n=32);  more affected = non 
dominant joint  in neurologically intact children (n=32);  95% Confidence Interval Norm (neurologically 
intact adults), less affected (la) = dominant joint (n=31);  95% Confidence Interval Norm (neurologically 
intact adults) more affected (ma) = non dominant joint (n=31) 
Abbreviations: SI = Similarity Index; STJ = SubTalar Joint 
Only one control child (12,11 years, month) showed voluntary contralateral 
gastrocnemius activation during knee joint movement, which was undetected by the 
tester during sEMG recording, but detected during offline sEMG-data processing. 
Age-dependency was also detected when scoring these children with the original 
SCALE (Figure 18). Above the age of ten years, almost all neurological intact children 
fall within the 95%CI of the adult population (Figure 19). Interestingly, the range of the 
sEMG magnitude, which is the second value of the VRI, was lower in children with 
CP (maximum of 100μV) compared to neurological intact participants (maximum of 
300μV). This finding might be related to the smaller muscle size and volume in 
children with CP (Shortland 2011).  
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Figure 18: Study 4 - SCALE vs. SCALE-SI  
for the A) hip, B) knee, C) ankle and D) STJ joint in children with CP and neurologically intact 
children. SCALE joint scores are plotted on the x-axis, while the SCALE-SI is displayed on the y-axis. 
This graph shows that the majority of neurologically intact children (triangular shape) had a SCALE score 
of 2 in combination with high SCALE-SI scores. 
 less less affected joint in children with CP (n=24);  more affected joint in children with CP (n=24), 
▲ less affected joint = dominant in neurologically intact children (n=32); more affected joint = non-
dominant in neurologically intact children (n=32)  
Abbreviations: SI = Similarity Index; STJ = SubTalar Joint 
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Figure 19: SCALE-SI vs. age 
in children with cerebral palsy (circular shape) and neurologically intact children (triangular shape) for 
the less affected leg (first column) and the more affected leg (second column), for the A) hip, B) knee, 
C) ankle, D) STJ joint. Age is displayed on the x-axis and SCALE-SI on the y-axis, showing age 
dependent development of SVMC. The light grey bar represents the norm SCALE-SI values around that 
age, showing that after the age of 10 years the majority of neurological intact children (triangular shape) 
falls within this normal range. 
 less affected joint in children with CP (n=24);  more affected joint in children with CP (n=24); ▲less 
affected = dominant joint in neurologically intact children (n=32); more affected = non-dominant joint 
in neurologically intact children (n=32);  95% Confidence Interval Norm (neurologically intact adults) 
Abbreviations: SI = Similarity Index; STJ = SubTalar Joint 
Our second discriminative validity hypothesis, regarding the proximal-distal 
concordance of the SCALE-SI, could not be confirmed. These findings are in contrast 
to previous papers which have shown this proximal-distal concordance of the original 
SCALE (Balzer et al. 2016; Fowler et al. 2010). There was only a trend towards a 
more distal impairment in the more affected leg when quantified with the SCALE-SI. 
However, unlike the results of the previous studies, we noticed the same in our sample 
when evaluating the clinical SCALE scores (Figure 13). Especially the hip SCALE-SI 
score did not differ from the adjacent knee joint. This might be related to the altered 
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testing-position in sitting position (to minimize positional changes in relation to the 
sEMG). Standardization of the testing movement was difficult, as this position allowed 
movements around all three lower extremity joints. Furthermore, the SCALE-SI’s 
diminished trend in proximal to distal concordance might be also explained by the fact 
that the SCALE-SI is measuring a slightly different constructs of SVMC in comparison 
to the SCALE. On the one hand, the SCALE-SI measures SVMC due to its sEMG 
sensitivity, movement (muscle strength) independently. On the other hand, due to the 
applied SI-algorithm, the SCALE-SI incooperates selective as well as pathological 
muscle activation within its equation, while the SCALE only relies on observational 
assessment of the selective movement. Both of these two specific characteristics of 
SCALE-SI are discussed within the limitaions and clinical implications in more detail.  
In relation to the lack of significant differences between the less and more affected 
limb for participants with unilateral involvement (n=4 in our sample), future studies 
should investigate these differences with much more participants. 
In addition to the correlation between the SCALE-SI and the GMFCS, differences of 
SCALE-SI across the GMFCS levels and between adjacent levels were computed. 
The Kruskal Wallis test revealed a significant difference when comparing SCALE-SI 
values between participants with different GMFCS levels. However, probably due to 
the limited sample size and the additional post-hoc statistical corrections for multiple 
comparisons, statistically significant differences were only found between GMFCS 
levels I and II.  
Future studies with a larger sample size should calculate clinical meaningful SCALE-
SI threshold values for the GMFCS, by the way of a ROC curve analysis, comparable 
to the one from Lim and colleagues (2005) in patients with spinal cord injury and their 
American Spinal Injury Association level. 
6.5.2 Reliability  
An ICC value of 0.9 indicates that the total score of the SCALE-SI is highly 
reproducible and can therefore be recommended for clinical and scientific use. It is 
currently not possible to evaluate whether a MDC of 0.26 and 0.23 (less and more 
affected leg, respectively) is clinically acceptable, as realistic change estimates for 
SCALE-SI of the lower extremity are currently lacking.   
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6.5.3 Limitations and methodological considerations  
The following methodological limitations should be taken into account when 
interpreting the results of this study. 
The first three limitations consider the main limitations in measuring SVMC using the 
SCALE-SI. The first two limitations of the SCALE-SI relate to adaptations of the test 
procedure aimed at minimizing movement artefacts and acquiring appropriate muscle 
activity cut-off points. The last limitation regards the underlying SI algorithm of the 
SCALE-SI. Firstly, we changed the original SCALE testing position of the hip from 
side lying into sitting. This was done to minimize movement artefacts in the sEMG 
signals. Nevertheless, as in this testing position the leg is moved against gravity, a 
higher amount of muscle strength is needed, and the test condition is more difficult to 
standardise. Accordingly, this altered hip position might be not optimal for testing 
SVMC.  
Secondly, to correct background levels of muscle activation during testing, we had 
originally planned to subtract the level of background sEMG activity measured during 
the initial baseline period from sEMG levels measured during the test conditions. In 
neurologically intact participants as well as in children with CP, the background 
muscle activity during baseline was in some muscles higher than during the test-trial, 
thereby generating negative values. This phenomenon has been observed previously 
(Fowler 2010; Lim et al. 2005) and reflects the difficulty in voluntarily relaxing the 
muscles. Hyperreflexia and/or spasticity might have increased baseline muscle 
activity additionally in the patients with CP. Although this procedure might be 
appropriate in neurologically intact adults, its appropriateness when measuring 
patients and especially children with positive UMN signs should be further 
established. Therefore, we decided to subtract the lowest amount of sEMG activity 
that was observed during the test-trial. 
Thirdly, due to the SI algorithm, the SCALE-SI does not distinguish between 
difficulties in desired selective muscle activation and pathological co-activation of ipsi- 
or contralateral muscles. As such, SCALE-SI is an unweighted index, as activation of 
each muscle “weights” (counts) equally. Furthermore, the number of muscles 
resulting in possible co-activation is much higher than the primary activated ones. In 
order to reduce co-activation, the testing positions were selected and adapted (i.e. leg 
pedestal) in such a way that it would, normally, hardly require any activation of 
 126 
uninvolved muscles. Nevertheless, the SCALE-SI is unable to differentiate between 
mirror movements and co-movements. The SI algorithm can only quantify the 
similarity of the muscle activation pattern of a participant to that of a ‘normal 
population’. 
Furthermore, the finding that the proximal-distal concordance is less prominent in the 
results of the SCALE-SI compared to the SCALE may also be explained by the fact 
that the SCALE-SI in comparison to the SCALE measures a slightly different construct 
of SVMC. Firstly, the SCALE-SI measures SVMC independent from observable joint 
movement (and thus muscle strength) on which the SCALE is based. Secondly, the 
SCALE-SI incorporates selective as well as pathological muscle activation within its 
equation, while the SCALE only relies on observational assessment of the selective 
movement. Both of these two specific characteristics of the SCALE-SI are discussed 
in more detail in section 6.2. 
Lastly, although we aimed for a sample size of at least 30 participants, data of only 
24 participants could be collected. The lack of recruitment was mainly caused by the 
following two issues. Firstly, pilot testing was prolonged to best possibly optimize the 
measurement procedure. Secondly, as the author’s research group developed a 
pendant SVMC measure for the upper extremity (Selective Control of the Upper 
Extremity Scale- (SCUES-)SI)), recruiting 30 participants, who were willing to be 
assessed twice, for both studies, was challenging within the given time frame.  
6.5.4 Clinical Implications and future work 
One major advantage of the SCALE-SI above the SCALE is its joint-movement and 
muscle strength independency, therefore allowing to measure SVMC also in very 
weak participants. While the SCALE rates absence of joint movement in the tested 
joint as ‘unable SVMC (0)’, the SCALE-SI could distinguish between participants with 
no movement but relatively normal physiological muscle activation patterns and those 
with no movement but also less physiologically and thereby more impaired SVMC. 
The sensitivity of the SCALE-SI in detecting physiological and impaired SVMC in 
participants with and without joint-movement might indicate its future application as a 
prognostic tool to optimize physiotherapy training plans. For instance, while training 
SVMC (e.g. by isolated joint movement training or functional training (e.g. FES)) might 
be indicated in children with CP with a certain level of SVMC (e.g. SCALE-SI above 
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0.75);a more functional training, solely focusing on learning or persevering an activity 
(e.g. walking) might be the therapy of choice, when the SCALE-SI is low.  
Besides the SCALE-SI’s first positive validity and reliability findings, assessment of its 
responsiveness is required before it can be recommended as a SVMC outcome 
measure. Also, clinically important changes in relation to daily activities should be 
established to further investigate the clinical relevance of the SCALE-SI measure for 
the patients. 
6.6 Conclusion 
In conclusion, these first psychometric testing results of the SCALE-SI serve as 
reference values when applying the SCALE-SI in future clinical and scientific practice. 
It shows that carrying out the SCALE procedure with simultaneously multichannel 
sEMG application of the lower extremity in children with CP is possible with a few 
adaptations of the original SCALE testing protocol. The three main characteristics of 
the SCALE-SI can be summarizsd as followed: i) the SCALE-SI measures SVMC 
independently from joint movement; ii) the algorithm of the SCALE-SI quantifies 
SVMC in comparison to the individual activation pattern of the norm, but cannot 
distinguish between selective, co- and mirror muscle activation; and iii) the SCALE-
SI is a valid and reliable measure when using separate limb and total (both limbs) 
scores. To establish the application of the SCALE-SI as an outcome measure for 
detecting therapy-induced changes of SVMC in children with CP, its responsiveness 
needs to be evaluated first. 
.      
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Chapter 7: Final Discussion 
7.1 Purpose of chapter 
This final chapter comprises a synopsis of all study findings and an integrated 
discussion of all results and study limitations within the overarching clinical and 
scientific neuro-paediatric context. First, main findings of each of the previous studies 
will be summarized to set a common basis for the following discussion (section 7.2). 
These findings will then be synthesized and discussed in their relation to the main 
purpose of this PhD project: Finding a sensitive and psychometrically robust 
evaluated SVMC outcome measure for the lower extremity in children with CP. 
Accordingly, the following subsections will discuss study findings and related 
considerations about validity (section 7.3.1), reliability (section 7.3.2), and clinical 
utility (section 7.3.3) of the SVMC outcome measures that were investigated in this 
thesis. Additionally, ideas for improving the psychometric properties of the measures 
in future studies will be presented. Section 7.4 presents some considerations for 
future responsiveness testing of the applied measures. Finally, methodological 
considerations, as well as further clinical implications concerning all studies are 
shown in section 7.5.  
Please note, to maximize reader-friendliness of this chapter, the author decided to 
include new figures within this discussion. These figures synthesize results of different 
studies as well as additionally analysed data for the purpose of this overall discussion. 
7.2 Summary of main findings  
This chapter summarises the main findings of all four studies.  
7.2.1 Main findings study 1 
The aim of this study was to investigate the impact of SVMC, among other common 
lower extremity impairments and trunk control, on gait capacity in children with CP. 
Although SVMC was omitted from the final regression model for gait capacity, the 
results of this study showed that SVMC was strongly associated with gait capacity (ρ= 
- 0.68), trunk control (ρ = 0.76), as well as muscle strength (ρ = 0.85). We assumed 
that the high correlations between SVMC, muscle strength and trunk control 
(multicollinearity) were the cause for the exclusion of SVMC from the final multiple 
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regression model. Of the three other independent variables, trunk control and 
spasticity each explained a different part of the variance of gait capacity and remained 
within the model (R² = 0.67). While a strong relationship between SVMC and gross 
motor function (van der Linden et al. 2018; Chruscikowski et al. 2017; Park and Kim 
2013; Kim and Park 2011; Ross and Engsberg 2007) and muscle strength (Balzer et 
al. 2016) has also been established in previous studies, these were the first findings 
which revealed the association of SVMC to trunk control. The results from these 
studies show the interconnection between SVMC, muscle strength and trunk control 
for gait capacity in children with CP. Thereby they indicate the significance of these 
impairments in gait assessment and, potentially, rehabilitation. 
7.2.2 Main findings study 2 
The second study established validity and reliability properties of the German 
language SCALE version by confirming previous results (Fowler et al. 2009; 2010) as 
well as by providing new evidence. The SCALE’s validity was confirmed by: i) a strong 
correlation between the SCALE and the FMA items (p= 0.88) ii) the GMFCS level (ρ 
≤ -0.80); as well as iii) by significant differences between the less and more affected 
limb in children with bi- and unilateral limb involvement and iv) between SCALE joint 
scores, showing a proximal-distal concordance. Additional hypotheses concerning the 
relationships of SVMC to muscle strength and spasticity were tested. While SVMC 
and muscle strength were strongly correlated (p= 0.88), its relationship with spasticity 
was lower (p= - 0.55). This latter finding was discussed in relation to the incompletely 
understood pathophysiological nature of SVMC. Intra-class correlation coefficients 
(ICCs> 0.9) and MDC (below 2 points) for the inter- as well as the intra-rater reliability 
of the SCALE were within clinically acceptable ranges. These results support the 
regular clinical assessment of SVMC of the lower extremity in children with CP and 
might, in the long term, improve medical understanding and treatment of this central 
impairment. Nevertheless, due to both the SCALE’s ordinal scaling and related lack 
of psychometric evidence on its responsiveness, its application is currently limited to 
diagnostic and prognostic purposes only. 
7.2.3 Main findings study 3 
This systematic review, which evaluated psychometric properties of SVMC outcome 
measures for the lower extremity in children with UMN lesions, identified the following 
four assessments: SCALE; SMC; m-Trost and Gillette’s SMC test and three 
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laboratory-based measures, namely lower extremity joint kinematics, sEMG, and 
torque steadiness. Overall, the main findings revealed: i) a limited number of 
psychometric studies assessed the validity and reliability of SVMC outcome 
measures, especially for laboratory-based measures; ii) the absence of studies 
evaluating responsiveness for any measure, and iii) the SCALE as having the highest 
level of evidence regarding its reliability, validity, and clinical utility compared to other 
clinical and laboratory-based measures of SVMC. Nevertheless, the SCALE’s 
application as a measure to assess therapy-induced changes in SVMC was 
questioned due to its broad ordinal scoring system. Accordingly, to augment the 
SCALE’s ability to measure differences in SVMC in children with UMN lesions, it was 
suggested that it be used in combination with laboratory-based measures (e.g. sEMG 
or kinematics).  
7.2.4 Main findings study 4 
Consequently, study 4 dealt with validity- and reliability-testing of a sEMG based 
measure using the SCALE’s measurement protocol. The SCALE-SI, which quantifies 
SVMC by comparing the similarity of a participant’s multi-muscle sEMG pattern to that 
of an average control group (neurologically intact adults), was found to be an objective 
and more sensitive method compared to the ordinal rating system of the conventional 
SCALE. Its concurrent validity was evaluated by its correlation to the original SCALE 
scores as well as to the GMFCS levels. While these correlations were above 0.7 for 
summed leg and total scores for the SCALE and GMFCS, the correlations for the 
SCALE joint scores (ρ=0.35 – 0.67) were lower than expected. Although this finding, 
as well as the lack of the expected proximal-distal concordance of the SCALE-SI, 
were in contrast to the previously formulated hypotheses, they could be (partly) 
explained by the fact that SCALE and SCALE-SI are measuring slightly different 
constructs of SVMC. In contrast to the SCALE assessment, which relies on the 
observation of movement, the SCALE-SI measures SVMC by sEMG will detect 
muscle activity even without observable joint movement. Further, the SCALE-SI 
algorithm takes selective as well as pathological co-activation into account and is 
thereby not capable to differentiate between mirror movements and co-movements. 
The SCALE-SI only quantifies how the patient’s multichannel sEMG activation pattern 
is – similar to normal. Concerning further discriminative results of the SCALE-SI, its 
validity was supported by the significant differences for all scores when comparing 
SVMC in children with CP and neurologically intact peers. Altogether, these results 
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show that combining the SCALE procedure with sEMG for quantifying SVMC of the 
lower extremity in children with CP is feasible and valid. When applying to test-retest 
situations, a change of the SCALE-SI total score above 0.14 can be considered as 
real change. However, to establish the SCALE-SI’s application as an outcome 
measure for detecting therapy-induced changes of SVMC in children with CP, its 
responsiveness still needs to be evaluated. 
7.3 Considerations when testing psychometric properties in SVMC 
measures  
Only through outcome measures with robust psychometric properties, scientists and 
clinicians can accurately and precisely evaluate the efficacy of an intervention. The 
results of the systematic review of this PhD project have shown that such an ‘ideal’ 
tool is not yet available for measuring intervention effects on SVMC in children with 
CP. Therefore, this chapter will summarize evidence from the previous studies and 
suggest ideas for promoting the development of an ‘ideal’ SVMC outcome measure 
in the future. Accordingly, this section of the general discussion will synthesize the 
knowledge regarding psychometric properties of SVMC measures (chapter 2.3) with 
the previously described study results about their meaning for testing validity (section 
7.3.1), reliability (section 7.3.2), and clinical utility (section 7.3.3) of SVMC measures. 
Each of these sections will start by briefly summarising the definition and main points 
of each psychometric property. This will be followed by discussion of the study results 
and experienced limitations in relation to this particular psychometric property. The 
last element of this section will present ideas and recommendations for studies aiming 
to investigate the responsiveness of the SCALE and SCALE-SI (section 7.3.4). 
7.3.1 Considerations when testing validity of SVMC measure  
In this section, the lessons learned from testing validity of the SCALE and the SCALE-
SI will be described and discussed in greater detail. In accordance to the different 
subtypes of validity as defined by COSMIN (chapter 2.3.4), we consider in criterion 
validity (section 7.3.1.1) and construct validity (section 7.3.1.2) which includes both 
convergent and discriminant (divergent) validity. Within each of these subsections, 
the applied hypothesis, which was used to establish validity in relation to the SCALE 
and SCALE-SI, will be described and discussed. In section 7.3.1.1, the problem of 
identifying an adequate reference measure in relation to concurrent validity of the 
SCALE and SCALE-Si will be discussed. Concerning hypotheses testing, meaning 
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discriminant and convergent validity, the following topics will be discussed: 
establishing discriminative validity of SCALE-SI by i) comparing children with UMN 
lesions with neurological intact peers,ii) confirming proximal-distal concordance; and 
establishing convergent validity by using theoretical concepts about the relationship 
of SVMC and iii) spasticity, iv) muscle strength, v) trunk control, and vi) gross motor 
function (e.g. gait). 
7.3.1.1 Considerations for criterion validity  
Criterion validity is defined by the COSMIN panel as “the degree to which the score 
of a measurement instrument is an adequate reflection of a gold standard”. It is further 
subdivided into concurrent and predictive validity. Concurrent validity is demonstrated 
when a test correlates well with a measure that has previously been validated (but is 
not a gold standard), showing that both tests measure the same construct. 
Ideally, the ‘gold standard’ is an objective measure which is 100% sensitive and 
specific concerning the presence and absence of a disease or disease state. In 
practice, for many measures, there are very few or no true ‘gold standard’ tests. 
Concurrent validity is tested by using an alternative pre-evaluated ‘gold standard’ test, 
measuring the similar or related construct of interest at the same time as the tool 
under validity evaluation (Mokkink et al. 2016). However, when comparing an 
instrument with a reference instrument that is not a ‘gold standard,’ it is unknown to 
which degree the correlation between instruments is influenced by the fact that both 
measures might not assess the exact same construct. 
a) Concurrent validity of the SCALE  
There is currently no gold standard for measuring SVMC. This might be related to the 
fact that SVMC can only be measured indirectly, as all related cortical activation 
patterns cannot be observed directly (section 2.3.6.1). Therefore, concurrent validity 
of the German version of the SCALE was established with the lower extremity items 
of the FMA (items III-IV) (study 2). The FMA is an internationally well-established 
assessment tool for stroke patients (Pandian et al. 2012). Item III tests if and how (0-
2) the participant can move the knee and ankle in a position of combined synergies. 
Item IV requires more selectivity, by testing if and how the participant can selectively 
move the knee and ankle out of a synergy when standing with the hip at 0 degrees. 
Although these test items and the increased level of difficulty from item III to item IV 
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in the FMA are different when compared to the SCALE, the construct of both tests 
seems to be similar, namely the ability of the participant to voluntarily activate certain 
muscle(-groups) by simultaneously deactivating others (synergistic ones). This 
common convergent theoretical concept was supported by a statistically significant 
high correlation of ρ=0.88 between these two measures. 
b) Concurrent validity of the SCALE-SI 
To establish concurrent validity of the SCALE-SI, the previously validated SCALE was 
used. Although both tests rely on the same definition of SVMC and are assessed 
using a similar protocol, they measure slightly different constructs of SVMC. Firstly, 
while the SCALE is scored through the observation of movement and uses an ordinal 
scoring system, the SCALE-SI is derived from sEMG with a continuous value between 
0 and 1. Secondly, due to the applied SI algorithm, the SCALE-SI is a measure which 
compares multi-muscle-activation pattern with the norm, but which cannot distinguish 
between the desired activation and pathological co-activation. In contrast, the SCALE 
focuses and rates how selective the joint movement was performed.  
Because the SCALE-SI is unlike the SCALE derived from sEMG, it is able to measure 
the presence of SVMC even when no joint movement occurs. Although the original 
SCALE testing positions were developed to minimize the influence of muscle strength 
when measuring SVMC, its rating system is to some degree muscle strength 
dependent. As the SCALE assesses SVMC via joint movement, a minimum amount of 
muscle strength is required. For example, to assess the hip or ankle joint, a MMT of 2 
(i.e. full range of motion without the influence of gravity) is needed or even a MMT of 3 
(i.e. full range of motion against gravity), when testing, for example, the knee joint. The 
SCALE-SI, however, only requires a muscle strength of MMT 1 (i.e. muscle activation). 
This joint-movement and muscle strength independency of the SCALE-SI is considered 
as a major advantage of the SCALE-SI above the SCALE, as it allows for measuring 
SVMC in very weak participants. While the SCALE rates absence of joint movement in 
the tested joint as ‘unable SVMC (0)’, the SCALE-SI could distinguish between 
participants with no movement but relatively normal physiological muscle activation 
patterns and those with no movement but also less physiologically and thereby more 
impaired SVMC. Figure 13 shows a wide spread of SCALE-SI for SCALE ‘unable/0’ 
and ‘impaired/1’ scores. This increased sensitivity of the SCALE-SI was desired to be 
able to detect smaller differences of SVMC in children with CP. When SVMC was 
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scored as ‘unable/0’ by the SCALE, which was mostly the case around the ankle and 
the STJ joint, SCALE-SI was either low or high, depending on the selectivity of the 
unobservable muscle activation pattern of the participant. The sensitivity of the SCALE-
SI in detecting physiological and impaired SVMC in participants with and without joint-
movement might indicate its future application as prognostic tool to optimize 
physiotherapy training plans. For instance, while training SVMC (e.g. by isolated joint 
movement training or functional training (e.g. FES)) might be indicated in children with 
CP with a certain level of SVMC (e.g. SCALE-SI above 0.75), a more functional training, 
solely focusing on learning or persevering an activity (e.g. walking) might be the therapy 
of choice, when the SCALE-SI is low.  
Considering the validity testing results of the SCALE-SI versus the SCALE, the 
increased sensitivity of the SCALE-SI may have resulted in the lower correlation on 
joint level. For instance, for the more affected knee and less affected ankle, 
correlations were lowest and not significant. Especially in these two joints, movement 
of four participants (in three of the knee and one for the ankle) looked physiological 
and were thereby rated as ‘normal/2’ by the SCALE, but the underlying muscle 
activation patterns were less physiological. 
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Figure 20: Concurrent validity: SCALE vs. SCALE-SI on joint level. 
A) hip, B) knee, C) ankle and D) STJ in children with CP (circular shape). SVMC joint scores are displayed 
on the x-axis for the SCALE and for the SCALE-SI on the y-axis, showing the correlation between these 
two measures in terms of SCALE-SI´s concurrent validity testing. Note: correlation for hip joint: less 
affected (la): ρ=0.53*; more affected (ma) ρ=0.45*; for knee joint: la: ρ=0.61*; ma ρ=0.35; for ankle joint: 
la: ρ=0.33; ma ρ=0.56*; for STJ joint: la: ρ=0.67*; ma ρ=0.55*; *: significant at α ≤ 0.05. 
less affected joint/leg children with CP (n=24)  more affected joint/leg children with CP (n=24);  
Overall, these lower correlations at joint level between the two measures do not 
indicate that the SCALE-SI is less valid. It rather indicates that future SCALE-SI 
validity studies should select an alternative ‘gold standard’, which can measure SVMC 
more accurately than an ordinal-scaled assessment tool and which measures SVMC 
independently from joint movement, as well. Clinically, the ability of the SCALE-SI to 
measure SVMC independent from muscle strength (MMT1) also allows for 
measurement of changes in SVMC in more severely impaired children with CP 
(GMFCS III, IV) and it might allow identification for whom SVMC is worthwhile to train.  
7.3.1.2 Considerations for hypotheses testing: convergent and discriminative 
validity  
In cases without a ‘gold standard’, convergent and discriminative validity are possible 
alternatives. These two types of validity belong to the COSMIN category (box) 
‘hypotheses testing’ (De Vet et al. 2011). When hypotheses testing is performed to 
evaluate validity (Appendix 1: Box F), a priori formulated hypotheses about the 
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relationship of the measurement scores and the scores of comparator instrument or 
group are tested. The expected relationship could either be that both tools measure 
the similar construct (convergent validity) or that the instruments are measuring 
different constructs (discriminant and divergent validity). (De Vet et al. 2011; Mokkink 
and Terwee 2010; Portney and Watkins 2000). Logically, the robustness of these two 
types of validity is strongly dependenton the previously defined construct of interest 
and the formulated hypotheses. 
a) Suggestions for establishing discriminative validity by comparing SVMC in 
children with CP versus neurologically intact peers 
For the evaluation of the discriminative validity of the SCALE-SI, we hypothesized in 
study 4 that children with CP would have lower SCALE-SI scores on joint, leg and 
total scores due to their corticospinal impairment. Thereby the aim was to explore the 
ability of the SCALE-SI in discriminating between these two groups, as well as 
between young (below ten years) and older (above ten years and under 18 years) 
neurologically intact children. We anticipated that younger children would also have 
lower SCALE-SI scores, as it has been shown that SVMC develops in line with the 
maturation process of the CNS until the age of 10 years (Cahill-Rowley and Rose 
2014; Staudt et al. 2003; Rothwell 1987). Indeed, this age-dependency in 
neurologically intact children was shown by the data of both the SCALE-SI and even 
the ordinal SCALE. SCALE scores in the control group of young children were mainly 
scored as ‘impaired’, as they either showed co- or mirror movements (rated by the 
SCALE descriptors) (Appendix 13). For example, when testing the knee joint, co-
movement of the foot was most frequently recorded and around the ankle or STJ joint; 
mirror movements of the contralateral foot frequently occurred. Considering the 
SCALE-SI scores of neurologically intact children, after the age of 10, scores for all 
joints fell within the 95%CI of the adult population (Appendix 12). To be able to 
compare SVMC of both groups of children with the most developed (i.e. adult) form 
of SVMC, the SCALE-SI prototype response vector was computed by the average 
muscle activity patterns of neurological intact adults. While in the adult reference 
population all SCALE-SI scores fall between 0.96 and 0.75, this range widens to 0.95 
- 0.50 in neurologically intact children above the age of 10 years. The lower and upper 
borders of the 95% CI are even broader in children with CP where SCALE-SI scores 
for the less affected limb varied from 0.82 - 0.37 or for the more affected leg from 0.70 
– 0.16. (Appendix 12). In relation to the age-dependency of SVMC, future studies with 
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an appropriate number of participants in all age groups, may apply an ‘Analysis of 
Covariance’ to control for age, when comparing SVMC in neurologically intact children 
and children with CP. 
Validating the SCALE-SI via comparison between children with CP and neurologically 
intact peers has thereby supported the previously suggested age-dependency of 
SVMC. Furthermore, this kind of validation improved understanding of SVMC per se 
as references values were missing up until now.  
b) Suggestions for establishing discriminative validity by the concept of 
proximal-distal concordance (difference on joint level)  
Another hypothesis, which was used to test discriminative validity of the SCALE (study 
2) and the SCALE-SI (study 4), was that SVMC would be lower distally. This concept 
is also known as proximal-distal concordance and was first described by Brunnstrom 
in 1996 in patients with stroke and later shown by Fowler and colleagues (2010) in 
children with CP. Neurophysiologically, this phenomenon is often explained by the 
cortical representation of the lower extremity on the homunculus (Figure 3). While the 
motor cortex area for the hip and trunk lay at the medial midpoint of one hemisphere, 
the motor cortex area of the toes and ankle lies deepest within the periventricular 
area. As the periventricular area is most commonly injured in children with spastic CP, 
corticospinal fibers supplying the distal joints get more frequently injured than those 
supplying the knee and hip (Staudt 2007; Glenn et al. 2007).  
While this proximal-distal concordance was observed when testing the German 
SCALE version (study 2), it was only marginally present for the SCALE scores in study 
4, and even less for the SCALE-SI of the more affected leg (Figure 14). The following 
four issues might explain this difference in findings. Firstly, the assessment of SVMC 
at the hip joint was altered in study 4 because of the requirements of recording sEMG. 
As mentioned in paragraph 6.5.3, it was found that testing the hip joint in sitting 
position instead of in the originally described side-lying position was not optimal for 
evaluating SVMC, as the sitting position was more difficult to standardize. 
Furthermore, the required hip movement depended more on muscle strength, 
because the leg had to be flexed against gravity. This might explain why the SCALE 
hip joint scores in study 4 were lower than in study 2 and why differences between 
SCALE-SI hip and knee scores were smaller than it has been expected from the 
results of study 2.  
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Secondly, the differences in GMFCS levels in both studies might be another possible 
explanation why a clear proximal-distal concordance was only observed in study 2. 
While in study 2 children with GMFCS level I dominated (n=23/39), the severity levels 
in study 4 were almost equally distributed (GMFCS I and II, n: 13/24; GMFCS III and 
IV, n:11/24). As in more severely impaired children (GMFCS III and IV) SVMC tends 
to be impaired in all lower extremity joints, differences between the SCALE joints are 
absent. Therefore, the greater proportion of severely impaired children in study 4 
might be another explanation why the proximal-distal-concordance was less obvious 
in study 4 compared to study 2. 
Another possible explanation for the inconsistency with regard to proximal-distal-
concordance of the two studies might be found in the fact that the SCALE-SI and 
SCALE are measuring slightly different aspects of SVMC. While the SCALE is 
dependent on a minimum of muscle strength (MMT 2-3) and an observable range of 
motion, the SCALE-SI measures SVMC independently from movement. As range of 
motion around distal joints is in general smaller compared to proximal ones (i.e. knee), 
differentiating between a SCALE score of 1 and 0 becomes progressively challenging. 
Especially if contractures are present, the movement range would become so small 
that it is almost impossible to observe whether the range of motion is above or below 
the active 50% range of motion, which would often result in a lower SCALE score at 
the more distal joints. Using sEMG for the SCALE-SI allows for the measurement of 
only slight but physiological muscle activation patterns around these distal joints. This 
increased sensitivity in detecting selective muscle activation of SCALE-SI in 
comparison to the SCALE especially around the ankle was also observed in relation 
to long-term orthosis treatment of many ambulatory children with CP.  
Due to the stabilizing and limiting effect of the orthosis, the child’s ability to learn to 
control and activate these distal muscles is very limited (learned-non-use). Afferent 
and proprioceptive input to the brain is decreased and might downregulate CTS 
connectivity and maturation especially during the early development stages of the 
central nervous system. As a functional consequence of this, muscles may become 
weak, although their physiological activation might be still possible. This will result in 
a lack of movement when assessed using the SCALE, but in a coherent sEMG 
activation pattern, as quantified by the SCALE-SI. Accordingly, as proximal-distal-
concordance is more prominent in the SCALE assessment, this concept might be 
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more related to movement and muscle strength and not solely to SVMC and motor 
cortex activation. 
  
Figure 21: Proximal-distal concordance:  
mean SCALE joint scores of A) study 2 n=39) and b) study 4 (n=24) and C) mean SCALE-SI joint scores 
of study 4 (n=24). Joints are displayed on the x-axis and their SVMC score (SCALE or SCALE-SI) on the 
y-axis for the less affected side in black and the more affected side in grey.   
/ ---- less affected joint in children with CP; / ---- more affected joint in children with CP  
Abbreviations: SCALE-SI: Selective Control Assessment of the Lower Extremity – Similarity Index; STJ: 
subtalar joint 
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c) Establishing discriminant validity: theoretical relationship between SVMC 
and spasticity 
By testing hypotheses regarding the relationship between SVMC (SCALE and 
SCALE-SI) and spasticity, the aim was to establish discriminant convergent validity of 
the SCALE and the SCALE-SI. This a priori formulated hypotheses were based on 
the current pathophysiological understanding of SVMC. As stated in chapter 2.2.5, 
SVMC is one possible negative UMN sign in children with a lesion of the first motor 
neuron. In clinical practice,  a mixture of another negative (e.g. muscle weakness) 
and additional positive (e.g. spasticity) UMN signs is often present in these patients 
(Carr 2014). Therefore, it is difficult to investigate positive and negative UMN signs 
separately. Their common pathogenesis and their interconnected hidden neural 
pathways complicate investigation of linear causality. Concerning SVMC and 
spasticity, there is an ongoing debate about the real pathophysiological nature of 
(decreased) SVMC (chapter 2.2.6). One opinion advocates a loss of selective control 
that is related to a loss of inhibition and the release of primitive flexor/extensor 
patterns and would thereby strongly relate to hypertonia (positive UMN sign). Another 
opinion argues that impaired SVMC is an impairment on its own (negative UMN sign), 
caused by the loss of connections to the CSTs. Finally, there is a third opinion that 
think of SVMC as the result of both negative and positive UMN signs.  
Results of study 1, 2 and 4 of this PhD project seem to be in favour of the second and 
third theoretical construct regarding the nature of SVMC. Correlation results between 
the SCALE or the SCALE-SI and the MAS were only moderate negative ones (ρ= -
0.43 (SCALE study 1) to -0.61 (SCALE-SI, study 4)), showing that there is a 
relationship, though not as strong as expected in relation to opinion one, in which 
impaired movement control is thought to appear purely due to impaired reflexes and 
hypertonia (Figure 15). Nevertheless, it should be noted that the overall level of 
spasticity was mild in all three samples, because there was a GMFCS level I to II 
dominance in study 1 and 2 and GMFCS level I-III dominance in study 4. Please note 
also that participants of study 1 (n=52) and study 2 (n=39) were partly the same 
(n=30). Thereby, a separate interpretation of the results of these two studies should 
be handled with great care. Nevertheless, their results were cautiously used to 
reinforce observed trends within the data of this PhD project. 
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Figure 22: Correlations SCALE, SCALE-SI vs MAS:  
A) correlations results SCALE vs MAS study 1 (n=52); B) correlations results SCALE vs MAS study 2 
(n=39); C) correlations results SCALE vs MAS study 4 (n=24); D) correlations results SCALE-SI vs MAS 
study 4 (n=24)  
Abbreviations: SCALE-SI: Selective Control Assessment of the Lower Extremity – Similarity Index; MAS: 
Modified Ashworth Scale  
Results for the MAS show a large spread of SCALE and SCALE-SI scores in patients 
with low MAS. Nevertheless, this variety in SVMC in patients with low spasticity might 
indicate that in these participants, impaired SVMC is not a consequence of hypertonia, 
but should be considered as a negative UMN by itself. This impression changes when 
looking to the other end of the scaling system, where a high level of spasticity is 
associated with a low SVMC in children with spastic CP. Only one participant (study 
4) was found, who had a relatively high level of spasticity and good SVMC (SCALE-
SI). This participant (GMFCS IV) had contractures around the ankle and knee as well 
as a high level of spasticity. Thereby, the active range of motion was limited, but 
muscle activation was physiologically undisturbed, as seen by the sEMG. Therefore, 
when interpreting the correlation results of study 4, this outlier should be kept in mind, 
as correlations within small samples are known to be strongly affected by one or two 
extreme values. 
Alternatively, these findings might also indicate that the MAS is too insensitive to 
assess hypertonia. This argument is supported by the current debate about whether 
there should be continued use of the MAS (Fleuren et al. 2010), due to its poor inter-
rater reliability. Also, because its scoring can be influenced by several interfering 
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factors which are difficult to standardise, like the emotional state of the patient. Due 
to this questioned sensitivity of the MAS as well as due to the incompletely understood 
nature of SVMC and its interconnection with spasticity, the idea to test convergent 
validity of SVMC measures by its relation to spasticity, might not conducive to the 
establishment of this psychometric property. Future psychometric studies for SVMC 
measures might, therefore, consider using an alternative spasticity measurement tool 
with appropriate psychometric properties that measure spasticity more objectively 
(e.g. sEMG supported Pendulum Test (Fowler 2010) or an isokinetic dynamometry 
measure (Pierce et al. 2006)). The benefit of using an isokinetic strength measure is 
the addition of velocity as standardisable measurement component, allowing the 
testing of velocity-dependent increase in tonic stretch reflexes in a controlled manner. 
Previous studies, which used an isokinetic strength measure (Biodex) around the 
ankle and knee in children with CP, found that this measure is feasible and reliable, 
and capable of investigating the influence of spasticity on voluntary force production 
(Pierce et al. 2006; Damiano et al. 2001; Engsberg et al. 2000; Ayalon et al. 2000). 
Accordingly, an isokinetic strength measure might allow for testing the correlation 
between spasticity and SVMC as well as for muscle strength and SVMC. 
In summary, the correlation results of these studies helped to gain a better 
understanding of the real nature of SVMC in children with CP. Larger cohort-studies 
are now needed, that include participants with a wider range of MAS values than 
reported in these studies, in order to facilitate a more conclusive understanding of the 
influence of spasticity on SVMC in children with CP.  
d) Establishing convergent validity: theoretical relationship between SVMC 
and muscle strength  
In contrast to spasticity, correlation coefficients between SCALE and muscle strength 
assessed by the MMT were strong (ρ>0.8) in study 1 and 2. This could indicate that 
a correctly applied MMT will partially reflect the ability to activate a muscle (group) 
selectively. Unfortunately, the MMT was not used in study 4. This was done in order 
to keep measurement duration to a maximum of 1 hour to ensure compliance of the 
participants for validity and test-retest reliability testing. Although correlations for the 
MMT were strong and the MMT is commonly and easily applied in the clinical and 
scientific setting, it might not be the optimal reference tool for evaluating validity of a 
SVMC measure. Firstly, MMT’s psychometric properties have not yet been 
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established for the lower extremities in children with CP. Secondly, its scaling system 
is quite broad in relation to its ordinal nature and does not assess the strength in 
different ranges of motion. An (instrumented) isokinetic strength measure might be a 
more appropriate comparison instrument, because it would allow the measurement of 
strength throughout the same range of movement, as with the measure of SVMC.. 
Additionally, it allows for the investigation of the influence of standardized movement 
speed on muscle strength and selective muscle activation. Establishing convergent 
validity of the SCALE-SI by an isokinetic-strength measure (Pierce et al. 2006; 
Damiano et al. 2001; Engsberg et al. 2000; Ayalon et al. 2000), as mentioned in the 
section above, might furthermore improve our understanding of the interrelated nature 
of these three UMN signs (impaired SVMC, muscle weakness and spasticity) in 
children with CP.   
e) Establishing convergent validity: theoretical relationship between SVMC 
and trunk control 
Referring back to Figure 3, showing the close neuroanatomical positions of the lower 
extremity and the trunk on the homunculus of the motor cortex led to the idea to 
investigate the relationship between these two motor control impairments. Although 
study 1 was not a psychometric study, interpretation of its correlation results between 
the SCALE and the TCMS might be extended to evaluate convergent validity of the 
SCALE within the context of this final discussion chapter.  
As expected, correlations were strong between the trunk and the SCALE (ρ=0.76, 
p<0.001). This might indicate that the ability to control one’s lower extremity and trunk 
are closely interrelated. A child with low trunk control will also have problems to control 
movement of the lower extremity. This interdependence is commonly observed within 
the clinical practice, but this is, to the author’s knowledge, the first study systematically 
investigating this connection.  
Future studies aiming to investigate convergent validity of the SCALE or SCALE-SI in 
relation to trunk control might select other references, i.e. more objective trunk-control 
measures, to further test the above stated hypotheses about SVMC of the lower limbs 
and the trunk. One idea would be the kinematic analysis of the centre of mass or 
pressure gained from a standardized trunk control force-plate measurement. 
Currently, our research group has developed such a force-plate based trunk control 
measurement tool, which tests trunk control playfully by means of a computer game. 
 144 
The game is played with the participants sitting upright and without them having foot 
contact on the force plate. The child is asked to selectively follow a predefined path 
by moving the trunk in different directions as well as to catch and hold specific target 
points by holding the trunk posture, respectively. Theoretically, within the context of 
the SCALE-SI’s validity testing, one would expect that children who are able to follow 
the predefined path more accurately and who are able at catching and holding specific 
target points, also have better motor control in their lower extremity.  
f) Establishing convergent validity: theoretical relationship between SVMC 
and gross motor function skills  
Finally, the possibility to establish convergent as well as discriminative validity of the 
SCALE or SCALE-SI via its relation to a gross motor skill measures will be discussed. 
The clinical observation behind this concept is that children with a higher level of 
mobility tend to have better movement control. This hypothesis was confirmed by 
study 1 via a moderate negative correlation between the SCALE and mTUG (ρ= - 
0.69; p<0.001), as well as by study 2 and 4 via a strong negative correlation between 
the SCALE respectively SCALE-SI and the GMFCS (ρ= -0.83 and ρ= -0.74; p<0.001). 
In relation to this discussion, the correlations between SCALE and GMFCS were also 
computed for study 1 and study 4. All correlations were equal or higher than ρ= -0.70 
(Figure 16). These high correlations between SVMC and gross motor functioning are 
furthermore confirmed by other studies (Chruscikowski et al. 2017; Y. Kusumoto et 
al. 2016; Fowler et al. 2009) and show the importance of SVMC on the ICF activity 
level. 
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Figure 23: Correlations between SCALE / SCALE-SI and GMFCS:  
A) correlations results SCALE vs GMFCS study 1 (n=52); B) correlations results SCALE vs GMFCS 
study 2 (n=39); C) correlations results SCALE vs GMFCS study 4 (n=24); D) correlations results SCALE-
SI vs GMFCS study 4 (n=24)  
Abbreviations: SCALE-SI: Selective Control Assessment of the Lower Extremity – Similarity Index; 
GMFCS: Gross Motor Functioning Classification  
In addition to the correlation between the SCALE/SCALE-SI and the GMFCS, 
differences of SCALE/SCALE-SI across all GMFCS levels and between adjacent 
levels were computed in study 2 and 4 to establish discriminative validity. Overall, in 
both studies, the Kruskal Wallis Tests revealed only a significant difference between 
GMFCS level I and II. This was probably due to the limited sample size as well as to 
the unequal distribution within each GMFCS level. Performing a power analysis (80% 
power, two-tailed alpha .05) revealed that a sample size of at least 19 participants in 
GMFCS level II and III and 29 participants in GMFCS level III and IV would be required 
to determine statistically significant differences between these GMFCS levels.  
Furthermore, future studies might be advised to employ a different mobility measure 
for establishing validity of the SCALE. A recent study showed that there is a moderate 
correlation (ρ= -0.603) between the Gait Profile Score, which is an index of how 
different a person’s gait is compared to neurologically intact persons and the SCALE-
score (Chruscikowski et al. 2017). In line with the results of this cohort-study, previous 
studies already demonstrated the relationship between the SCALE and specific gait 
parameters. Another interesting finding was shown by a recent study about the 
influence of SVMC among other lower limb impairments on ‘RaceRunning’ 
performances in athletes with hypertonia, ataxia or athetosis. The correlation between 
100m ‘RaceRunning’ speed and SCALE (ρ = 0.47) was lower than when compared 
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to gait, but it was still statistically significant. Interestingly, the strongest association 
between the ‘RaceRunning’ speed and the other lower extremity impairment was 
found with spasticity. This higher impact of spasticity shown within this study might be 
explained by the higher GMFCS level (IV-V) of ‘RaceRunning’ athletes, of whom the 
majority were not able to walk (van der Linden et al. 2018). 
Comparing participant characteristics of this sample, with previous studies predicting 
gait in children with CP (e.g. Balzer, Marsico et al. 2017), revealed that the included 
participants had lower levels of mobility and higher levels of spasticity (i.e. MAS total 
scores higher). Accordingly, in more severely impaired people with CP, the results of 
this study imply that, spasticity, in addition to impaired SVMC and muscle strength, 
limits mobility. 
7.3.2 Considerations when testing reliability of a SVMC measure  
As stated in chapter 2.3.3, reliability is defined as the degree to which a measurement 
is free from measurement error (Portney and Watkins 2000). The sources of 
measurement error are dependent on the measurement instrument applied as well as 
on the chosen population and other external factors. 
Study 2 focused on the agreement within one rater andbetween two different raters. 
As the SCALE testing procedures are described in detail in the manual and because 
of the simplicity and ease of use of the SCALE, a well-standardized testing protocol 
helped to minimize possible error-sources. Furthermore, a second rating (by an 
independent rater) was achieved through video-recordings. Rating the SCALE from 
video recordings might be recommended, as it allows the sole concentration on 
scoring and not the simultaneousy conduct of the assessment and communication 
with the participant. As the test duration of the SCALE is quite short (around 15 
minutes), all participants could remain focused, concentrated and compliant. While 
intra-rater reliability (Kusumoto et al. 2016; Balzer et al. 2016) as well as inter-rater 
reliability (Kusumoto et al. 2016; Fowler et al. 2009) of the SCALE have been 
evaluated and shown to lie within excellent ranges, future studies might want to 
concentrate on test-retest reliability of this assessment tool. By testing this type of the 
SCALE’s reliability, one could get an impression of the influence of potentially 
interfering factors, for instance how the participant’s compliance or state of health 
might alter the testing conditions when applying the SCALE twice. 
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Considering absolute reliability of the SCALE, scores like the MDC changes were only 
reported in study 2. The two other studies on the SCALE’s reliability presented relative 
reliability values. As absolute reliability (or measurement error) is critical for clinical as 
well as scientific work, future studies should also establish values of absolute 
reliability.  
In relation to the SCALE-SI, the focus of the reliability testing lied less on the inter-
rater reliability but more on testing the measurement error when applying the 
measurement tool twice (study 4). This type of reliability is known as test-retest 
reliability and recommended for all outcome measures. Due to the known variability 
of sEMG measures (i.e. electrode placement, impedance, muscle size), the 
expectations for between-session test-retest reliability were less, compared to the 
SCALE’s excellent intra/inter reliability values (study 1). By strictly following the 
SEMINAN guidelines and by accurately noting down the distance of the electrode 
placement from bony landmarks, it was aimed to minimize error in relation to electrode 
placement. A customized seat was used to minimize the bias of movement artefacts 
upon the sEMG data. Movement artefacts of mainly the m. semitendinosus and m. 
gastrocnemius appeared less (testing within the pilot phase) when measurements 
took place on the seat. Nevertheless, movement artefacts appeared and are possible 
sources of error. Artefacts appeared most often during hip joint testing, during lifting 
and lowering the thigh from the seat, which sometimes caused a vibration on the 
sEMG sensor. Another possible source of bias might have been the setting of event 
markers (using a manual trigger) for the event windows for each of the three repetitive 
SCALE test-joint movements; i.e. definition of the start and endpoint of every single 
joint movement (e.g. start and end of knee extension and flexion movement one, two 
and three). In contrast to the original protocol of the SI (Voluntary Response Index), 
which uses a computer-generated audio signal as testing-starting and end point (Lim 
and Sherwood 2005), manual triggers simultaneous to the verbal command of the 
tester were applied in study 4. This technique might have been less precise and might 
have caused a greater variability in the time frame for each event window but was 
considered as the best possible alternative method to set event markers. 
Nevertheless, future studies might consider to either use the above mentioned 
method of a computer-generated audio signal or simultaneous recordings of the joint 
movements (e.g. goniometers) to obtain a more accurate way of establishing the start 
and end of the joint movements. Overall, the SCALE testing procedure seemed to be 
feasibly combined with the sEMG. The only exception here might have been the 
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testing of the SVMC of the hip joint in sitting position. Future studies might consider 
testing hip SVMC in accordance to the original SCALE protocol.  
Thus, the lower ICC values at joint level might be explained by the aforementioned 
limitations. Nevertheless, relative reliability of the summed scores (but not the 
individual joint scores) is within clinically acceptable ranges (ICC > 0.70). 
Interpretation of absolute reliability values, i.e. whether a MDC 0.14 (SCALE-SI total 
score) is clinically acceptable, is not possible at the moment as real change estimates 
for SVMC of the lower extremity are not yet available. 
7.3.3 Considerations concerning clinical utility of SVMC measures  
Clinical utility is defined by the impact and usefulness of the results of a measure in 
relation to the individual, the family and society (Mokkink et al. 2016). Benefits and 
risks that have to be considered include the psychological, social and economic 
consequences of testing as well as the implications for health outcomes. Therefore, 
validity, reliability and responsiveness are critical measurement qualities of a tool, but 
if the instrument is not feasible within the certain practical context, it will be useless. 
Although clinical utility was not an explicit focus of this study, due to its importance for 
clinical as well as research practice, experiences with the SCALE and SCALE-SI will 
be discussed in this section. Furthermore, clinical utility of suggested measures will 
be discussed.  
Application of the SCALE was feasible, as it can be performed within 15 minutes, 
does neither require any special training nor equipment, and is child-friendly. 
Compared to other SVMC assessments (SMC, m-Trost, Gillette’s SMC), it assesses 
all five main lower extremity joints and applies a testing procedure and scoring system 
which aims to minimize the influence of muscle strength on SVMC. For those with 
less experience with the SCALE, it might be recommended to capture the assessment 
on film and to apply the scoring afterward using the video recording. As it is important 
that clinicians as well as researchers can readily and freely access the tools they 
require, the original SCALE as well as the German SCALE version are freely available 
to all. (http://uclaccp.org/images/ResearchPapers/SCALE%20Validity_appendix_ 
%2009.pdf) 
(http://www.kispi.uzh.ch/rza/de/forschende/publikationen/downloads/Documents/Bal
zer_Suppl.Material_SCALE_German.pdf) 
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The SCALE-SI testing items (i.e. joint movements) are, except for the hip, the same, 
but the testing procedure becomes more complex by the application of the sEMG. 
Measuring sEMG requires an sEMG system (approximately £50,000), specially 
trained testers (with hard- and software expertise as well as knowledge of the 
electrode placement) as well as additional time and knowledge to process and 
analyse the sEMG data. Because the correct electrode placement is critical, the 
duration of the SCALE-SI assessment is twice as long as the SCALE (30 min). 
Surface electrode placement (and removal) is not considered to be painful, however, 
in practice, removing electrodes was experienced as very uncomfortable by some 
children. The use of a plaster-remover (Niltact spray) helped to deal with this 
limitation. Because the application of the SCALE-SI demands for specific equipment 
and trained personnel, it might be feasible within some clinics as well as within the 
research setting but not within smaller practices, unlike the SCALE.  
7.3.4 Considerations when testing responsiveness in SVMC measures 
Responsiveness is “the ability of an instrument to detect change over time in the 
construct to be measured” (Mokkink et al. 2010). Accordingly, whenever a scientist or 
a clinician aims to detect, whether a patient’s health condition has changed over time 
due to recovery or an intervention, responsive outcome measures are required. 
Depending on the availability of a ‘gold standard’, responsiveness is tested either via 
criterion or construct validation. 
In relation to the initial clinical question of this PhD, “Will my child learn to walk 
normally within your therapy?”, the desired outcome of this PhD would have been an 
evidence-based answer to this question. Right from the beginning of this project, it 
was clear that answering this question would only be possible with the existence 
and/or availability of a valid, reliable and responsive outcome measure. Only when 
using a tool with adequate psychometric properties, it is possible to carry out an 
intervention study on the effectiveness of a physiotherapy training strategy to improve 
SVMC of the lower extremity and subsequently gait quality in children with CP. In our 
rehabilitation centre, physiotherapeutically supporting the child to walk more 
‘normally’ is mainly performed by training selective single-joint movements (e.g. ankle 
dorsiflexion) in static positions (e.g. in sitting, during standing, during initial contact 
position) as well as during functional movements, (e.g. during walking, via aids like 
FES). Accordingly, the systematic review aimed to evaluate psychometric properties 
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of outcome measures, measuring SVMC improvements of the lower extremities in 
children with UMN lesion. As the review results showed a relative scarcity of 
previously evaluated tools and the absence of responsiveness testing, the aim of this 
project was adapted and then geared toward developing a new SVMC outcome 
measure and testing its psychometric properties. Consequently, the SCALE-SI was 
developed, and its validity and reliability tested. However, as responsiveness testing 
of this new tool laid beyond the initial scope of this project, it remains the missing 
“step” in being able to address to the initial question of this project. Therefore, this 
section presents considerations and ideas in relation to a future responsiveness 
studies for the SCALE-SI. Firstly, considerations about finding an optimal intervention 
for testing responsiveness will be discussed by referring to the current debate about 
trainability of SVMC. Secondly, possible study designs for future responsiveness 
studies will be presented. 
7.3.4.1 Finding an adequate intervention for responsiveness testing 
In relation to SVC outcome measure responsiveness, an intervention is required, 
which is known to be effective in changing the outcome of interest in at least a part of 
the participant. Although this COSMIN definition appears to be sound, it gives rise to 
the question “which came first: the chicken or the egg’”, as an intervention is needed 
that is known to improve SVMC. However, in order to establish the effectiveness of 
an intervention, a valid, reliable as well as responsive outcome measure is needed. It 
is this causality dilemma which exactly makes it so difficult to test responsiveness in 
outcome measures. 
In relation to SVMC, this dilemma might even be exaggerated by the ongoing debate 
about trainability of SVMC in patients with UMN lesions. Mainly the following two 
issues are under current discussion. Firstly, there is an absence of consensus about 
if, to what extent or in what kind of patients impaired SVMC can be trained and how 
to do this most efficiently. Secondly, the additional value of training SVMC for the 
patients’ functioning in daily life is discussed.  
Considering the first point of debate, up until now there is evidence missing as to what 
degree SVMC can be trained in patients suffering from a UMN lesion. Indeed, the 
impaired neuroanatomical structures cannot be restored or healed medically. 
Nevertheless, the concept of neuroplasticity as explained in section 2.2.9.1, describes 
the “ability of the brain to form and reorganize synaptic connections, especially in 
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response to learning or experience or following injury” (Nudo 2013). This activity or 
(use-dependent) plasticity of the brain (“neurons that fire together will wire together”) 
has been shown in animal, neurologically intact humans and in research with patients 
with UMN lesions. Although the majority of studies in this field have shown changes 
in upper extremity motor control, the fact that this evidence for SVMC of the lower 
extremity is currently lacking does not indicate that neuroplasticity does not exist for 
the lower extremities. It rather shows that measuring the neuroanatomical structures 
of the upper extremities is easier, as well as it shows that SVMC of the upper extremity 
is more commonly trained. While impaired SVMC is of great importance when carrying 
out fine motor movements of the hand, its accurate functioning is needed to a lesser 
extent for lower limb functional tasks like standing and walking, where muscle strength 
seems to be also of great importance for moving against gravity.  
Due to the functional relation of many selective upper limb movements, SVMC training 
of the upper limbs is naturally imposed into therapy and the patient’s everyday life. In 
contrast, SVMC of the lower extremity, for instance by training selective ankle 
dorsiflexion, can be less well integrated into a purposeful activity training. Due to 
reduced possibilities of incorporating SVMC training of the lower extremity within 
functional training, the neuroplastic potential of the neuroanatomical structures 
innervating the lower extremity might have been underestimated. In this context, the 
lack of evidence concerning selective training of the lower extremity should have 
increased visibility and might help to guide future studies within this context.  
The second main point of debate is the value of improved SVMC for the child’s quality 
of life. While some advocate to train solely on the activity level, aiming for maximizing 
functional performance of the patient, others argue that by training SVMC the patient’s 
movement control will improve and thereby his/her movement efficiency. This 
improved motor control potential would then lead to an uplift of the patient’s 
performance on the activity level. As an evidenced-based answer to this debate can 
only be given by the results of robust intervention studies, which falls beyond the 
scope of this PhD project, future research in this area is needed.  
Furthermore, it becomes clear, that the selection of a reference measure to 
responsiveness of the SCALE-SI is currently based on clinical practice and not on 
scientific evidence. Based on i) the author’s clinical experience as a specialized 
neuro-paediatric physiotherapist as well as in relation to ii) the principles of 
neuroplasticity and due to iii) the results of the SVMC intervention studies (Chapter 
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2.2.8: Table 1), an intervention to assess the responsiveness of the SCALE-SI in 
children with CP would have to fulfil the following criteria. I) it should include functional 
activities; ii) be attractive / (‘fun’) and easy to understand (cognitive deficits). Further, 
it should iii) allow for a high number of repetitions, iv) be easy to standardise, v) and 
it should previously be shown to have an effect on SVMC. For example, an 
intervention using a robotic ankle/knee device in combination with virtual reality may 
fulfil these criteria. Although this intervention is not related to the patients’ real daily 
activities, it would offer the possibility to playfully train selective ankle movements 
(Chen et al. 2016; Sukal-Moulton et al. 2014; Byanton et al. 2006). Furthermore, the 
use of virtual reality has shown to allow for standardization as well as for a high 
number of ‘repetitions without repetitions’ (Meyer-Heim and Van Hedel 2014). 
Alternatively, instead of using a robotic joint device, FES (to the dorsiflexors) may be 
a feasible intervention, both on its own (e.g. during single joint movement and 
functional movement as well as during activities like gait) or in combination with virtual 
reality. The additional benefit of FES would be that it acts directly on the muscles as 
well as that it adds sensory input to learned movements (Pool et al. 2014). In the 
opinion of the author, this would constitute two suitable intervention options for testing 
responsiveness of SVMC. Of course, interventions like NDT or Vojta also aim to 
improve SVMC, but as these interventions are less standardisable, they seem to be 
less suitable for responsiveness testing. Interventions like SDR or BTX, which are 
thought to influence SVMC indirectly by reducing the limiting effect of spasticity, might 
be alternative options.  
7.3.4.2 Outlook study design for responsiveness testing of the SCALE-SI 
The study design of a responsiveness study should control for as many as possible 
interfering factors. In order to be able to draw a robust conclusion regarding the ability 
of the SCALE-SI to measure a change in SVMC in children with CP, the following 
prerequisites should be fulfilled: i) an appropriated study design (approach) should be 
selected; ii) an adequate intervention, based on motor learning and neuroplasticity 
principles, should be applied (section 7.3.4.1), iii) a representative sample of children 
with spastic CP should be recruited; and iv) adequate measurement time points and 
comparison measures should be selected.  
The aim of this section is to consider and explain the various aspects of a potential 
study protocol to establish responsiveness of the SCALE-SI in children with CP.   
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i) Study approach  
Although the importance of responsiveness is well accepted, there is less consensus 
with regard to the way responsiveness should be assessed and reported. A review 
performed by Husted and colleges in 2000 showed that there are two approaches 
known as “internal” and “external” responsiveness. Internal responsiveness measures 
responsiveness by the ability of the tool to record a change over a particular pre-
specified time frame. Using this approach responsiveness is often quantified by effect 
sizes (type I-II). 
Effect sizes have been introduced by Cohen to provide a standardized measure of 
the magnitude of an effect. These measures are used to interpret changes in health 
status or magnitudes of treatment effects (Cohen 1988). The COSMIN group, 
however, considers that an effect size only has a meaning as a measure of 
responsiveness if the magnitude of an effect (change) is known beforehand, because 
otherwise interpretation of the measured value cannot be clearly distinguished from 
the treatment effect (De Vet et al. 2011). 
Therefore, they advocate the external responsiveness approach, in which 
responsiveness is quantified by the correlation between the change in the measure 
of interest and the corresponding change in a reference (gold standard) measure. 
However, other researchers question the meaningful application of quantifying 
responsiveness via correlation coefficients, as the clinical relevance of expected 
correlation thresholds is not as readily interpreted as effect size measures (Husted et 
al. 2000; Angst 2011).  
This dilemma with regard to the assessment of responsiveness is particular 
challenging in the context of this thesis, as in the field of SVMC neither prior establish 
effect sizes exist, nor “gold standard” or “external reference (tool)” exist. For a future 
study assessing the responsiveness of measures of SVMC (like the SCALE-SI), the 
candidate therefore suggests quantifying responsiveness using the methods of the 
internal approach (effect sizes) and the external approach (correlation with a 
comparator instrument in absence of an external reference/gold standard measure). 
ii) Change in SVMC through treatment or normal development 
No matter which responsiveness approach is chosen, a change in the construct of 
interest, either due to (normal) development or treatment, must be observable.  
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With regard to development, changes in SVMC occur with maturation of the central 
nervous system. Although these changes are known to occur in children with CP, their 
timing and intensity vary greatly in this heterogeneous population. Further, although 
such a development approach might be interesting in relation to SVMC of the upper 
extremity, the author doubts its applicability to the lower extremity for the following 
reason. As previously explained, ambulatory children with CP might experience 
“learned-non-use” of the lower extremity associated with strict orthosis management 
regimes (common in Switzerland). Accordingly, natural development (maturation) of 
SVMC around the ankle, which may be primarily impaired due to their brain damage, 
might be further suppressed by the learned-non-use.  
As the primary interest of this PhD is related to therapy-induced changes of SVMC, 
we would favour to apply an intervention to investigate the responsiveness of the 
SCALE-SI. The intervention of choice would be an activity-based motor learning 
approach including FES and motivating virtual reality gaming to increase therapy 
compliance of the younger patients. Although previous studies have shown that 
interventions such as robotic training or FES in combination with virtual reality (section 
2.2.8) have an immediate effect on SVMC (Byanton et al. 2006), a longer, more 
intensive training programme may be necessary to ensure sufficient time for structural 
and functional changes in relation to SVMC to occur. Based on previous intervention 
studies (Chen et al. 2016; Sukal Moulton et al. 2014; Jung et al. 2013; Wu et al. 2011), 
an intervention duration of six weeks, with three training sessions per week, is 
suggested to induce and assess changes of SVMC in the lower extremity in children 
with CP. 
An alternative approach to measure expected changes of SVMC might be found in 
interventions like SDR or BTX, which are thought to influence SVMC indirectly by 
reducing spasticity. Nevertheless, as this approach would be based on the 
controversial pathophysiological nature of SVMC, their expected treatment effect is 
more speculative than pre-established, and therefore considered to be less 
appropriate. Furthermore, as mentioned in chapter 2.2.4, (early) intervention aiming 
to decrease exaggerated afferent input (i.e. BTX) should be considered with caution. 
For these reasons, the author recommends therapeutic interventions which aim to 
increase activity in residual CST functioning instead. 
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iii) Sample 
The population of interest would be, in accordance to COSMIN guidelines at least 30 
children with CP, fulfilling the following inclusion criteria: clinical diagnosis of spastic 
CP, age between 5 and 18 years, GMFCS I-III, and ability to follow simple instructions. 
Children with a primarily dystonic or ataxic impairment, an unstable situation 
regarding their tonus-regulating medications and/or children who had a BTX injection 
within the last six months or any surgical correction within the last year of the lower 
extremity, should be excluded. Furthermore, only children, who are capable of 
understanding the training and assessment instructions, which is relevant concerning 
voluntary motor control, would be included. Regarding the GMFCS level, we would 
aim to recruit equally within the different levels to allow for inter-group comparison.   
iv) Measurement procedure and tools  
To evaluate internal responsiveness of the SCALE-SI, the SCALE-SI would be 
recorded before and after the intervention to calculate its effect size (Cohen’s d or 
non-parametric effect size where appropriate). In order to quantify the SCALE-SI´s 
responsiveness externally, the change in SCALE-SI score should be compared to the 
change on another SVMC measure score. 
The author would suggest the SCALE assessment and Transcranial Magnetic 
Stimulation (TMS) as two possible comparator measures for external quantification of 
the responsiveness of the SCALE SI. As the SCALE’s ability to detect changes might 
be limited in relation to its ordinal scoring system (sections 4.5.4; 6.5.4; 7.3.1.2), only 
moderate to low positive correlations between the changes scores of the SCALE-SI 
and SCALE are expected.  
TMS is a non-invasive method measuring the integrity of the CST using sEMG 
recordings of the target muscle. A coil is placed on the head and creates a changing 
magnetic field over the motor cortex. This causes an electric current to flow from the 
cortex via electromagnetic induction to the related skeletal muscle. TMS has been 
used most extensively to evaluate physiological and impaired CST function (Beaulieu 
et al. 2014; Vry et al. 2008; Kesar et al. 2012). As stimulation of the muscles of the 
lower limb (e.g. m. tibialis anterior) is more difficult due to the neuroanatomical 
position of the foot on the motor cortex, the majority of studies are found on the upper 
extremity (Beaulieu, Massé-Alarie, et al. 2017). Nevertheless, one very interesting 
study in relation to the interest of this PhD was a study performed by Yang and 
 156 
colleagues (Yang et al. 2013). They studied the probable effectiveness of early gait 
training in young children with hemiplegic CP (under the age of 2 years). One main 
objective of their study was to investigate the effectiveness of an intensive activity-
based therapy program (on average1 h/day, 4 days/week) on enhancing walking and 
gait quality in five hemiplegic children younger than 2 years. This very young age was 
selected on purpose in order to train these children in the critical period of CST 
maturation. Moreover, to prove the hypothesis that learning within this time window is 
more effective than after maturation has completed. Preliminary results show that 
improvements in walking (GMFM 66) and gait analysis outcomes, such as walking 
symmetry, exceeded previous reports, which supported their hypothesis. Their 
second goal was to refine TMS techniques for measuring motor and sensory 
pathways to and from the legs in a reliable manner in this young age group. By using 
several adjustments (e.g. use of a large, double-cone coil with an outside diameter of 
125 mm, double pulses, and triggering in standing position to have a similar level of 
background activity while the child was playing), they concluded that this was 
possible, therewith allowing future large studies to measures the effectiveness of such 
early intervention program as well as in relation to its changes of CST functioning (e.g. 
motor evoked potential, stimulation threshold, latency, reflex response).  
In accordance to such an adapted TMS measurement protocol (Yang et al. 2013), 
measuring Motor Evoked Potentials (MEP) of the tibialis anterior before and after the 
suggested intervention seems to be feasible. An increase of the amplitude of the MEP 
of the tibialis anterior would be associated with improved CST functioning and could 
be the comparator measure to compare changes in the SCALE-SI with. However, 
although that TMS measures the intactness of the most important pathway involved 
in SVMC, the CSTmisses several important characteristics of SVMC. Firstly, as 
activation of the muscle is stimulated externally, it does not require the participant’s 
voluntary activation, which is central when referring back to the definition of SVMC 
(Sanger et al. 2006). Secondly, it only measures the motor output in relation to the 
stimulated area. Thereby, measurement and detection of involuntary movements (co- 
and mirror movements) is lacking. Furthermore, larger studies assessing the 
psychometric properties of TMS mainly focused on evaluating reliability of TMS in 
either neurological intact adults or adults with a neurological condition. A recent review 
on the consistency and measurement error of TMS in neurologically intact participants 
concluded that “evidence about the reliability of TMS outcomes is scarce and affected 
by several methodological and statistical problems” (Beaulieu, Flamand, et al. 2017). 
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Accordingly, it would be hypothesized that only a moderate positive correlation 
between the change scores of the both measures would be found. 
Finally, as an additional external and clinical anchor for evaluating the SCALE-SI´s 
responsiveness, the therapist perception of the occurred change in SVMC could be 
assessed by asking the question “Do you think that SVMC has improved during the 
intervention?” and relating the answer (e.g. on a five point Likert scale) to the change 
recorded  in SCALE-SI.  
7.4 Common methodological considerations, limitations and future 
work  
This section will cover further methodological considerations, limitations as well as 
ideas for future studies, which have not been covered in the previous sections of this 
chapter (7.3). Firstly, limitations in methodological considerations to the regression 
analyses of study 1 will be discussed. Secondly, common limitations of all studies in 
this thesis as well as ideas for future work will be presented. 
7.4.1 Multicollinearity 
One main methodological consideration in relation to the multiple regression analysis 
of study 1 (Chapter 3), was the problem of multicollinearity. Multicollinearity is present 
when the independent variables of a multiple regression analysis are strongly related 
to each other. This makes it impossible to obtain unique estimates of the explained 
variance as these variables account for the similar variance of the dependent variable. 
Thereby, their beta values are interchangeable, increasing the risk of type II error 
(Miles and Shevlin 2001). The correlation matrix in study 1, which aimed to predict 
gait capacity by lower extremity and trunk impairments, revealed high correlations (ρ 
> 0.6) between the MMT vs. SCALE, MMT vs. TCMS, and SCALE vs. TCMS. 
Furthermore, the average variance inflation factor of the starting model was above 
“1”, which is considered as a threat to the validity of the model (Field 2005). Due to 
this multicollinearity, the SCALE and MMT scores explained a similar amount of 
mTUG variance and were removed from the final model on gait capacity, while the 
TCMS and MAS remained in the model. As already mentioned in study 1, these 
results do not indicate that SVMC and leg muscle strength does not influence gait 
capacity. The MAS, which on its own only correlated weakly with the mTUG, seems 
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to explain another part of the variance. Therefore, only the MAS and the variable with 
the highest beta value (TCMS) were kept in the final model.  
This interpretation is supported by the results of the simple regression analyses, which 
showed that SCALE and MMT explained the second and the third largest amount of 
variance in mTUG (43% and 40%, respectively). A more robust statistical solution to 
deal with multicollinearity would be to run a factor analysis. How such a structural 
equation modelling could look like is presented in the study of Park and Lim (2013). 
Their study confirmed the construct of motor impairment and performed structural 
equation modelling between motor impairments (muscle strength, spasticity, range of 
motion, SVMC), gross motor function (Gross Motor Function Measure), and functional 
outcomes regarding activities of daily living (Functional Skills domain of the Paediatric 
Evaluation of Disability Inventory) in children with CP. Results of this study revealed 
that motor impairments had a large direct effect and explained the majority of the 
variance in gross motor function. Furthermore, the path coefficients of all motor 
impairments together as well as those of individual ones (SVMC; muscle strength) 
allowed the estimation of the influence of each factor on the dependent variable. 
Thereby, they were able to show that an increase of one standard deviation in motor 
impairments was associated with a decrease of 0.869 standard deviations in gross 
motor function. Further, they showed that an increase of one standard deviation in 
strength and SVMC was associated with an increase of 0.723 and 0.660 standard 
deviations in gross motor function, respectively. As this statistical approach requires 
a larger sample size (> 30-460), it might be considered for future studies investigating 
similar research questions within a larger sample (Wolf et al. 2015). 
Furthermore, a future study investigating the influence of SVMC and other lower 
extremity and trunk control motor impairments by structural equation modelling might 
aim to increase the robustness of the measured values by using objective, pre-
evaluated, measurement tools, instead of observer-dependent ones like in study 1. 
For instance, instead of applying the SCALE, the SCALE-SI could be used, or instead 
of using the MMT, an isokinetic measure should be applied. As outcome measures 
for the dependent variable, walking tests like the mTUG or other measures like three-
dimensional gait analysis using a full body model (i.e. to measure lower and upper 
extremity as well as trunk kinematic, kinetics) or the ‘Gait Profile Score’ might be 
chosen. Thereby, in addition to temporal gait characteristics, kinematic data could be 
entered in the model as well. Possibly, results of such a study would allow for a more 
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in-depth understanding of the neurophysiological contribution of SVMC and the other 
selected variables on gait function in children with CP. 
In conclusion, carrying out structural equation modelling would allow for the 
investigation of the influence of SVMC among other motor impairments on gait 
activities, solving the threat of multicollinearity. 
7.4.2 Generalizability is limited to children with GMFCS levels I-III  
A common methodological limitation of all studies in this thesis is that generalizability 
of their results is limited to children with CP with GMFCS levels I-III. The dominance 
of participants with a better level of walking ability (GMFCS I and II) should be 
considered when interpreting the results of the studies. Nevertheless, this restriction 
to children with higher gross motor abilities is related to the overall dominance of 
children with CP with severity levels GMFCS I and II in the entire population as well 
as to the cognitive demands of the SVMC testing procedure. As the latter requires 
that participants fully understand the purpose of the test-purpose (selective single-
joint movement only, no co- and mirror movements), we had to exclude relatively more 
frequently participants with GMFCS levels III and IV compared to levels I and II. In 
general, it is more difficult to recruit children with lower mobility level and who have 
adequate cognitive functioning. Therefore, the underrepresentation of children with 
more severe mobility problems might also be present in future studies.  
7.4.3 Estimation of clinical meaningful threshold 
Another limitation of study 2 and 4 was the unequal sample distribution within the 
different GMFCS levels as well as the overall limited sample size (study 1: n=39; study 
4: n=24). Based on sample size guidelines (Miles and Shevlin 2001), further statically 
procedures to estimate clinical meaningful thresholds in relation to the SCALE’s / 
SCALE-SI’s ability to discriminate between individual GMFCS levels were not 
performed. Future studies with larger samples might, therefore, consider performing 
a ROC curves to determine the SCALE-SI’s ability to differentiate between adjacent 
GMFCS levels. SCALE-SI cut-off values for differentiating between GMFCS levels, 
will be determined at the level with the highest Youden Index (= sensitivity + specificity 
-1), reflecting the best combination of sensitivity and specificity. Furthermore, the area 
under the curve can be calculated, which is a measure of the accuracy of the ROC 
analysis (Youden 1950). The area under the curve is given by a value between 0 and 
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1, whereas 0.5 represents change and indicates results of a random process. Values 
between 0 and 0.5 indicate worse results than a random process, while a 1 indicates 
that there are no false positives or false negatives, i.e. the test is perfect. The research 
group around the Voluntary Response Index and the SI (Lee et al. 2004; McKay et al. 
2004; McKay et al. 2005) computed a ROC analysis in patients with spinal cord injury. 
Their ROC results showed that the SI could not differentiate well between participants 
with higher motor functioning (American Spinal Injury Association levels D and E), as 
in these participants muscle activity was too close to that of healthy subjects, with a 
resulting clustering of SI values near 1.0 (ceiling effect).  
Computing such analysis for the SCALE-SI could result in similar clinical meaningful 
findings as well as cut-off values. 
7.4.4 Future work  
Considering the mentioned limitation of the SCALE-SI algorithmbeing a combined 
quantification of all muscle activations, irrespectively if it is a matter of selective or 
pathological (co- and mirror-movements) activations, this results in the inability to say 
if mirror movements or co-movements are worse in the sense of SVMC. As this 
differentiation has until now not been scientifically investigated but might be relevant 
to improve efficient treatment planning in children with CP, one might consider 
upgrading the SI algorithm with an equation, which is capable of “weighing” non-
physiological movements. For instance, by looking at the collected reference 
activation pattern of the neurological intact adults and children, and by applying 
methods like nonnegative matrix factorization (Steele et al. 2015), this might be 
accomplished.  
Another important but until now un-investigated prerequisite of SVMC is adequate 
sensory input, i.e. proprioception. Considering the further establishment of the 
SCALE’s or the SCALE-SI’s convergent validity, future studies might aim to test the 
hypotheses that a deficit in lower extremity proprioception is correlated with a low 
level of SVMC. The biggest challenge within such a study might be to find an adequate 
measurement tool for proprioception, as measuring sensory deficits is challenging. 
Most recent scientific investigations as well as available measurement instruments 
testing sensory deficits in children with CP are designed to test somatosensory 
awareness of the upper extremity (e.g.Van de Winckel et al. 2013). One study 
investigating proprioception of the lower extremity used a custom-built device to 
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assess joint-position sense and kinaesthesia in the transverse plane of hip 
internal/external rotation. Their results showed that children with a diplegic or 
hemiplegic CP had proprioception deficits in all limbs (Wingert et al. 2009). Although 
their custom-made proprioception testing procedure seems to be adequate, 
evaluation of its psychometric properties is outstanding but essential if applied for the 
purpose of validating a SVMC tool.  
Another topic of interest would be to investigate if SVMC has an impact on a child’s 
participation and personal factors like self-esteem. In particular, self-esteem seems 
to be of interest in relation to SVMC as it is related to movement aesthetics. Due to 
the rhythmic pattern of walking, un-physiological walking patterns are readily detected 
and can cause social-stigmatization. This was also shown by one previous study 
(Riad et al. 2013). Riad and colleagues showed that the gait pattern deviating more 
from that of healthy pears (Gait Profile Score) of physically high functioning children 
with unilateral CP (GMFCS I-II) correlated with lower self-esteem. This was even more 
pronounced when non-physiological arm movement was involved.  
Future studies might therefore investigate the impact of SVMC of the lower extremity 
in children with CP on gait (performances and capacity), self-esteem and its social 
consequences by using a multiple regression model or structural equational 
modelling.   
7.5 Conclusion 
The starting point of this PhD project was the author’s desire to give parents from 
children with CP an evidenced-based answer to their frequently asked question “Will 
my child learn to walk normally within your therapy?”. The origin of this question is 
mainly the fear that the child will be socially stigmatized due to an altered lower 
extremity control during gait. Besides this personal fear, research within the last 
decade has shown that impaired SVMC in the lower extremity can initiate a vicious 
cycle, limiting other body functions and hampering gross motor function.  
Accordingly, the desired product of this PhD project was initially to provide an 
evidence-based answer to the question whether physiotherapy is effective in 
improving lower extremity SVMC in relation to normalizing the patient’s gait pattern. 
Since an answer to this question implied an intervention study, a sensitive yet robust 
outcome measure for SVMC with established psychometric properties was needed. 
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As such a measure was missing, the initial aim of the project changed into the 
following intermediate goals: 
1) finding new evidence in relation to the importance of SVMC for gait and its 
functional interconnection with other common motor impairments (study 1), 
2) establishing assessments that could be applied in clinical routine 
examinations of SVMC in the German speaking medical field (by means of the 
German version of the SCALE) (study 2), 
3) finding all available previously tested SVMC measurement instruments and 
evaluating their psychometric properties (study 3), 
4) developing and testing a new objective SVMC outcome measure (SCALE-SI) 
and establish its psychometric properties (study 4), 
5) providing suggestions for testing responsiveness of the SCALE-SI in a future 
study (Chapter 7: Final discussion). 
Retrospectively, the initial question of this PhD project is still not answered. 
Nevertheless, by phrasing and realising necessary sub-goals, this thesis added 
important evidence and tools required for answering the question which is so 
frequently asked by parents in the future. As soon as future studies will have 
established responsiveness of the developed and tested SCALE-SI, an intervention 
study testing the effectiveness of physiotherapy in improving SVMC of the lower 
extremity, will provide the initially desired answer to the question “Will my child learn 
to walk normally within your therapy?”. Thereby, although the author could not reach 
her initial goal within the scope of this project, the process as well as all intermediate 
goals met along this journey were considered as being worthwhile in relation to their 
value for other scientists, clinicians and patients.  
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Appendix 1: COSMIN checklist 
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Step 2. Determining if the statistical method used in the article are based on CTT or IRT 
Box General requirements for studies that applied Item Response Theory (IRT) models  
  excellent good fair poor 
1 
Was the IRT model used adequately described? e.g. One Parameter Logistic 
Model IRT model IRT model not   
 
(OPLM), Partial Credit Model (PCM), Graded Response Model (GRM) 
adequately adequately   
 
described described 
  
    
2 
Was the computer software package used adequately described? e.g. 
RUMM2020, 
Software 
package Software package   
 
WINSTEPS, OPLM, MULTILOG, PARSCALE, BILOG, NLMIXED 
adequately not adequately   
 
described described 
  
    
3 Was the method of estimation used adequately described? e.g. conditional Method of Method of   
 
maximum likelihood (CML), marginal maximum likelihood (MML) 
estimation estimation not   
 adequately adequately   
    
  described described   
4 
Were the assumptions for estimating parameters of the IRT model checked? 
e.g. assumptions of assumptions of assumptions of  
 unidimensionality, local independence, and item fit (e.g. differential item 
functioning 
the IRT model the IRT model the IRT model not  
 checked partly checked checked or  
 
(DIF)) 
 
   unknown  
      
 
To obtain a total score for the methodological quality of studies that use IRT methods, the ‘worse score counts’ algorithm 
should be applied to the IRT box in combination with the box of the measurement property that was evaluated in the IRT study. 
For example, if IRT methods are used to study internal consistency and item 4 in the IRT box is scored fair, while the items in 
the internal consistency box (box A) are all scored as good or excellent, the methodological quality score for internal 
consistency will be fair. However, if any of the items in box A is scored poor, the methodological quality score for internal 
consistency will be poor. 
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Appendix 2: Search-Construct SVMC measurement-tool list 
Pubmed 
(selective voluntary motor control[TIAB] OR selective movement*[TIAB] OR 
Selectivity[TIAB] OR voluntary movement*[TIAB] OR volitional movement*[TIAB] 
OR quality of movement*[TIAB] OR muscle activation[TIAB] OR muscular 
activation[TIAB] OR movement pattern*[TIAB] OR physiological movement*[TIAB] 
OR sensorimotor control[TW] OR foot targeting[TW] OR foot placing[TW] OR 
coordinated movement*[TIAB] OR motion compensation OR compensatory 
movement* OR muscular coactivation OR mirror movement* OR muscle synerg* 
OR muscular synerg* OR movement synerg* OR cortical overlap[TW] OR motor 
control[TW] OR joint coupling[TW] OR (interjoint OR inter-joint AND coordination) 
OR force modulation[TW] OR submaximal contraction*[TW] OR maximal voluntary 
contraction*[TW]) OR ("Muscle, Skeletal"[MeSH] OR "Motor Skills Disorders"[Mesh] 
OR "Neuromuscular Manifestations"[Mesh] OR "Motor Activity"[Mesh] OR 
"Recovery of Function/physiology"[Mesh] OR "Gait Disorders, Neurologic"[Mesh])) 
AND (upper motor neuron lesion*[TW] OR "Cerebral Palsy"[Mesh] OR "Brain 
Injuries"[Mesh] OR "Stroke"[Mesh] OR "spinal cord injuries"[MeSH])) AND 
((instrumentation[sh] OR methods[sh] OR Validation Studies[pt] OR Comparative 
Study[pt] OR "psychometrics"[MeSH] OR psychometr*[tiab] OR clinimetr*[tw] OR 
clinometr*[tw] OR "outcome assessment (health care)"[MeSH] OR outcome 
assessment[tiab] OR outcome measure*[tw] OR "observer variation"[MeSH] OR 
observer variation[tiab] OR "Health Status Indicators"[Mesh] OR "reproducibility of 
results"[MeSH] OR reproducib*[tiab] OR "discriminant analysis"[MeSH] OR 
reliab*[tiab] OR unreliab*[tiab] OR valid*[tiab] OR coefficient[tiab] OR 
homogeneity[tiab] OR homogeneous[tiab] OR "internal consistency"[tiab] OR 
(cronbach*[tiab] AND (alpha[tiab] OR alphas[tiab])) OR (item[tiab] AND 
(correlation*[tiab] OR selection*[tiab] OR reduction*[tiab])) OR agreement[tiab] OR 
precision[tiab] OR imprecision[tiab] OR "precise values"[tiab] OR test-retest[tiab] OR 
(test[tiab] AND retest[tiab]) OR (reliab*[tiab] AND (test[tiab] OR retest[tiab])) OR 
stability[tiab] OR interrater[tiab] OR inter-rater[tiab] OR intrarater[tiab] OR intra-
rater[tiab] OR intertester[tiab] OR inter-tester[tiab] OR intratester[tiab] OR intra-
tester[tiab] OR interobserver[tiab] OR inter-observer[tiab] OR intraobserver[tiab] OR 
intra-observer[tiab] OR intertechnician[tiab] OR inter-technician[tiab] OR 
intratechnician[tiab] OR intra-technician[tiab] OR interexaminer[tiab] OR inter-
examiner[tiab] OR intraexaminer[tiab] OR intra-examiner[tiab] OR interassay[tiab] 
OR inter-assay[tiab] OR intraassay[tiab] OR intra-assay[tiab] OR interindividual[tiab] 
OR inter-individual[tiab] OR intraindividual[tiab] OR intra-individual[tiab] OR 
interparticipant[tiab] OR inter-participant[tiab] OR intraparticipant[tiab] OR intra-
participant[tiab] OR kappa[tiab] OR kappa's[tiab] OR kappas[tiab] OR 
repeatab*[tiab] OR ((replicab*[tiab] OR repeated[tiab]) AND (measure[tiab] OR 
measures[tiab] OR findings[tiab] OR result[tiab] OR results[tiab] OR test[tiab] OR 
tests[tiab])) OR generaliza*[tiab] OR generalisa*[tiab] OR concordance[tiab] OR 
(intraclass[tiab] AND correlation*[tiab]) OR discriminative[tiab] OR "known 
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group"[tiab] OR factor analysis[tiab] OR factor analyses[tiab] OR dimension*[tiab] 
OR subscale*[tiab] OR (multitrait[tiab] AND scaling[tiab] AND (analysis[tiab] OR 
analyses[tiab])) OR item discriminant[tiab] OR interscale correlation*[tiab] OR 
error[tiab] OR errors[tiab] OR "individual variability"[tiab] OR (variability[tiab] AND 
(analysis[tiab] OR values[tiab])) OR (uncertainty[tiab] AND (measurement[tiab] OR 
measuring[tiab])) OR "standard error of measurement"[tiab] OR sensitiv*[tiab] OR 
responsive*[tiab] OR ((minimal[tiab] OR minimally[tiab] OR clinical[tiab] OR 
clinically[tiab]) AND (important[tiab] OR significant[tiab] OR detectable[tiab]) AND 
(change[tiab] OR difference[tiab])) OR (small*[tiab] AND (real[tiab] OR 
detectable[tiab]) AND (change[tiab] OR difference[tiab])) OR meaningful 
change[tiab] OR "ceiling effect"[tiab] OR "floor effect"[tiab] OR "Item response 
model"[tiab] OR IRT[tiab] OR Rasch[tiab] OR "Differential item functioning"[tiab] OR 
DIF[tiab] OR "computer adaptive testing"[tiab] OR "item bank"[tiab] OR "cross-
cultural equivalence"[tiab])))) AND Humans[Mesh])) NOT ("Randomized Controlled 
Trial"[Publication Type] OR "Controlled Clinical Trial"[Publication Type] OR 
"addresses"[Publication Type] OR "biography"[Publication Type] OR "case 
reports"[Publication Type] OR "comment"[Publication Type] OR 
"directory"[Publication Type] OR "editorial"[Publication Type] OR 
"festschrift"[Publication Type] OR "interview"[Publication Type] OR 
"lectures"[Publication Type] OR "legal cases"[Publication Type] OR 
"legislation"[Publication Type] OR "letter"[Publication Type] OR "news"[Publication 
Type] OR "newspaper article"[Publication Type] OR "patient education 
handout"[Publication Type] OR "popular works"[Publication Type] OR 
"congresses"[Publication Type] OR "consensus development 
conference"[Publication Type] OR "consensus development conference, 
nih"[Publication Type] OR "practice guideline"[Publication Type] OR "intervention 
studies"[MESH])) AND Humans [Mesh] AND child [Mesh] 
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Appendix 3: Overview of SVMC measurement-tools 
Please see next page for the results of the intial serach (please see Appendix 2 for 
the serach term) aimimng to find available SVMC measurement-tools for patients with 
UMN lesions.  
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Appendix 4: Study - German Version SCALE 
Please see next pages. 
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Appendix 5: Study 2 - English SCALE version (original) 
Please see next pages. 
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Appendix 6: Study 3 - Search terms for all databases 
Systematic Review evaluating psychometric studies of SVMC measures for the lower 
extremity in children with UMN lesions 
Pubmed 
((selective voluntary motor control[TIAB] OR selective movement*[TIAB] OR 
Selectivity[TIAB] OR voluntary movement*[TIAB] OR volitional movement*[TIAB] OR quality 
of movement*[TIAB] OR muscle activation[TIAB] OR muscular activation[TIAB] OR 
movement pattern*[TIAB] OR physiological movement*[TIAB] OR sensorimotor control[TW] 
OR foot targeting[TW] OR foot placing[TW] OR coordinated movement*[TIAB] OR motion 
compensation OR compensatory movement* OR muscular coactivation OR mirror 
movement* OR muscle synerg* OR muscular synerg* OR movement synerg* OR cortical 
overlap[TW] OR motor control[TW] OR joint coupling[TW] OR (interjoint OR inter-joint AND 
coordination) OR force modulation[TW] OR submaximal contraction*[TW] OR maximal 
voluntary contraction*[TW]) OR( cortical activation*[TW])  ) OR ( selective motor control test 
*[TIAB]) OR ( selective control assessment of the lower extremity [TIAB]) OR ( foot-tapping-
test[TIAB]  ) OR ( lower extremity motor score[TIAB]  ) OR ( gross motor performance 
measure[TIAB]  ) OR ( quality function measure ) OR ( fugl meyer assessment ) OR ( 
brunnstrom recovery stages*[TIAB]  ) OR ( stroke rehabilitation assessment of 
movement*[TIAB]  ) OR ( observation ) OR ( lower extremity motor score ) OR ( brain motor 
control assessment ) OR ( voluntary response INDEX ) OR  ( active range of motion*[TIAB]  
) OR ( active ankle movement*[TIAB]  ) OR ( electrogoniometer*[TIAB]  ) OR ( video*[TIAB]  
) OR ( electromyography*[TIAB]  ) OR ( dynamometer*[TIAB]  ) OR ( force transducer*[TIAB]  
) OR ( torque transducer*[TIAB]  ) OR ( relative phase ) OR ( target position*[TIAB]  ) OR ( 
target force*[TIAB]  ) OR ( target torque*[TIAB]  ) OR ( target trajectory*[TIAB]  ) OR ( 
visuomotor tracking ) OR ( tracking performance*[TIAB]  ) OR ( maximal voluntary 
contraction ) OR ( submaximal torque steadiness*[TIAB]  ) OR ( moment generation*[TIAB]  
) OR ( reaction time ) OR ( isometric muscle force ) OR ( integrated electromyography ) OR  
( muscle activation latenc**[TIAB]  ) OR ( latenc* time*[TIAB]  ) OR ( activation time*[TIAB]  ) 
OR ( on-off ratio*[TIAB]  ) OR ( activation ratio*[TIAB]  ) OR ( reaction time frequency 
analysis*[TIAB]  ) OR ( wavelet analysis*[TIAB]  ) OR ( instantaneous mean 
frequency*[TIAB]  ) OR ( principal component analysis*[TIAB]  ) OR  ( torque 
steadiness*[TIAB]  ) OR ( accuracy INDEX*[TIAB] ) OR ( tracking INDEX*[TIAB]  ) OR ( force 
INDEX*[TIAB]  ) OR ( motor evoked potentials*[TIAB]  ) OR ( transcranial stimulation*[TIAB]  
) OR ( fmri*[TIAB]  ) OR ( diffusion tensor imaging*[TIAB]  ) OR ( fractional anisotropy*[TIAB] 
)) OR ("Muscle, Skeletal"[MeSH] OR "Motor Skills Disorders"[Mesh] OR "Neuromuscular 
Manifestations"[Mesh] OR "Motor Activity"[Mesh] OR "Recovery of 
Function/physiology"[Mesh] OR "Gait Disorders, Neurologic"[Mesh])) AND (upper motor 
neuron lesion*[TW] OR "Cerebral Palsy"[Mesh] OR "Brain Injuries"[Mesh] ) OR ("central 
nervous system diseases") OR ("Gait Disorders, Neurologic") OR ("pyramidal tract*") OR 
("corticospinal tract*")  AND ((instrumentation[sh] OR methods[sh] OR Validation Studies[pt] 
OR Comparative Study[pt] OR "psychometrics"[MeSH] OR psychometr*[tiab] OR 
clinimetr*[tw] OR clinometr*[tw] OR "outcome assessment (health care)"[MeSH] OR outcome 
assessment[tiab] OR outcome measure*[tw] OR "observer variation"[MeSH] OR observer 
variation[tiab] OR "Health Status Indicators"[Mesh] OR "reproducibility of results"[MeSH] OR 
reproducib*[tiab] OR "discriminant analysis"[MeSH] OR reliab*[tiab] OR unreliab*[tiab] OR 
valid*[tiab] OR coefficient[tiab] OR homogeneity[tiab] OR homogeneous[tiab] OR "internal 
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consistency"[tiab] OR (cronbach*[tiab] AND (alpha[tiab] OR alphas[tiab])) OR (item[tiab] 
AND (correlation*[tiab] OR selection*[tiab] OR reduction*[tiab])) OR agreement[tiab] OR 
precision[tiab] OR imprecision[tiab] OR "precise values"[tiab] OR test-retest[tiab] OR 
(test[tiab] AND retest[tiab]) OR (reliab*[tiab] AND (test[tiab] OR retest[tiab])) OR stability[tiab] 
OR interrater[tiab] OR inter-rater[tiab] OR intrarater[tiab] OR intra-rater[tiab] OR 
intertester[tiab] OR inter-tester[tiab] OR intratester[tiab] OR intra-tester[tiab] OR 
interobserver[tiab] OR inter-observer[tiab] OR intraobserver[tiab] OR intra-observer[tiab] OR 
intertechnician[tiab] OR inter-technician[tiab] OR intratechnician[tiab] OR intra-
technician[tiab] OR interexaminer[tiab] OR inter-examiner[tiab] OR intraexaminer[tiab] OR 
intra-examiner[tiab] OR interassay[tiab] OR inter-assay[tiab] OR intraassay[tiab] OR intra-
assay[tiab] OR interindividual[tiab] OR inter-individual[tiab] OR intraindividual[tiab] OR intra-
individual[tiab] OR interparticipant[tiab] OR inter-participant[tiab] OR intraparticipant[tiab] OR 
intra-participant[tiab] OR kappa[tiab] OR kappa's[tiab] OR kappas[tiab] OR repeatab*[tiab] 
OR ((replicab*[tiab] OR repeated[tiab]) AND (measure[tiab] OR measures[tiab] OR 
findings[tiab] OR result[tiab] OR results[tiab] OR test[tiab] OR tests[tiab])) OR 
generaliza*[tiab] OR generalisa*[tiab] OR concordance[tiab] OR (intraclass[tiab] AND 
correlation*[tiab]) OR discriminative[tiab] OR "known group"[tiab] OR factor analysis[tiab] OR 
factor analyses[tiab] OR dimension*[tiab] OR subscale*[tiab] OR (multitrait[tiab] AND 
scaling[tiab] AND (analysis[tiab] OR analyses[tiab])) OR item discriminant[tiab] OR interscale 
correlation*[tiab] OR error[tiab] OR errors[tiab] OR "individual variability"[tiab] OR 
(variability[tiab] AND (analysis[tiab] OR values[tiab])) OR (uncertainty[tiab] AND 
(measurement[tiab] OR measuring[tiab])) OR "standard error of measurement"[tiab] OR 
sensitiv*[tiab] OR responsive*[tiab] OR ((minimal[tiab] OR minimally[tiab] OR clinical[tiab] OR 
clinically[tiab]) AND (important[tiab] OR significant[tiab] OR detectable[tiab]) AND 
(change[tiab] OR difference[tiab])) OR (small*[tiab] AND (real[tiab] OR detectable[tiab]) AND 
(change[tiab] OR difference[tiab])) OR meaningful change[tiab] OR "ceiling effect"[tiab] OR 
"floor effect"[tiab] OR "Item response model"[tiab] OR IRT[tiab] OR Rasch[tiab] OR 
"Differential item functioning"[tiab] OR DIF[tiab] OR "computer adaptive testing"[tiab] OR 
"item bank"[tiab] OR "cross-cultural equivalence"[tiab])))) AND Humans[Mesh])) NOT 
("Randomized Controlled Trial"[Publication Type] OR "Controlled Clinical Trial"[Publication 
Type] OR "addresses"[Publication Type] OR "biography"[Publication Type] OR "case 
reports"[Publication Type] OR "comment"[Publication Type] OR "directory"[Publication Type] 
OR "editorial"[Publication Type] OR "festschrift"[Publication Type] OR "interview"[Publication 
Type] OR "lectures"[Publication Type] OR "legal cases"[Publication Type] OR 
"legislation"[Publication Type] OR "letter"[Publication Type] OR "news"[Publication Type] OR 
"newspaper article"[Publication Type] OR "patient education handout"[Publication Type] OR 
"popular works"[Publication Type] OR "congresses"[Publication Type] OR "consensus 
development conference"[Publication Type] OR "consensus development conference, 
nih"[Publication Type] OR "practice guideline"[Publication Type] OR "intervention 
studies"[MESH])) AND Humans [Mesh] AND child [Mesh]  
Ebscohost: CINAHL and PsycINFO 
selective voluntary motor control OR selective movement* OR selectivity OR selective 
motorOR selective motor control  OR  voluntary movement* OR volitional movement* OR 
violate movement* OR quality of movement* OR muscle activation OR muscular activation 
OR movement pattern* OR physiological movement* OR sensorimotor control OR foot 
targeting OR foot placing OR coordinated movement* OR motion compensation OR 
compensatory movement* OR muscular co-activation OR co-contraction OR mirror 
movement*OR muscle synerg* OR muscularsynerg* OR movement synerg* OR synerg* OR 
 226 
muscle activation pattern OR cortical overlap OR motor control OR joint coupling OR (inter 
joint OR inter-joint AND coordination) OR force modulation OR submaximal contraction* OR 
maximal voluntary contraction*OR cortical activation OR selective motor control test OR 
selective control assessment of the lower extremity OR foot-tapping-test OR lower extremity 
motor score OR gross motor performance measure OR quality function measure OR 
fuglmeyer assessment OR brunnstrom recovery stages OR stroke rehabilitation assessment 
of movement OR observation OR lower extremity motor score OR brain motor control 
assessment OR voluntary response index OR active range of motion OR active ankle 
movement OR electrogoniometer OR video OR electromyography OR dynamometer OR 
force transducer OR torque transducer OR relative phase OR target position OR target force 
OR target torque OR target trajectory OR visuomotor tracking OR tracking performance OR 
maximal voluntary contraction OR submaximal torque steadiness OR moment generation 
OR reaction time OR isometric muscle force OR integrated electromyographyOR muscle 
activation latenc* OR latenc* time OR activation time OR on-off ratio OR activation ratio OR 
reaction time frequency analysis OR wavelet analysis OR instantaneous mean frequency 
OR principal component analysis OR torque steadiness OR accuracy index OR tracking 
index OR force index OR motor evoked potentials OR transcranial stimulation OR fMRI OR 
diffusion tensor imaging OR fractional anisotropy AND(upper motor neuron lesion*)  OR 
("Cerebral Palsy") OR ( "Brain Injuries") OR ("central nervous system diseases") OR ("Gait 
Disorders, Neurologic") OR ("pyramidal tract*") OR ("corticospinal tract*") AND ((MH 
“Research Measurement+”) OR (MH “Outcomes Research”) OR instrumentation* OR 
methods OR validation stud* OR comparative stud* OR psychometr* OR clinimetr* OR 
clinometr* OR (MH "Outcomes (Health Care)+") OR (MH "Treatment Outcomes+") OR (MH 
“outcome assessment”) OR outcome assessment OR outcome measure* OR observer 
variation OR (MH “Health Status Indicators”) OR (MH “reproducibility of results”) OR 
reproducib* OR (MH “discriminant analysis”) OR reliab* OR unreliab* OR valid* OR 
coefficient OR homogeneity OR homogeneous OR “internal consistency” OR (cronbach* 
AND (alpha OR alphas)) OR (item AND (correlation* OR selection* OR reduction*)) OR 
agreement OR precision OR imprecision OR “precise values” OR test-retest OR (test AND 
retest) OR (reliab* AND (test OR retest)) OR stability OR interrater OR inter-rater OR 
intrarater OR intra-rater OR intertester OR inter-tester OR intratester OR intra-tester OR 
interobserver OR inter-observer OR intraobserver OR intra-observer OR intertechnician OR 
inter-technician OR intratechnician OR intra-technician OR interexaminer OR inter-examiner 
OR intraexaminer OR intra-examiner OR interassay OR inter-assay OR intraassay OR intra-
assay OR interindividual OR inter-individual OR intraindividual OR intra-individual OR 
interparticipant OR inter-participant OR intraparticipant OR intra-participant OR kappa OR 
kappa’s OR kappas OR repeatab* OR ((replicab* OR repeated) AND (measure OR 
measures OR findings OR result OR results OR test OR tests)) OR generaliza* OR 
generalisa* OR concordance OR (intraclass AND correlation*) OR discriminative OR “known 
group” OR factor analysis OR factor analyses OR dimension* OR subscale* OR (multitrait 
AND scaling AND (analysis OR analyses)) OR item discriminant OR interscale correlation* 
OR error OR errors OR “individual variability” OR (variability AND (analysis OR values)) OR 
(uncertainty AND (measurement OR measuring)) OR “standard error of measurement” OR 
sensitiv* OR responsive* OR ((minimal OR minimally OR clinical OR clinically) AND 
(important OR significant OR detectable) AND (change OR difference)) OR (small* AND 
(real OR detectable) AND (change OR difference)) OR meaningful change OR “ceiling 
effect” OR “floor effect” OR “Item response model” OR IRT OR Rasch OR “Differential item 
functioning” OR DIF OR “computer adaptive testing” OR “item bank” OR “cross-cultural 
equivalence”)  
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EMBASE 
(selective voluntary motor control) OR (selective movement*) OR (selectivity) OR (voluntary 
movement*) OR (volitional movement*) OR (violate movement*) OR (quality of movement*) 
OR (muscle activation) OR (muscular activation) OR (movement pattern*) OR (physiological 
movement*) OR (sensorimotor control) OR (foot targeting) OR (foot placing) OR 
(coordinated movement*) OR (motion compensation) OR (compensatory movement*) OR 
(muscular co-activation) OR (co-contraction) OR (mirror movement*) OR (muscle synerg*) 
OR (muscular synerg*) OR (movement synerg*) OR (synerg*) OR (muscle activation 
pattern) OR (cortical overlap) OR (motor control) OR (joint coupling) OR (inter joint OR inter-
joint AND coordination) OR (force modulation) OR (submaximal contraction*) OR (maximal 
voluntary contraction*) OR (cortical activation) OR (selective motor) OR (selective motor 
control test) OR (selective control assessment of the lower extremity) OR (foot-tapping-test) 
OR (lower extremity motor score) OR (gross motor performance measure) OR (quality 
function measure) OR (fuglmeyer assessment) OR (brunnstrom recovery stages) OR (stroke 
rehabilitation assessment of movement) OR (observation) OR (lower extremity motor score) 
OR (brain motor control assessment) OR (voluntary response index) OR (active range of 
motion) OR (active ankle movement) OR (electrogoniometer) OR (video) OR 
(electromyography) OR (dynamometer) OR (force transducer) OR (torque transducer) OR 
(relative phase) OR (target position) OR (target force) OR (target torque) OR (target 
trajectory) OR (visuomotor tracking) OR (tracking performance) OR (maximal voluntary 
contraction) OR (submaximal torque steadiness) OR (moment generation) OR (reaction 
time) OR (isometric muscle force) OR (integrated electromyography) OR (muscle activation 
latenc*) OR (latenc* time) OR (activation time) OR (on-off ratio) OR (activation ratio) OR 
(reaction time frequency analysis) OR (wavelet analysis) OR (instantaneous mean 
frequency) OR (principal component analysis) OR (torque steadiness OR accuracy index) 
OR (tracking index) OR (force index OR motor evoked potentials) OR (transcranial 
stimulation) OR (fMRI) OR (diffusion tensor imaging OR fractional anisotropy) AND (upper 
motor neuron lesion*) OR (cerebral palsy) OR (brain injuries) OR (stroke) OR (spinal cord 
injuries) OR (central nervous system diseases) OR (gait disorders) OR (pyramidal tract*) 
AND ('validation study'/exp OR psychometr* OR clinimetr* OR ‘outcome assessment’/exp 
OR outcome assessment*:ab,ti OR 'comparative study'/de OR outcome measure* OR 
'observer variation'/exp OR 'observer variation':ab,ti OR 'reproducibility'/exp OR 
reproducib*:ab,ti OR 'discriminant analysis'/de OR reliab*:ab,ti OR unreliab*:ab,ti OR 
valid*:ab,ti OR coefficient:ab,ti OR homogeneity:ab,ti OR homogeneous:ab,ti OR ‘internal 
consistency’:ab,ti OR (cronbach*:ab,ti AND (alpha:ab,ti OR alphas:ab,ti)) OR (item:ab,ti AND 
(correlation*:ab,ti OR selection*:ab,ti OR reduction*:ab,ti)) OR agreement:ab,ti OR 
precision:ab,ti OR imprecision:ab,ti OR ‘precise values’:ab,ti OR test-retest:ab,ti OR 
(test:ab,ti AND retest:ab,ti) OR (reliab*:ab,ti AND (test:ab,ti OR retest:ab,ti)) OR stability:ab,ti 
OR interrater:ab,ti OR inter-rater:ab,ti OR intrarater:ab,ti OR intra-rater:ab,ti OR 
intertester:ab,ti OR inter-tester:ab,ti OR intratester:ab,ti OR intra-tester:ab,ti OR 
interobserver:ab,ti OR inter-observer:ab,ti OR intraobserver:ab,ti OR intra-observer:ab,ti OR 
intertechnician:ab,ti OR inter-technician:ab,ti OR intratechnician:ab,ti OR intra-
technician:ab,ti OR interexaminer:ab,ti OR inter-examiner:ab,ti OR intraexaminer:ab,ti OR 
intra-examiner:ab,ti OR interassay:ab,ti OR inter-assay:ab,ti OR intraassay:ab,ti OR intra-
assay:ab,ti OR interindividual:ab,ti OR inter-individual:ab,ti OR intraindividual:ab,ti OR intra-
individual:ab,ti OR interparticipant:ab,ti OR inter-participant:ab,ti OR intraparticipant:ab,ti OR 
intra-participant:ab,ti OR kappa:ab,ti OR kappa*:ab,ti OR kappas:ab,ti OR repeatab*:ab,ti 
OR ((replicab*:ab,ti OR repeated:ab,ti) AND (measure:ab,ti OR measures:ab,ti OR 
findings:ab,ti OR result:ab,ti OR results:ab,ti OR test:ab,ti OR tests:ab,ti)) OR 
generaliza*:ab,ti OR generalisa*:ab,ti OR concordance:ab,ti OR (intraclass:ab,ti AND 
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correlation*:ab,ti) OR discriminative:ab,ti OR ‘known group’:ab,ti OR factor analysis:ab,ti OR 
factor analyses:ab,ti OR dimension*:ab,ti OR subscale*:ab,ti OR (multitrait:ab,ti AND 
scaling:ab,ti AND (analysis:ab,ti OR analyses:ab,ti)) OR item discriminant:ab,ti OR interscale 
correlation*:ab,ti OR error:ab,ti OR errors:ab,ti OR ‘individual variability’:ab,ti OR 
(variability:ab,ti AND (analysis:ab,ti OR values:ab,ti)) OR (uncertainty:ab,ti AND 
(measurement:ab,ti OR measuring:ab,ti)) OR ‘standard error of measurement’:ab,ti OR 
sensitiv*:ab,ti OR responsive*:ab,ti OR ((minimal:ab,ti OR minimally:ab,ti OR clinical:ab,ti OR 
clinically:ab,ti) AND (important:ab,ti OR significant:ab,ti OR detectable:ab,ti) AND 
(change:ab,ti OR difference:ab,ti)) OR (small*:ab,ti AND (real:ab,ti OR detectable:ab,ti) AND 
(change:ab,ti OR difference:ab,ti)) OR meaningful change:ab,ti OR ‘ceiling effect’:ab,ti OR 
‘floor effect’:ab,ti OR ‘Item response model’:ab,ti OR IRT:ab,ti OR Rasch:ab,ti OR 
‘Differential item functioning’:ab,ti OR DIF:ab,ti OR ‘computer adaptive testing’:ab,ti OR ’item 
bank’:ab,ti OR ‘cross-cultural equivalence’:ab,ti) 
SCOPUS  
TITLE-ABS-KEY((selective voluntary motor control ) OR ( selective movement* ) OR ( 
selectivity ) OR ( selective motor ) OR             ( selective motor control ) OR ( voluntary 
movement* ) OR ( volitional movement* ) OR ( violate movement* ) OR ( quality of 
movement ) OR ( muscle activation ) OR ( muscular activation ) OR ( movement pattern* ) 
OR ( physiological movement* ) OR  ( sensorimotor control ) OR ( foot targeting ) OR ( foot 
placing ) OR ( coordinated movement* ) OR ( motion compensation ) OR ( compensatory 
movement* ) OR ( muscular co-activation ) OR ( co-contraction ) OR ( mirror movement* ) 
OR ( muscle synerg* ) OR ( muscular synerg* ) OR ( movement synerg* ) OR ( synerg* ) OR 
( muscle activation pattern ) OR ( cortical overlap ) OR  ( motor control ) OR ( joint coupling ) 
OR ( inter joint OR inter-joint AND coordination ) OR ( force modulation ) OR ( submaximal 
contraction* ) OR ( maximal voluntary contraction* ) OR ( cortical activation ) OR ( selective 
motor control test ) OR ( selective control assessment of the lower extremity ) OR ( foot-
tapping-test ) OR ( lower extremity motor score ) OR ( gross motor performance measure ) 
OR ( quality function measure ) OR ( fugl meyer assessment ) OR ( brunnstrom recovery 
stages ) OR    ( stroke rehabilitation assessment of movement ) OR ( observation ) OR ( 
lower extremity motor score ) OR ( brain motor control assessment ) OR ( voluntary 
response INDEX ) OR ( active range of motion ) OR ( active ankle movement ) OR ( 
electrogoniometer ) OR ( video ) OR ( electromyography ) OR ( dynamometer ) OR ( force 
transducer ) OR ( torque transducer ) OR ( relative phase ) OR ( target position ) OR ( target 
force ) OR ( target torque ) OR ( target trajectory ) OR ( visuomotor tracking ) OR ( tracking 
performance ) OR ( maximal voluntary contraction ) OR ( submaximal torque steadiness ) 
OR ( moment generation ) OR ( reaction time ) OR ( isometric muscle force ) OR ( integrated 
electromyography ) OR ( muscle activation latenc* ) OR ( latenc* time ) OR ( activation time ) 
OR ( on-off ratio ) OR ( activation ratio ) OR ( reaction time frequency analysis ) OR ( 
wavelet analysis ) OR ( instantaneous mean frequency ) OR ( principal component analysis ) 
OR ( torque steadiness ) OR ( accuracy INDEX ) OR ( tracking INDEX ) OR ( force INDEX ) 
OR ( motor evoked potentials ) OR ( transcranial stimulation ) OR ( fmri ) OR ( diffusion 
tensor imaging ) OR ( fractional anisotropy )) AND TITLE-ABS-KEY((upper motor neuron 
lesion* ) OR ( cerebral palsy ) OR ( brain injuries ) OR ( pyramidal tract* ) OR ( corticospinal 
tract* )) AND NOT (stroke) OR (adult*) AND ((MH "Research Measurement+") OR (MH 
"Outcomes Research") OR instrumentation* OR methods OR validation stud* OR 
comparative stud* OR psychometr* OR clinimetr* OR clinometr* OR (MH "Outcomes (Health 
Care)+") OR (MH "Treatment Outcomes+") OR (MH "outcome assessment") OR outcome 
assessment OR outcome measure* OR observer variation OR (MH "Health Status 
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Indicators") OR (MH "reproducibility of results") OR reproducib* OR (MH "discriminant 
analysis") OR reliab* OR unreliab* OR valid* OR coefficient OR homogeneity OR 
homogeneous OR "internal consistency" OR (cronbach* AND (alpha OR alphas)) OR (item 
AND (correlation* OR selection* OR reduction*)) OR agreement OR precision OR 
imprecision OR "precise values" OR test-retest OR (test AND retest) OR (reliab* AND (test 
OR retest)) OR stability OR interrater OR inter-rater OR intrarater OR intra-rater OR 
intertester OR inter-tester OR intratester OR intra-tester OR interobserver OR inter-observer 
OR intraobserver OR intra-observer OR intertechnician OR inter-technician OR 
intratechnician OR intra-technician OR interexaminer OR inter-examiner OR intraexaminer 
OR intra-examiner OR interassay OR inter-assay OR intraassay OR intra-assay OR 
interindividual OR inter-individual OR intraindividual OR intra-individual OR interparticipant 
OR inter-participant OR intraparticipant OR intra-participant OR kappa OR kappa's OR 
kappas OR repeatab* OR ((replicab* OR repeated) AND TITLE-ABS-KEY((measure OR 
measures OR findings OR result OR results OR test OR tests)) OR generaliza* OR 
generalisa* OR concordance OR (intraclass AND correlation*) OR discriminative OR "known 
group" OR factor analysis OR factor analyses OR dimension* OR subscale* OR (multitrait 
AND scaling AND (analysis OR analyses)) OR item discriminant OR interscale correlation* 
OR error OR errors OR "individual variability" OR (variability AND (analysis OR values)) OR 
(uncertainty AND (measurement OR measuring)) OR "standard error of measurement" OR 
sensitiv* OR responsive* OR ((minimal OR minimally OR clinical OR clinically) AND 
(important OR significant OR detectable) AND (change OR difference)) OR (small* AND 
(real OR detectable) AND (change OR difference)) OR meaningful change OR "ceiling 
effect" OR "floor effect" OR "Item response model" OR IRT OR Rasch OR "Differential item 
functioning" OR DIF OR "computer adaptive testing" OR "item bank" OR "cross-cultural 
equivalence")) AND ( LIMIT-TO(PUBYEAR,2017) OR LIMIT-TO(PUBYEAR,2016) OR 
LIMIT-TO(PUBYEAR,2015) ) AND ( EXCLUDE(SUBJAREA,"AGRI" ) OR 
EXCLUDE(SUBJAREA,"BIOC" ) OR EXCLUDE(SUBJAREA,"BUSI" ) OR 
EXCLUDE(SUBJAREA,"CENG" ) ) AND ( EXCLUDE(SUBJAREA,"CHEM" ) OR 
EXCLUDE(SUBJAREA,"DECI" ) OR EXCLUDE(SUBJAREA,"DENT" ) ) AND ( 
EXCLUDE(SUBJAREA,"COMP" ) OR EXCLUDE(SUBJAREA,"EART" ) OR 
EXCLUDE(SUBJAREA,"ECON" ) OR EXCLUDE(SUBJAREA,"ENER" ) ) AND ( 
EXCLUDE(SUBJAREA,"PSYC" ) OR EXCLUDE(SUBJAREA,"PHAR" ) OR 
EXCLUDE(SUBJAREA,"IMMU" ) ) AND ( LIMIT-TO(LANGUAGE,"English" ) ) AND              ( 
EXCLUDE(EXACTKEYWORD,"Adult" ) OR EXCLUDE(EXACTKEYWORD,"Nonhuman" ) ) 
Cochrane Search Term  
("selectivity" OR "selective motor control" OR "motor control" OR "torque" OR "muscle 
activity" OR "muscle activation") AND (“lower extremity” OR “leg”) AND ("cerebral palsy” OR 
“acquired brain” OR ”upper motor neuron lesion”) 
PEDRO  
selective motor control  
motor control AND cerebral palsy 
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Appendix 7: Study 3 - established specified COSMIN rating rules 
Item specified COSMIN rule 
For all Boxes  
Item 01 ‘Was the percentage 
missing items described?’ 
Item 02 ‘Was described how 
missing items were handled?’ 
As SVMC instruments are either assessments or 
laboratory-based tools, and not questionnaires, item 
01 and 02 are not relevant, therefore these items 
should be scored as ‘NA’.   
Nevertheless, completeness of the data reported in the 
paper should be checked and if any unexplained 
missing data are detected, this should be scored under 
the item ‘methodological flaws’. 
Item 03 ‘Sample size 
adequate?’ 
Omitting item 03 for the overall COSMIN box scores 
Item ‘Were there any important 
flaws in the design or methods 
of the study?’ 
- Unexplained missing data is detected  
- Sample characteristics of the comparator group 
(normally developed children) is missing/lacking   
BoxB Reliability  
BoxB07 ‘Were patients 
stable…?’ 
BoxB08 ‘Was the time interval 
appropriate?’ 
BoxB09 ‘Were the test 
conditions similar?’ 
If more than one type of reliability is scored in one 
paper (i.e. inter-rater and test-retest reliability) Box B is 
filled out for each type of reliability separately (as the 
items 07-09 will be scored differently).  
BoxB04 ‘Were at least two 
measurements available?’ 
BoxB05 ‘Were the 
administrations independent?’ 
For inter-rater reliability testing of SVMC clinical 
assessments (i.e SCALE; Trost, SMC) parallel 
observation is possible, or rating via video scoring (as 
these assessments evaluate SVMC via observation of 
the movement quality). The scoring of the two 
administrations should be independent.  
BoxB07 ‘Were patients 
stable…?’ 
SVMC stable patient = no interventions aimed at 
improving motor control, no changes in medications 
(which might have an influence on motor control) 
between the two test administrations 
BoxB08 ‘Was the time interval 
appropriated?’ 
 
Appropriate time interval for SVMC testing for: 
- Interrater Reliability: for SVMC clinical assessments 
(i.e SCALE; Trost, SMC) parallel observation possible, 
or rating via video scoring) (as theses assessments 
evaluate SVMC via observation of the movement 
quality)  
- Test-retest Reliability: 1 day until 8 weeks (as SVMC 
is thought to be a stable impairment, as long as the 
patient’s condition is stable) 
- Intrarater Reliability: ≤2 weeks (to make sure, that the 
rater is not aware of their scores on the first 
administration) 
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BoxF Hypotheses Testing  
BoxF04 ‘Hypotheses formulated 
are priori?’ 
BoxF05 ‘Expected direction of 
correlation stated?’ 
BoxF06 ‘Expected magnitude of 
correlation stated?’ 
If the paper stated no explicit hypotheses (i.e. cohort 
studies) only the aim/purpose of the study), item 
boxF04 should be rated as ‘Unclear what was 
expected’ or ‘Hypotheses vague or not formulated but 
possible to deduce what was expected’ and not as 
‘NA’ as for construct validity a hypothesis is needed. 
Consecutive for boxF05 and 06 
‘Expected direction/magnitude of the correlations or 
differences NOT stated’ should be scored. 
BoxF07 ‘Convergent validity 
adequate description of 
comparator’ 
BoxF08 ‘Convergent validity: 
measurements properties 
adequately described in the 
population of interest?’ 
In the cohort studies included in the review, validity of 
the used SVMC instrument was established by 
comparing SVMC of CP and normally developed 
children. Therefore, no comparator measurement was 
used, in this cases items boxF07 boxF08 should be 
scored as ‘NA’. If the sample characteristics of the 
‘comparator group’ (normally developed children) are 
missing or incomplete this should be scored under 
item boxF09 ‘methodological flaws’ 
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Appendix 8: Study 3 - Quality Criteria for Measurement Properties 
Property Rating Quality criteria 
Content validity  
(BoxD) 
+ 
A clear description is provided of the measurement 
aim, the target population, the concepts that are being 
measured, and the item selection AND target 
population and (investigators OR experts) were 
involved in item selection 
? 
A clear description of above-mentioned aspects is 
lacking OR only target population involved OR 
doubtful design or method 
- No target population involvement 
Criterion validity  
(Box H) 
+ 
Convincing arguments that gold standard is ‘‘gold’’ 
AND correlation with gold standard >0.70 
? 
No convincing arguments that gold standard is ‘‘gold’’ 
OR doubtful design or method 
- 
Correlation with gold standard <0.70, despite 
adequate design and method 
Construct validity 
(BoxF) + 
Specific hypotheses were formulated AND at least 
75% of the results are in accordance with these 
hypotheses 
? Doubtful design or method (e.g., no hypotheses) 
- 
Less than 75% of hypotheses were confirmed, despite 
adequate design and methods 
Reliability 
(BoxB) 
+ ICC or weighted Kappa>0.70; 
? 
Doubtful design or method (e.g., time interval not 
mentioned) 
- 
ICC or weighted Kappa <0.70, despite adequate 
design and method 
Responsiveness  
(BoxI) 
+ 
Correlation with an instrument measuring the same 
construct >0.50; 
OR at least 75% of the results are in accordance with 
the hypotheses 
OR AUC>0.70 AND correlations with related construct 
is higher than with unrelated constructs  
 
? 
Solely correlation determined with unrelated 
constructs 
 
- 
Correlation an instrument measuring the same 
construct <0.50; 
OR <75% of the results are in accordance with the 
hypotheses; 
OR AUC<0.70 AND correlations with related construct 
is higher than with unrelated constructs 
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Appendix 9: Study 3 - Evidence Level of Measurement Properties 
Levels of Evidence for the Overall Quality of the Measurement Properties (Based on 
the Cochrane Back Review Group, Van Tulder et al. 2003)30 
Level Rating Criteria 
Strong +++ or --- 
Consistent findings in multiple studies of good 
methodological quality 
 
OR in one study of excellent methodological quality 
 
Moderate ++ or -- 
Consistent findings in multiple studies of fair 
methodological quality OR in one study of good 
methodological quality 
 
OR in one study of good methodological quality 
 
Limited + or - One study of fair methodological quality 
Conflicting ± Conflicting findings 
Unknown ? Only studies of poor methodological quality 
+= positive results; ?=indeterminate results; -=negative results.  
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Appendix 10: Publication study 1 
Please see next pages. 
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Appendix 11: Publication study 2 
Please see next page. 
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Appendix 12: Publication study 2 
Please see next page. 
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